Pathogenesis of liver injury : virus-induced autoantibody response against asialoglycoprotein receptor in woodchuck (Marmota Monax) viral hepatitis by Diao, Jingyu




PATHOG!':N!':SIS OF LIVER IN.llIll\":
VIR lIS-INDlIC!':DAli TO ANTl IlOI)" RESPONSE ,\(;AINST
ASIALOGLYCOPROT EIN RECEPTOR IN WOOIl CII\ ICII:
(Ma rmota Mill/ ax) VIRAL HEPATITI S
h)'
e Jingyu Diao
A thesis submitted 10 the School of Graduate Studies
in partial fulfillment oltbc requirements for
the degree of'Mastcr ofScience
Faculty or Medicine
Memorial University of Newfoundland
May 1996
Stjohn's Newfoundland
.+. Nalional1j braryofCanada BibhothequeM lionaledu Canada
DirecliOndesacquisiUons et
desservicesbibliographlques
3'».I\IO Wel~
011.... 11(CW",IO )
K1AQt.M
The author has granted an
irrevocable non-exctuslve licence
allowing the National Library of
Canada to reproduce, loan,
distr ibut e or sell copies of
his/her thesis by any means and
in any form or format , making
thi s thes is available to interested
persons.
The author ratalns ownership of
the copyright in his/her thesis.
Neither the thesis nor substantial
extracts from it may be printed or
otherwise reproduced without
his/her permission.
L'auteur a accerde une licence
Irrevocable et non exclusive
permettant a la Blbllotheque
natlonale du Canada de
reproduire, prefer, distribuer au
vendre des copies de sa these
de quelque manlere et sous
quelque forme que ce soit pour
mettre des exemplaires de celie
these a la disposition des
personnes lntereeeees.
L'auteur conserve la propriete du
droit d'auteur qui protege sa
these. Ni la these ni des extraits
substantials de celte-ci ne
doivent etre imprimes ou
aulremenl reproduits sans son
aulorisation.
ISBN 0-612-175B6-3
Canada
ABS'rRA C'r
The purposeof thisresearchwasto recognize the induction and pathngl'lIic potential
ofsu toantibcdics against a liver-specificnsialcglyeoprotciu receptor (ASGI'R) in tlll' course
of hepadnavirus infection. Three sections of research work by uslnga woodchuck llilluel of
hepatitis B as an experimentul systemarc presented in this thesis
First,woodchuck hepatic ASGPR(wASGPR)\\' ,IS purified ami itspolYPl'lllide subunit
composition, ligand binding properties and antigenicity wen: clmructcrizcd. The isolated
receptor is a hetero-oligomcriccomplexconstitutedofrwo subunitswith molecular masses
of 40- and 47-kDa. Antisera were generated in guinea pigsby challenge with the allinity-
purified, bioactivewASGPRand rabbit ASOI'R(rASGPR) prcpurutious and in woodchucks
by immunization withpurifiedrASGPR. With the help ofrhcsc antisera, a stnHI!:amigcnic
cross-reactivity of the wASGPR polypeptideswith the ASGl'Rs trout other species was
demonstrated. Further, usingantisera raised ngainst isolated rASGPR polypeptides, thc
distinct antigenic specificity of each of the wASGI'R subunits was revealed. Surface
expression of wASGPR on the woodchuck hcputocyrus was dcmonstrutod by
immunofluorescent stainingof theisolatedcells. Detailed analyses of the purlflcdwoodchuck
hepatic plasmamembranes (HPMs) showedthat both subunits of wASGPR werepresent in
the HPM preparations, although the membrane-bound47·kDa subunit was idenufiableonly
after exposure of HPMs to the ligand of the ASGPR.
Second. the induction,dynamic paucrns andspecificity or ,llltoantihodie$to hepatic
wASGPR were studied in animalswith experimentalwoodchuck hepatitis virus (WilY)
infection. Results showed thatWHY lnrccrlc»induced anti·ASOI'R auronruibodics or led to
the rise in their levels in almostall animals experimentally infected with Wi lY (12 or 13)
Thisdemonstrated that the inductionof this hcputocytc-specillc autcrunctivitywas a common
consequence ofW HV infection The relationship between anti·ASG PR reactivity existing
prior to WI-IV inoculation and the outco me of experimental WHY hepatitis was also
investigated. The results revealed that the occurrence of chronic hepatitis was significantly
greater in the grou p of aniiliaIs with pre-existing anti-ASGPR autoan tibodies (54.6%) than
that among woodchucks without autcnmib odics in preinoculatio n sera (15.6%; P < 0.05),
sugges ting that the outcome of WI-IV infection might be intluenced by the status of anti-
ASGPR autoreactlvity. wester n blot analyses showed tha t wuv-indcced ant i-ASGPR
autoantibodies recognizedboth4 0- and 47-kDa subunitsofwASGPR lind rASG PR, implying
that both recepto r polypeptides may serve as targets for the pathogenic immune reactio ns
Furthermore, no antigenic cross-reactivity between wASGPR and WHY antigens could be
identified by using antibodies against ASGJ'R or WI lYenvelope. suggesting that mechanisms
other than viral protein mimicry could be involved in the induction of nnti-ASGPR
autoantibody in the course ofWHV infection.
Th ird. in vitro investigations of the pathogenic effects or the WHV-i nduced anti-
ASGPR autoantibodies showed that these antibodies had the ability 10 inhibit specific ligand
binding to the hepatocyte sur face ASG I'R. Also. 19 fractions from the same ami-ASGPR
reactive sera were hcpntocytc tc xic in the presence of active complement. T hese findings
indicate that virus-induced autoa ntibodies agains t hepatic ASGPR have the pote ntial to
directly contribute 10 liver injury and to the distortion o f the hepatocyte clearance of
asialoglycoproteins in viral hepatitis. Further careful studies are required to determine the
significance ofnnli·ASGPR nutoimnnmhy in the pathogene sis of'Jivcr injury in viral hepatitis.
T he woodchuc k model of virus-induced ASGPR-specilic autoimmun ity could play an
important role in these investigations.
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GENERAL BACKGIlOUNIl
Viruses areknown as the smallest microorganismsof alllite forms. 'these microbes
have to enter into host cellsto propagate. The life cycle of'nviruscan besimply divided into
three steps: att achment and entry into host cell, primaryreplication, and spread within the
host. Eachstep ofthe viral life cyclecan be harmful. sometimes lethal to the host, since the
normal biologic al activitics oflhc host arc interrupted by the invader. O n the ot her hand. ho st
cells and host defence systems have developed pro tective barriers againstviruses, such 8;.
physical barrie rs, non- specific natural nnd spec ific responses (Abbas ct al., 1( 9 1)
Interactions b et ween ho st end virus arc not comp let ely unde rstood; however, it is widely
acceptedthatbo jhvirusand hostdefense responses are frequentlyinvolved in the process of
viraldiseases (Fields at al., 1990 ). Thestudies on the pathogenesisofbuman viral inlct ion
are usually ca rriedout using cell or tissue cultures, as well as appropriateanimalmodels.
Clinical observat ions and analysis of hUIIIl\n specimens(c.g., blood samples lIml tissu es
obtained by au topsy or biopsy) are alsocommonly used (Fields ct nl., 1996)
The fu nctions and morphology of liver can be affected directly or indirectly by
infectionswith bothhepatotropicand non-hcpmorroplc viruses (Robinson, 19( 0), In humans,
viral hepatitis is a disease with diffuseintralobular andportal inflammation which can be
induced by infections with primaryhcpato rroplc viruses, such ashepatitis A virus ( I IAV ),
hepati tis B (H BV), hepatitis C virus (I ICV), hepatitis 0 virus (l IDV), hepmirisE virus
(HEV), andthe most recently discovered hepatitis G viruse.
DNA v irusesthat eshibit prominentliver tropismwith a tendencytowards chronic
infection have been referred10 as the hcpndnnviruscs (Fields ct al.,1990.1. I tuman hepatitis
B virus (HBY) is a ncncytopathic DNA virus which is a prototype onhc hcpadnavlrus family
(Hapad}/{/l'iridae) (Fields et al., 19( 0) Imv infection anti lHlv-induccd diseasesarc o ne
of'theleading public hcahhproblems. About300 million peopleworldwide are developing
chronic HBV infection, It is estimated that half of the chroniccarrierswill develop liver
cirrhosisor hepatocellular carcinoma (I ICC)(Robinson,1994;Sherlocket el.,1970). The
pathogenic mechanismsof I-mV infection are not well recognized (Chisari and Ferrari,
1995a),althoughresearchin this areahasbeen carriedout lOT nearly 30years. One of tile
major obstacles to the studyof this subjectis the lack of propagation systems, suc h as
efficientcell lines or appropriateanimals, forI-IBV infectioninvitro or ill vivo (Chisariand
Ferrari, 1995a) .
Woodchuckhcpmitis virus(WI-IV) isanother memberof the family Hepoduavirtdoe,
Thisvirus showsstrongmolecularandbiological analogies with I-IOV (Summers era!., 1978;
Galibcrt et al., 1982;FcitclscnOfaI., ICJS4). Because oftbcsc similarities, experimental
infection of woodchuckwithWIIVrepresents an important natural model for thestudy of
HOV-induced diseases (Snyder ct aI., 1982; Korba ct aI., 1989). In thefollowing sections,
anoverview ofour currentunderstanding olthe generalbiological featuresof bepadnaviruses
(especially HI3V) and thepathogenesis of'hcpadnnviral infectionwillbe presented and a
generalresearchproposallor this thesiswillbe given.
A.llcIHltl n:wirusF':lJuily.
There areseven well-documented hcpetotroplcDNA viruseswhichbelongto the
Family Hepadnaviridac. These virusesare: HBV, WHY,groundsquirel hepatitisvirus
(GSHV), tree squirel hepatitis virus(TSHV),arctic squirrel hepatitis virus(ASHV), duck
hepatitis Il virus(DHlW) and heron hepatitis B virus(HI-IBV). Other candidatemembers
of this r.,mily maybe kangaroohepatitis virus(KHV) andstink snakehepatitis virus(SSHV)
Generally, these viruses Can be divided into two subgroups, mammalian and avian
hcpadnaviruscsf f' iclds ctal., 1990,1996)
Scientisis beganto study thevirusesin the bcpadnavirus familyin the 1960s when
Slumber et al. (1965) discovered lIBV envelope panicles in Ihe serum or an aboriginal
Australian. Toda y, HBY is known as aprincipaletiologicagent causing varied clinicalforms
of infectious hepatitis. such as acute hepatitis. Iitltuin<lnt hepatitis and chronic hcpmitis.
Infection with HBVinadults isusuullyasymptomnric nnd self-limited. However. about 10%
of HBV-infected adults and up to 90% of childreninfected with IIIIV during the neonata l
perioddevelop persistentinfection (Beasley ct :11. , 198 I; StC\'CllS ctnl.• 1(75) These people
win have an incre asedrisk ofdevelopingliver cirrho sis andl ice (Robison, 1994; Sherlock
etal., 1970). No effective treatment isavailable to te rminate the established IIUV inli..ctlon,
although vaccines havebeenproduced 10 preventunvintcct jonittvirus-naive individuals
(ChisariandFerrai, 1995a; Hollinger, 198711). Other viruses in the hcpaduavirusfamilywere
described more recently. WIN was firstfoundin ussocinuun withliver nccroinflamnutlo n
andHCC ina woodchuck (Ai amlOfrl J//(l/It~\·) colony in the I'hiladelphia Zoo (Summcrsu nl.,
1978). Later, DHBV was discovered in the scnnn of Peking ducks (Mason ct al., 11J1W)
Subsequently, GSHV was found in wild-cmtghl ground squirrels and I lI lBV in herons
(Feitelson et ill.• 1 9114 ~ 1986)
Viruses in the hepndnavirus family have u very narrow hustrange (Fcitclsonetal.,
1984; 1986). For example, HDVcall infecthumans and chimpanzeesbUI not other species
WHVinfectswoodchucks andground squirrels. D!tnv hasonly beenfound in Peking ducks
anda few other domestic ducks under uauuut conditions I\ mong the virusesin this family,
WHY is the virus most closelyrelated 10 I IUV. wi th a 65% sequencehomology at the
nucleotidelevel ami sharing mnoy antigenic determinants(Galibert crnl., 1( 82). Bo th viruses
infect the liver and the lymphoid system(Korba et <II.. 1989) andusuallyinduce similar
patterns of specific immune responses to viral antigens as well as non-organ specific
autoimmuneantibodyresponses(Fieldsetal., 1990; Dz wunkowskiand Michalak, 191)(1), In
addition, there arc many similarities in the disease developmentaficr IIIIV and WHY
infection. For example, the progress from acute hepatitis 10 chronichepatitis and Ihcn 10
Hee also occurs in woodchuckswith WIlYinfection,although virus-inducedliver cirrhosis
develops onlyin humans (Summcrs 1'1al.,1978). Inboth HllV andWHY infections, 10%
of infected adults devclop chronic hepatitis, whilenearly 100%of infected neonatesdo so.
Presently, WilY infection in woodchucksis considered as the most relevantexperimental
systemfor thestudy of the pathogenic mechanismsof human HEW-induced liver diseases.
TI1is systemalso represents a valuable model for testing novel preventive andtherepectic
approaches against HBYinfection(Feitelson e t al.,1986 ; Hornbuckle et al., 19&5; Korbaet
aI1986).
n. Human IICIJati lis H Virus nud Immune Responses 10IlDV.
0.1. HumanHepatitis 11 ViM
8.1.1. J-In VVirion
At least throe different fbrmsortlnv panicles havebeen observed inhumanblood
under the electron microscope(Hollinger, I987b). Most of the particles are incomplete
stlbviralspheresformedby thevirus envelope lipoproteins with a sizebetween 15-20 nmin
diameter. Filamentsof20 ><20-200 nmarcanotherform offree circulating HBVparticles.
The mature virions arc spherical pan.c'cs (42-47 nm in diameter) which contain virus
envelope lipoproteins nnd an inner-core (20nm indiameter). The inner-core, which canbe
released fromthe virionby treatment wilhdetergent,car riesviral DNAand other viral non-
structural proteins
B.I.2. Organization of the HDVGenome.
The HBY genome. withacircular DNA molecule of3200 nucleotides,is one of the
smallest genomesof identifiedviruses (GanemandVarnus, 1987). Thecircularviral DNA
is partially double-stranded withasingle-stranded gap up to 500!c of thecircle length. Atthe
beginingofDNAsynthesis. a fililydou blc-strandcd circular DNA formsafter beingpatched
by a DNApolymerase in thevirion Four overlapping opl.'ll - ro~mli ng frames (ORF~ ) have been
ident ified in HBV DNA, which encode atleast 7 differen t viralp roteins or peptidc s. These
ORFsare tenncd:S-ORFlor surface proteins(1IOpre-5/S). C·ORF for1111 CIC\ll.'lIpsid protein
(coreprotein, HBc)and I.'protein(1-lBe, a cleavageproduc t of'thc coreprotein), II_ORFfor
polymeraseprotein, and X-O RF for X protein.
B. l .3. HBV Proteins.
Sodiumdodecyl sulfate - polyacrylamide gel electrophoresis (50S-PAGE) of 1mV
envelope reveals protei ns with sixdifferent molecularsizes [Herrmannet ul., IIJK'I; Ncuram
et al., 1985; Stibbe and Gerlich, 1983)_ These proteins arc called sm:LI1 (24-1..1):1protein and
27·kDa glycoprotein. or P24 and GP27 respectively). middle(GP33 and G1'3fl) and large
(P3 9 and GP42) HBY surface proteins {Hljs protein, or I-Ills antigen, Iln sA!!.), Allthree
pairs of proteins have the same ( ·termini but different Nctcrmini, The genes in S-O IlF
encodingthese proteins aredivided into three segments.ter med preSI, preS2 and S. 51111\11
HBs protein is encoded by the S segment, middle liDs protein is encoded by prcS2 and 5
genomic regions, while thelarge Hils proteinis encoded by theentire S-ORF
Understanding of the biological function of II0 s proteins in the process of viral
infectionremainsincomplete. The small IIBs proteins are important for the assemblyand
secretion of virus (Lamb et al, 1983). A bindingsite for polymerized human serumalbumin
(pHSA) was found in the prcS2 region, suggesting pl 1SA may act as a bridge lilr the
interaction between HDV and hepatocytcs since an albumin receptor is cxhihited on the
surface of human he parocytes (Ncurnth ct nl., 1985), Thc preSI appears to be more
important for direct binding between virusand hepatocytes and probablyother cells (e.g.,
peripheral blood mon onuclear cells. PBMC) (Ncurath ct al., 1985 ~ 1986), In addition,
overexpresslon and accumulation of 1-I0sAg in transgenic mice demonstrated that IIIlV
envelopeproteinsin hepatocytescould be hcpatocytctoxic (Gilles ct al., 1992)
Thecore (nucleocapsid, I-!Bc) proteinhas a molecular mass of 22 kDa and contains
a typicalamino acid-repeatsequence of DNAbinding proteins (Hruska lind Robinson, 1977).
Nofreecore proteinsarc observed in the serumof HIlV-infected patients, but Bile proteins
occur in thecytoplasmof'hcputocytcs when:they self-assemble to nucleocapsid particles with
the association of viral polymerase and viralDNA. Hlje is another protein of HBV with
molecular mass of 15 kDa, which has beenidentified as a proteolytic cleavage product of tile
core protein. Illle is a soluble protein and cun be detected in the serum of HBY-infected
patients {Budkowska et al.• 1977; Petit and Pilot, 1(8 5). HOcand HBe differboth in their
biophysical features and antigenicity.
The IIllVgenome also encodes a polymerase protein (P protein) with RNAreverse
tmnscripmsc lindRNa~ II activities(Toh et at , 1983). Another viral protein, the X-protein
containsabout 154 amino acids (Moriarty cr al., 1(85). Studies of transcription tnvnro by
expressing X-gene inculturedcells(Spandauand Lee. 1(88) and in vtvo by using transgenic
mice (Balsano ct al., 19(4) suggested that the X-proteinmay modify viral and cellular gene
expression
B.2. Immune Responses to HIlV Antigens
B.2,I. llumoralImuamc Response to HOV Antigens
Antibodies to I-I BY proteinsare important serologicmarkers for thediagnosis of HBV
infection (Fields et al.,1990). In thecourse of infection, appearance ofa nti-HBc is IIsign of
viral replication. which can usually be detected within2 - 4 weeks after the emergence of
IIIh Ag (IIBV surface antigen) in the circulation. Following and-Hac , anti-Hge and anti-
lIP.s appear. indicating the declineof viral replication and the start of disease resolution.
Anti-Hlls containsneutralizing antibodies that arc considered a marker of the termination of
IIBY acute infection (i loofnagle, 1( 81)
There isnodirect evidenceshowing that antibodies to HBV proteins mediate the liver
injury. Indirectevidence shows that viralproteins(core. surface and c antigcns of liBV)
expressedonthe surface of'hcpatccyresarc recognized byspecific antibodics (Schlichtal1d
Schaller, 1989),suggesting that anti-viral antibodies may contribute to the injury of
hepatocytes through antibody-dependenl cell-mediatedcytotoxlchy(AOeC) or cOlllplement-
dependent cytotoxicity (CDC)_ III l'ifmstudies usingisolated human Ilcpatl1cytcs li-tllll
patientswithchronic hepatitishaveshown that anti-Ilgc couldbecytotoxic in thepresence
ofactivecomplement(Michalakct aI.,1995), Thisissue stillrequires imcnsivcinvestigation
It is clear, however, that anti-viral antibodies are responsible for some of theextrahepatic
diseases associated,\lithHOVinfection (e.g. inmulIlocomplcxdiseases). all Iheolherhum!,
the successof HBVvaccines usin] I-HlsAgpeptideor proteinsas iunnuuugen III stimulate
hosthumoral immune response indicatesthat ami-Hllshas great protective valueill the early
phase of viral infection(Fields et nl., 1996), In fact, it is thnugbtthat !lnli-IIIlV-protein
antibodiescontribute to theclearance of cxtraccllunr vlrat pnniclcs during virali l\lcl~t ioll
(Hoofnagle, 1981).
B,2.2. Cellular Immune Response to IIBV Antigens
Major histocompatibility complex(MI-IC)-rc5Irictcd T cellsresponding\0 Illultiple
epitopesin HBV proteins (enveope. nucleocapsid and po'ymcrasc)havebeenidcntitlcd in
theperipheralblood andliver-infiltratinglymphocytes ofputientswithacute hepatitis (Chisari
and Ferrari. 1995a). These cells include MI-IC class l-rcsrricrcd CDS' cytotoxic T
tymphocytcs(CTL),MHC classu-rcsrlctcd C04' helper T cells ,md MIle class ll-restrictcd
C0 4' CTL. In the earlystudies, these T cellsweredetected by testing their prolifcsulvc
responsesto purified solubleviral proteins. Thedetected cellswere mainlyCf)4' T cells
specific for 1-!BcAg, but not for HBsAg or preS2 antigens. In recent years, ~ method was
developedtoestablish T cell clones specificfor IIllV proteins, includingill l'il/"fJ stimulation
of PBMCfrom patientswithacuteand chronic hepatitis Bwith syntheticpcptides derived
fromdifferentHDV genes (i.e., C, S andP), Results from these studies show that HBs, HBc
and I' proteins contain T cell cpitopcs. In addition, evidence from the studies of HBV
transgenic mice shows that COB' CTLs most likelyplaya dominant role in viral clearance and
the pathogenesis of liver inju ry. These cells are able to secrete Iymphokines (i.e. IFN•..,) to
inhibit HBV gene expression and replication and to induce Hn v-i nfectcd cells to undergo
apoptosis. TheCOB' CTL can also induce non-viral specificinflammatory reactions (Gilles
et at , I992b; Guid ott i et al., 1( 94)
C. Pathogenesis of Liver Inj ury in nrc Course of IIBV Infection.
Hepatitis due to I-IBV infection can be acute, chronic or fulminant. Distinguishing
belween acute and chronic hepatitis is based on the histological picture and the duration of
the disease (Seen: 1( 90). One of the major liver morphological features of acute viral
hepatitis is intralobular spotty necrosis At the fully developed stage, panlobular disarray,
increased cellularity and plciomorphism of hepatocytes can be observed. This is caused by
a combination of liver changes consisting of hepatocellular degeneration and necroses,
hepatocellular regeneration, sinusoidal cell activation and iufl amrnation In chronic hepatitis,
thedisease persists for at least 6 monthsassociatedwith syndromes of hepato cellular damage,
inflannuaticn and fibrosis.
The pathogenic mechanisms that engage in viral diseases are multiple and complex
(Notkins and Oldstone, 1(8 6). Two basic mechanisms arc frequently involved, one is direct
cytopathicem.:cl due 10 the biological interactions cf thc virus with the cell, and the other is
the response of'njultlplc host defence mechanisms to the virus infected cell. There is no final
conclusion about Ihe pathogenesis of liver injury during HBV infection. Since HBV is
noncytopa thic, host antiviral immune responses are considered as the primary pathway to
inducethe damageto thehcoatocytcs (Chisari and Ferrari, 1995a). As mentioned above, the
CTL is thought to be the most likely candidate Because endogenously synthesized viral
antigens are likely presented by MHC class l motcculcs on the surface ofHllv-iutccted
hepatecytes, theseviral antigens may be recognized by class 1- restricted CDS' CTL. One
of the mechanisms of hepatocyte damage by CTL is to induce programmed cell death or
inflammatorycell injury. C0 4' helper T cells may haw indirect cytotoxic effects, as they
produce cytokines. (e.g., tumour necrosis factor).which maybe able to directly induce liver
injury. Antibodies 10 HDV proteins expressed on the surface of bcpatocytes nmy also
produce hepatocyte damage through ADCC and CDC mechanisms.
Inaddition 10 virus specific immune responses,participation of muohmuuuc responses
triggered by viral infection is also considered in the pathogenesis or liver htiury, since
euroreacuvity is a common feature of viral hep:llitis (McFarlane, 1991; Schattner and Ruger-
zisman, 1990). Autoantibodies 10 liver-specific nutoantlgcns. including asi.,loglyco[Jmtcin
receptors (ASGPR). havebeen identified as the I:...·getsof'nutnimunmereactions in patients
with autoimmune liver diseases or withllllV infection, General information Oil this subject
willbe provided in Part II of this thesis. To date. there nrc few studies addressing the role
of virus-induced autoimmune responses in the pathogenesis ofliver damage.
D, Animal Models ror lIep:lIitis B,
Studies on the pathogenetic mechanisms of virusinduceddiseases require mvunr
(cultured cells) or invivo (susceptible animals)systemsfor viral propagation. Due to the lack
of such systems,initialstudies on the pathogenesisof disease related 10 ImV-inlection were
mainly based on the clinical analysis of patients (Fields et lit , 1990; 19%), The problems
associatedwith this approach are the difficultiesof'obuintng multiple samples Item the same
patients throughout the course of disease and the diflieuhlcsof monitoring the complete
clinicalhistories of the patients (Korba ct al, 1( 86)
Appropriate animal models lire helpful in solving these problems by providing
experimental systems with a well-controlled laboratory environment Experimental animals
canbe infected with defineddoses of well-characterized virus pools.
Since the 1970s, scientists have been attempting to develop animal models for
hepatitis 8. Chimpanzees have beenidentified as highly susceptibleanimalsfor H8V (Fields
et aI., 1990; Korba et aI., 1986). Experimental transmission of HBV to these animals has
demonstrated the development of hepatitis with patterns of humoral immuneresponses
resembling those occurring in infected humans. However. HBV-induced hepatitis in
chimpanzees usually hasonly mild histological severityof liver damage. In addition,there is
no evidenceshowing HCC development in HBY-infected animals, Therefore, the HBV-
infectedchimpanzee is a valuablemodel for evaluation of preventivestrategies againstvirus
but not for determination of viral pathogenicmechanisms of HBYoncogenesis
With the developmentofmicroinjection technology. transgenic miceexpressing HBV
viralproducts andevenreplicating Hnv havebeen introduced for studies on pathogenicity
of HDV-rciateddiseases (Chisari. 1995b). Comparedto other animalmodels usedin this
research area. one of the benefits is that the immune system in mice has been well
characterized. thus simplifying the anatysis oft he cellularimmune responses. Currentstudies
using this animalmodel have revealed many newaspects ofHBV pathogenesis. It has been
demonstrated that Ml-IC class l-restricted CTL specific for viral epltopes. and cylokines
induced bytheseCTL[e.g.• IFN-y) undoubtedlycontribute to the hepatocyte injUlYin HBV
infection (Gilles et al., 1992b; Guidotti et at, 1994). However. results with transgenic
animals. although signilicant.may not necessarily explainviral infections in their naturalhosts.
Conclusionsfromthe studies of HBY-transgenicmicecan not be assumed to fully apply to
the pathogenesisofHBV infection in humans.
The discovery of other mammalian and avian hepadnaviruses makes it possible to
investigate the hepadnaviral pathogenesis in natural hosts(Feitelsoner al., 1986). For
example. woodchucksinfected byWHYor Pekingdueks infected by DHBVare availablefor
such investigations andfor theevaluationof newdrug- or gene-therapiesagainst HBV-related
ro
diseases (Cote and Gerin. 1995). Because or the strong similarity between IIIl V lind WIiV
infections intheirspecilie hosts. interms of thc viruses themselves. the natural history of viral
infection. host immune responses. and disease developments and outcomes. infection of
woodchucks with WHY has beendemonstrated as all excellentexperimental model for the
pathogenesis of HBV-related diseases (Korba et at . 1986; Summer et at. 1978). With
respectto the pathogenesisofliver injury during WHY-iutccticn, studies have demonstrated
that WHY viral antigens (WUs, WHe and WHe) expressed in the hepatocyte plasma
membranes of infeeted animals canbe the target of host humunc response. Recognition of
these antigensby specific antibodies may lead to the destructionof hcpatocytes (Michalak er
aI., 1990). PBMC responses to WHcAg. and cytckinc production in these responses, have
been identified as being important for the resolution of WIIV infection, and may also be
responsible for liver injury in the process of WIIV infection (Cote and Gcrin. 19( 5).
E, Genera l Proposa l.
Thepurpose of this research is to study the pathogenic role ofautoantibodies in the
induction of liver injuryduring hcpadnavirus infection. Studies focus on II hepatocyte surface
target antigen, aslaloglycoproteln receptor (ASGPR). ASGPR has be n considered as an
importantautoantigen in autoimmune hepatitis (AlH). Autoantibodies to ASGPR could be
of particular importance in the pathogenesis of liver diseases. because they may be able to
either influenceASGPR's biological function or comribuatc to destruction of hepatocytes.
In the majority of patients with HBV-induced hepatitis, nutoanubodics to ASGPR have been
detected, However. the correlation between HDV invasion and the appearance of these
autoantibodiesremainscontroversial. due to the inability to clearly identify the onset of viral
invasion,to determinethe status ofanti·ASGPR autoimmune response prior to viral infection
and to conduct a detailed longitudinal study of infected patients. In addition, the role of
autoantibodyto ASGPR in the pathogenesis of hepatocyte-damage in patients withhepatitis
Bis not established
In this study,a woodchuck modelof hepatitis B was employed to investigate the
inductionandthe possible pathogenic significanceofanti-ASGPRautoantibodies. Sincethe
woodchuck ASGPR (wASGf'R) has not been studied, current work also includes the
identification and biological characterization of wASGPR The study consists of the
following threeparts
PartI, Isolation,characterization and hepatocyte-surface expression of woodchuck ASGPR
(wASGPR).
The following questionsarc posed
a What are the molecularsizeand biochemical featuresofwASGPR?
b. Whatarc theimmunologic andantigenicpropertiesofwASGPR?
c. Is wASGPR expressed on the surfaceof'hcpatocyres? Whatare the structural and
immunologic properties of hepaticplasmamembrane-boundwASGPR1
Part II. Induction of autoantibodies against ASGPR in experimental woodchuck viral
hepatitis
Questionsaskedare:
a. Whatis the frequencyof autoantibodies against ASGPRin a normal,WHY-free
woodchuck population?
b. Is WHY invasion ableto induce anti-ASGPR autoantibodies?
c. What arc the dynamics of autoantibody productionagainstASGPRin the course
of WHV infection? Do their patterns have a valuein prediction of the outcomeof
hepatitis?
d. Does the status ofa nti-ASGPR autoimmunity influence the outcome ofWHV-
induced hepatitis?
c. What isthereceptorsubunit specificityof anti·ASGPR autoantibodiesinducedby
n
WHVinfection?
f. Are WHY andwASGPRimmunologicallycross-reactive?
Part III. Pathobiological effectsofanti-ASGPR antibodies
Questionsaskedare:
a. Do anti-ASGPR antibodiesinhibitligandbinding byASGPR?
b. Are anti·ASGPR antibodiescytotoxic to cellsexpressingASa PR')
c. Is there any differencein terms of the biological effects between anli-ASGPR
antibodiesinduceddue to WHV infection and those from animalsimmunized with
ASGPR?
Il
PART I
ISOL ATIO N, CHARACTE IUZAT ION AND HEPATO CYT E·
SURFACE EXPR ESSIO N O F WOODCH UCK
ASIALOGLYCOI 'ROTEI N RECEPTOR
1.1. INTRODUCTI ON
1.1.1. Glycoproteins and A~i :J1oglyeopl"Olein s.
Glycoprotcins are proteins containing 0111'or more carbohydrate chains. The most
commonmonosaccharides on theoligosaccharide chainsof glycoproteins are galactose (Gal),
glucose, mannosc, fucose, Ncacetylueuraminic acid (NcuAc). Necetylgalacrosamlne
(GaINAc), and Ncacetylglucosaminc(Kornlield and Kornlicld, 1985). The carbohydrate
chains are bound covalently to asparagine, serine or threonine of the protein by O· or N·
glycosidic linkage. The most typical monosaccharide at the termini of oligosaccharide chains
is NeuAc which is usually followed by subterminal Gal or GalNAc residue. The
slaloglycoprorcin becomesasialoglycoprotein(ASGP) when thesialic acids (NeuAc)are split
and the subterminal Galor GalNAc residues are exposedat the end of oligosaccharide chains.
Liberation of the sialic acid is termed dcsielylenon(Ashwell and Harford, 1982; Kjel:en and
Lindahl,1 991).
Glycoproteins exist in cells of both prokaryotic and eukaryotic cells. as well as in
viruses. Ineukaryotic cells. biosynthesis of glycoproteins is a process of glycosylationwhich
takes place in the endoplasmic reticulumand Golgicomplex (Hiscbbergand Sinder, 1987).
Ancr synthesi- 30mI'glycoprotcins arc transported to the cell plasma membranes (cellular
or membrane glycoprotclns), whileothers arc released 10 the extracellular environment
(secretoryor extracellular glycoprotcins). In nmrunals,1Il0S1 of'thc plasmaproteins,except
albuminand some lipoproteins,are sialoglyccproteinswhich arc mainly synthesized in the
parenchymal cells of the liver (Spiess, 1990). Othercellsor tissues alsoproduce extracellular
sialoglycoproteins, e.g.,plasma cellssynthesize innuunoglohullus andIhyroid gtands produce
thyroglobulin. Although sialoglycoprcrcins lire widelydistributed. native ASGI's arc rarely
found under ill vim conditions (Stockert. 1995). Perhaps, this is because they hnve II much
shorterhalf-lifethansialoglycoproteins. The lirst describednatural ASGI' was the so-culled
"slow-moving thyroxine-binding globulin" which was foundin the circulationotpnticntswith
liver cirrhosis (Mashall et at, 1972). To date, a growing number cf'protcinsappear to be
cleared from circulation through specificreceptor systems. Expcrhucntaldcsialylution of
theseproteins usually increases the clearance, suggesting that comparable processes occurs
in vivo (Ashwell and Harford, 1982). ASGPs can be prepared ill vunr by treatment of
isolated native sialoglycoproteins with acid or neuraminidase which cleaves the sialicacid
residues. Also, synthetic glycoccnjugatcs can be obtainedby chemicalmethods. such as the
imidate coupling method and the reductive alkylation method to achieve a preparation with
lessmicroheterogeneity and fewer structural complexities than the natural glycoprotcius(Lee
et al., 1987a and 1987b).
Glycoproteins have been extensively studied over the past two decades. Increasing
evidencerevealsthe wide diversity of their biological functions. However, understanding of
the glycosylationand dcsialylation process is still incomplete. Recent studies indicate that
oligosaccharide recognition is an important step tor specific protein-protein interactions
betweendifferent celltypes (e.g., leukocytes and endothelialcells) (Stoolman, 1989). As for
the secretoryg1ycoprotcins, the possible biological significance of glycosytaricn may be in the
modification of'the protein conformation. It has been found that specificsaccharide moieties
could contribute to the protein's conformational structure and, in consequence, change its
biological activity (Rose ct aI., 1984) In addition, it is also possible that gtycosylmion may
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control thehalf-lifeof glycoprcrcins through a mechanismof protecting the peptidechains
from proteolytic cleavage or recognition by receptors for clearance, Ashwell and his
colleagues(MoreU et at, 1968; 1971)found thatinjected'-le u-labelled asialoceruloplasmin
couldbe rapidly clearedfromserumand recoveredfrom rabbit livers within 24 min, while the
half-lifeof nativeceruloplasmin in the circulation was 56 hours, Similarly rapidclearance of
desialylatcdavianglycoproleinsinjected into rabbits wasobservedbyRegocezi er al. (1975)
Theseresultssuggestan importantrolefor oligosaccharides indetermination of the turnover
rate of serumglycopmtcins The terminal sialic acid residues seem to act as clements
preventing removal of the proteins from the circulation and their cleavage allows rapid
clearance ofglycoprotcin (Drickerman, [991). Since the differentGal-terminated branches
of oligosaccharides arc selectively recognized by ASGPR, the composition of the
carbohydratechains, the site and the mechanismof tile removalof terminal sugar(s) may
significantly contribute10the persistence of glycoprotcinsin Ihecirculation(Rice et at ,
19(0) .
1.1.2. Endoeytosis.
To maintainvital processes, cellsdevelop ways to transport substances across the
membrane. Endocytosis is oneof thebasicmechanisms for the transferof macromolecules
intocells. This proccss is mediatedbyspecific receptor systemsand can be dividedinto the
following steps: binding ormacromolcculcs (ligands) to receptors, formation of coatedpits.
internalization of ligand-receptor complex by coated vesicles, delivery of ligand-receptor
complexes to thecrdosonal sortingcompartment, dissociationof Jiglind-receptor complexes
by acidification, degradationof ligand and recyclingof the receptor to the cell surface
(Schwartz, 1990; WUandWu, [991). There are severaldifferent classesof receptorswhich
are involved in endocytosis. Forexample, traoscytotlc receptoris for the transportation of
polymeric immunoglobulin, growth factor hormone receptors (such as epithelial growth
J(.
factor) and recycling transport receptors lor the transfer of low-density lipoproteins.
transferrin and ASGPs. The receptor lor ASGP(ASGPR) has been well-characterized as II
model of receptor-medillted endocytosis.
1.1.3. Asialoglycoprolrin Rl'ccplor( ASGI'R).
ASGPRisa receptor responsible lor the clearance of desialylatcd glycoprotciusfrom
the circulation. This receptor is also called Gal lectin (or hepatic lectin, III.) As noted
previously, initial knowledge about the biological properties of ASGI'Rs comes from
observations of themetabolismof'cemloplasnrln Morell ct OIL (196&) foundthatthe terminal
sialicacidresidues of ceruloplasminwerea key factor in controlling the turnover rate of this
proteininthe circulation of tilerabbit This studyalso showed that the disappearance nf "'Cu-
labelled astefocerutoptnsrnln from the serum is accompanied by thc appearance or the
radioactive protein in the liver. Autoradiography of liver sections revealed that the
parenchymal cells,but not Kupper celts. were the sites of depositionof'aslnloceruloplnsmin
Subsequent experiments demonstratedthat binding sill'SspecificallyrCl:ognizing ASGPs. but
not their sialyatcd derivatives. arc anchored in the purifiedliver plasmamembranes (Morell
et aI., 1971). The interaction between ASGP and liver plasma membranesrequires the
presenceofealcium ions and occurs in a narrow pl l range 01'6.0to 7.8. Based upon these
featuresof ASGPR, a method for the isolation of ASGPR by using affinity chromatography
on ASGPsor Galhas beenestablished. This method was first employedfor the purification
ofASGPR fromrabbit liver (rASGPR) (Hudginet al., 1974). Since then, extensivestudies
on ASGPRhavebeenperformed and they have provided important insighlinto the structure
andfunctionofthis membrane protein. The interaction belween ASGI'Rlind its ligandshas
been usedas a molecular model for the study of reccptur-mcdiatcd endocytosis In addition,
theprospectsforclinicalapplications of ASGPRlook promising, such as targeted diagnosis
and therapy of liver diseases (Wu and wu. 1991). In the fullowing sections, the current
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knowkdge on thebiochemicalpropertiesof ASGPRwillhe reiterated from several reviews
on this issue (Ashwell andHarford, 1982; Brcitfcldet at, 1985; Drickamer, 1991; Lodisb,
1991; Schwanz, 1990; Spiess, 1990; Wuandwu. 19( 1)
1.1.3.1. niochemical l'roperliesofASGI' R,
As an integral membrane protein (Morell and Scheinberg, 1972; Chiacchia and
Drickamer, 1984), ASGI'R has 10 be extracted by nonionicdetergent (e.g., Triton X-lOO)
from membranesfollowed by purification by ligandaffinitychromatography(e.g., ASap or
Gal). Purified ASGPRpreparationscontainwater-soluble, lipid-free proteins inassociation
with8to IOOIc carbohydrate, and retainhighASGPbindirq,activity. Suchpreparations also
exhibit a high degree of protein aggregation which makes it difficult to determine the
molecular size of the purified receptor, Currently, there are three main approaches for
determination of receptormolecular masses. The classical methods are gel filtration and
sedimentation equilibrium to directly determine the molecular size of ASGPR in aqueous
solution. Detergents canbe employedto disassociatethe receptor proteins, andCa" or CaZ'
plus ligand (such as Gal) is usually added to maintain the stability of receptor protein.
Molecularmassof receptor speciesmeasured by these methods reflectthe size of thenatural
receptor moleculeexhibited within the native plasma membranes. The most advanced
approach to determine the functional size of receptors in their natural environment(i.e.•
withinbiological menjbrane]is radiation inactivation analysis, The concept of this technique
is based on exposing receptor-containing plasma membranes to increasingdosesof high-
energyionizing radiation to induce a radiation-dependent loss of receptorbiological activity
which canbe measuredbybindingofa specific ligand, Results of thisanalysiswillgivethe
minimalfunctionalsizeof tile receptor molecule which is independent of the molecules' shape
or volume Nevertheless, the mostcommon method to determinethe numberandthesizeof
polypeptidesubunits inpurified ASGPRproteins is sodiumdodccyl sulfate- polyacrylamide
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gel electrophoresis (SOS-PAGE), Thisanalysis requires proteindenaturation by treatment
withSDSand ~~mercaptocth:mol . andthe results willreflec t onlythe polypeptide constinuion
of the receptor molecule. not thesizeof the receptor with biologicalfunction, Whenall these
biochemical methods fail. immunological and molecular biology approachescan be utilized
to characterizeASGPR proteins. The usefulness of these different nnnlytical tl'Chniqllcswill
also be addressed in the followingsections of this introduction
To date. the molecularcomposition of'bcpatic ASGPRfrom rabbit,rat, mouse, human
and chickenhas been characterized (sec Table 1.1) (Anderson et al., 1982; Baenziger and
Maynard. 1980; Bischolf and Lodish 1987; Dricknmcr ct at . 19S,t llnrfonl ct :1L. 1982;
Hong et at , 1988; Kawasaki and Ashwell. 1976; 1977; Mcphauland nc rg, I(lS6; Schwartz
et a1.• 1983; 1984;Steer ct at . 1981; 1990; Tanabect al., 1979), Overall.the studies indicate
that the mammalian ASGPRs arc composed of two or three polypeptide chains (suhunits)
with molecular masses ranging between 40- and 60-kDa. Most likely, these subunits fonn
hetero- or homo-oligmericcomplexes in hepatocyte plasma membranes, since the receptor
functional size is always larger than that of the constituent subunits (Schwartz, 1( 84). The
number of polypeptide subunits varies in ASGPRs derived from different species Three
subunits with distinct molceulnrmasses were found in the allinity purified filt (r\ASGI'R or
rat hepatic lectin, RHL) and mouse ASGPRs (mouse hepatic lectin . Mi lL), while only two
subunits are observed in rabbit (rASGPR) and human ASGPRs (Table 1.1) The receptor
subunitsare distinguishedas major andminor forms. depending on their relativ7,lhundancc
In rASGPR, the ratio of major (40 kDa) to minor (48 kDa) subunits is found to he 2: I
(Kawasaki and Ashwell. 1976) and in human ASGPR. ~ : I (46-kDa to ~O·k f):l subunit,
respectively)( McPhaul and Berg. 1986), The relative abundance of the major (4:t kDOlI and
minor (54and64 kDa) subunits in rtASGPRis 8:I:I (Drickerumcrct OIl .. 19114 ). These ratios
are based on measuredproteinstaining of the affinity purilicd receptor preparationsseparated
on SDS-PAGE andthey may not reflect the realproportions orreceptor suhunits in particular
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locations of the cells (e.g., in hepatocyteplasmamembranes). In addition, it is ditlicult to
detect theexistence anddetermine the molecular sizeof lessabundant polypeptidespecies of
thereceptor. Inthisrespect, the best example might be the identiflcntiou ofthe minor subunit
of humanASGPR. Initial studies consistently showedthat only one subunit (III , 46-kDIl)
could be detected in the receptor prcpnrations derived from human liver or from a hU1111ln
hepatoma cell line (HepG2). However, examination or a eDNAlibrary orbuman ASGPR
revealed the existenceofa clone encoding the secondreceptor subunit (112) with lUI amino
acid sequenceshowing58% homology to 111 (Spiessand Lodish, 1985b). Because of this
observation, the H2 with molecular mass of about 49 • 50-kDa was linally ldcntified in
HepG2 cellsby Bischoff and Lodish (1987), usingantibodies directed against iI synthetic
peptide with predicted sequencebasedon the eDNAsequence.
1.1.3.2. tnrerspecles Ilolllology Among ASGI'It Nnclcuiideand Ami no Aritl Sequences.
Since the 1980s, eDNAlibraries of ASGPR nom rat, mouse, humanandchickenhave
been established (Drickamcr, 1981; Leung et 111. , 1985; Monroe and lIuber, IlJ94a; Sanford
andDoyle, 1990; Spiesset at , 1985a). The existenceof two ASGl' !t gencs in tnnnuuals has
been detected and theirorganization have been found quite similar to each other. The genes
include six to nine cxcns corresponding 10 the DNA sequence encoding four distinct
structural and functional domains of II,,,,receptor; the cytoplasmic tail, transmembrane
sequence,extracellular neck region and Ca' t-dcpcndcu ligand rccognlrioudomain All the
knownmammalian ASGPRsare highly homologous, as shown by computer-assisted multiple
sequence comparisons of the receptor amino acid and cDNA sequences or ASGJllls
(Drickamer et al., 1984; 1987; 1988). Oneof theinlcrcslillg findings was that identical genes
encode the two different minor species ofrtASGPR(54. lind 64-kDa polypeptides, RillA
and RHL-J. respectively) or mousc ASGPR (45- and SI·kDll polypeptides, MIlL2 and
Ml-IL3. respectively) receptor subunits. Ihc differencebetween these two minor subunits in
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both receptors is thestructure of theircarbohydrate chains(Halberg et el., 1987). Further
analysisoflneaminoacidsequencesof ASGPRsfrom rat and human livers revealedthat the
identity of the aminoacid sequences amongall the subunit polypeptides isabout 39G1.. A
greater homology was found between the two major species (HI vs. RHL.I: 80%) than
betweentheminor species (112vs. RI-IL--213 : 624'10) or betweenthe major and minor species
(HJ vs. 1-12: 58%, HI vs. RHL--V3: 56%, RHL·J vs. RHL-21J : 52%, RHL--J vs. H2: 50'/. ).
These results suggest that lhemost conservedregion fallsin the sequence of major subunits.
Relat ivd y high homology of ASGPRs between chicken and mammals is also observed
(DezOlJskaer al. 1991; Drickamer et at, 1984).
Homology in the primary structures of ASGPRs from different species raises the
possibilitythat commonirucrspccics antigenic determinants exist in these receptors. Schwartz
et al. (l 98Ia) prepared a rabbit antiserum and a monoclonal antibody against a rtASGPR
preparation to identify and quantify hepatic rtASGPR. They found that the monoclonal
antibody could completely inllibit the binding of l!ll·labclled ligand to the immobilized
receptor. Also. both the monoclonal and polyclonal antibodiesprecipitated all constituent
polypeptidesof nASGPR. This observation suggests that the receptor subunits contain a
commonimmunogenic domain which isresponsiblefor the ligand binding. Another research
group alsofound that a ligand binding site waspresented on both subunits of rtASGPRand
recognized by a mcncctonatantibodyto rtASGPR (Harfordet a1., 1981; 1982). Harford er
at ( 1981) prepared a subunit monospecific antiserum by immunization of a rabbit with the
major 43-kDa subunitof rtASGPR purified by preparative SDS·PAGE. Interestingly, this
antiserumrecognized an antigenic determinant presented on allconstituent polypeptides of
rtASGPRbut exhibitedno inhibition of ligand binding by the purified receptors. According
to the authors, this result might be due to the dcuaturaticn of receptor subunits during
purification before the subunits were used for irmuunizaticn.
Inthe human ASGPRsystem,theantigenicity of ligand binding sites or the structures
related to ligand-binding has nlsc been demonstratedby specific antibodies to ASGI'R,
Schwartz and Diane ( 1983) demonstrated that the binding of Illl-labellcd ligand to the
ASGPR on HepG2 cells was blocked by antibodiesrised either against puritled human
ASGPR, the Sps-dcnarcrec 46-kDa polypeptide of humant\ 5GI'R or rtASGIlR. These
antibodies differed by their a ffinities of inhibition, The I ~, (50% inhibition) of anti-huma n
A5GPR wasapproximately5 " 10" M, whereas thatof the anti-46-kD:1subunit was5 ' 10,1
M and that of the anti-rtASGPRwas 1.5 '< IO·H.
Taken together, current data indicate thai A5GPRs are interspccics conserved
molecules. There is a significant degree orhomology in their ligaudbinding silesas wellas
in non-function-related regions.
1.1.3.3. Subunit Intera ctions and ASGI'R Ligand Hinding Activity.
Despite the amount of knowledge accumulated 011 the A.SGPR structure and its
biological function, there are stilla numberof unsolved issues related to the nature ofthe
interactions between the major and minor subunitsand their functionsin receptor-ligand
bindingandligand endocytosis. To address these questions,studies have been carried out in
rat andhumansystems. Data appear to demonstrate that both the mejor and minor subunits
are required for assembly of highaffinity ligand bindi ng sites on ASGPR molecules and10
mediate efficient endocytosis
In 1987, Halberg et al. developed a methodto separatethe majorand minorsubunits
of rtASGPR. The concept was based on the observationthaIthe minor RIIL-2 and RIIL-3
were more sensitive than the major RI-IL-1unit to various oxidizingand reducing agents.
Treatment of rtA5GPR with B-merceptocthnncl for I hour at room temperature resulted in
the loss of ligand binding activity displayed by RI-lL-2 and IUIL-). while RIlL-J still
recognized the ligand. These resultsconfirmedthe earlier observation(i lsuch ct al.. 1986)
that RHL·] alone can specifically bind Gal residues on ASCI' MC1111whi le, expressillnof
RIIL-213 in an i/lvi ll'O transcription/translationsystemcreated byconstruction of RHL·2I3-
insulinfusion proteins, demonstratedthat RIIL-2I3also contained a Gal-recognitiondomain,
Moreover, cross-linkingof surface receptor byantibodiesshowedthat the RHL-I and RHL-
2/3 subunits self-associated into homo-oligomer. The major and the minor subunits were
independentmolecules andhad no structural relationship with each other. In contrast to this
observation,using immunoprccipitation technique, it was shown that the major and minor
subunits of rat ASGPR internet ncncovalcnrlywithin plasma membranes (Sawyer et al.,
1988). Similar conclusions were alsoobtainedby Braitcrman et al. (1989). In this last study,
the authors performedco-uansrccnon of'mt hepatomatissue culture (HTC) cells with RHL·1
and RI-IL·2/J . It was found that cellsexpressing RHL-\ alone could only bind synthetic
ligand,Gal·Lysine(Gal-Lys),whilethecells expressingboth subunits could bind. uptake and
degrade ASGPs (e.g., ASOR). The authors concluded that RHL·1 was sufficient to
recognize ASGP and mediate the endocytosis of ASGP, while RHL·2I3 might playa
supportingrolein the formation of the high affinity ASGPR macromolecule in the plasma
membranes. Therefore, incontrast to Halberg et al. (1987),th ey assumed that the native
ASGPRis a hetera-oligomcr. In the most recent studiesusingsyntheticglycopeptides and
photochemicalcross-linkingtechniques. Rice era1. (1990)clarified the role of both major and
minor subunits in ligand binding. They demonstrated that tile precise binding geometries
betweenthe ligandand RHL·I, and the ligand and RHL·2/3 differed. They suggested that
the structure of ASGPR withhigh affinity for ligand wasconstructed by all the constituent
subunitsof r1ASGPR.
Therelationshipbetweenthesubunits ofhumanASGPRhave been investigated in the
HepG2 cell line(Bischoff'nndLodish, 1987; Schwartzer aI., 1981b; 1982; 1983). Using
chemical cross-linkingand enzyme-induced degradation of receptor molecules in plasma
membranes.it has beenfoundthat thetwo subunits of human ASGPR(HI and H2) fonna
hetero-oligomerinHepG2(BischolfandLodish, 1987) Better understandingof this subject
came fromthe studiesperformed by transfc ctionof marineNi l [ J1'3 fibroblasts withgenes
for HI andH2 (Shiaand Lodish. 19 89). It was demonstrated that111couldb.... e xpressed in
the tran sfected fibroblast andtransportedto the cell surface, whileIt! alone appea red III have
ashort half-life andcould not beexpressedas amature moleculeon the cellsurface because
ofrapid degradation. However. the H2degradation was overcomeafter co-tnmsfcctingboth
HI and H2into thesamecell.suggestlogthnt thestabilityof'thc receptor bcuctit tcd Irumthe
presence ofboth subunits. Interestingly. the presence ofbnth III and 1-12 wasalso required
forligandbinding, internalization and degradationinthe transfcctcd cells, as ml.ASOlt could
not be recognizedbycells expressingonly one receptor subunit. In contrast. GCIlCll ct nl.
(1989 ) demonstratedthat transfcctcd 111 subunitcould befunctinunlwi thout co traaslcction
of subunit H2. Further experiments pcrfbrmcd by llcnisct <11. (1990) dcmcusmncd the
fonnationoft he HI·H2 complexesinboth human ASGI'R trensfcctcdmurine NII I rn and
HepG2 cells. The HI and H2 subunhson the surfaceo flkpG2 cellswere associa ted III form
stable hctero-oligomcrs and all the HI bound with 112 o n the surface { I f tmnsfectc d
fibroblasts. Therefore. it is possible that1-12. like RI-I L-2/J. plays a role in there-o rg neizat ic u
of receptor subunits to forma high nflurityGal-bindingsite
Inthe most recent studies. it wasshown that a singletyrosine(Tyr) inthe cytoplasmic
domains ofHI and RHL-I wasa determinant forphosphurylntlon and served to r the signal
transdu ction of ligand-receptor internaliza tion or intracellular traficking (Haynes ct al .•
1994). H2 also has a serine (Ser) residue available for phosphorylation, which is not
necessaryfor endocytosisbut docscontribute to targeting the rcccptor-figundcomplexto the
basolateralregion of the cellplasma membranes(Geffenet OI l.. lfJfJ I)
1.1.3.4. Distribution of ASGPR.
It hasbeenwelldemonstrated tbu dcsinlylation ofserum glycoproteiusre sults in tile
deposition of ASGPon the surface of liver parenchymal cells (Tollcshaugcl al., 1977)
ldem iflcation ofsubccllular distri bution o f ASGPR wasaccomp lished by both b iochemi cal
and immunol o gic methods. Res ults obtain ed by Pr icer and Ashwell ( 1916) and Tanabe et
al.( 19 79) ind icated tha t both plasma membranes a nd intracellularorgan elles(e.g., smo ot h
endo p lasmicret iculum and Golgi) of rat liver hadthe capability to bind ASGP. Subsequently,
Brid gcs et al. (1982) a nd Weige l andOka ( 1983) identified a large amount of intracellu lar
ASG PRinisol atedrat hcpatocytes . Immunocytoche mistry a nd immuno electro n microscopy
analysis performed byusing antibodies dire cted either against ligand or ASGPR s howed th at
abou t 65% of the recep tor po o l was lo cated in the intr acellular compartment of rat
hcpa tocytcs. Within th e intracellularcompnnmcnt . 20%o f tile receptors were associat ed
with the rough endoplasrnlcrcticulum, 30% withGolgl apparatus, and 50 % with Ihesmo oth
endo p lasmic re ticuluman d present in the compart ment ofuncoupling of receptor and liga nd
vesicl es (CURL )
Subcellular locali zation of human hepatic ASGPR has been studied in HepG2 c ells
(Schwanz ct a l., 1982). Incontra st 10 the distribut ion of rtA SGPR in r at hepato cytes. 87 0/.
of the ligand binding sites we re plasma membrane-associated. In tracellu la r ASG PR
accoun tedfor o nly 13% of thc tot a l ASGPR. However, the results of im munoh istochemica l
stainin g of sec tionsfro m human liver{Sipos ct et.. 1989) was ingoo d agreement with the
findings in rat liver and showed that between 40 and 90% of the AS GPRs were loca t ed
intraccllularly.
11 is w orth no t ing that the ASG PRs on the hepatocyte surface are not eve nly
distri bu ted b ut show polarity. T h is polarity has been visualized by us ing
immun ocytoche mistryan d clcctroruulcrcscopy techniques. The densityof staining of ASGPR
ligand binding sireswas 70-fold greater on the s inusoidal (blood-fa cing) sur face of t he
hepat ocyte plasma me mbrane t han on other me mbrane regions ( i.e., late ra l and bile
canalicular)(Wal l, etal., 1981). Ge uzc or at. (1983) havealso found th aI ASGPRson re sin
sectio ns of pa renchyma l cells fr o m rat liver are mainly located in t he sinuso idal plas ma
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membrane (8 5%), the concentraiion bei ng nearly 10 times that in the latera l and bile
cana licular me mbranes . III the caseof hu man AS GPR, the receptor wasalso found to be
mainly distributed o n the sinusoidal surfa ce of hcpatocyt cs from patients without liver
diseases(Burgesset al., \992). Slgnillcantly \essASG PRwas detected onthe later alsurfa ce,
and ASGPRwas abse nt on the canalicular plasma membranes. A similardistributionwas
found byMizunoetal. ( 1993). interestingly , both rese archgroupsreported that suchpola rity
of A SGPR exhibition changed in livers of patients with cirrhosis or poorly-diflcreu iatcd
hepatocellular carcino ma(He e ). In the se eases, a decreased expressionof ASGI'Rwas
found onthe sinusoidal plasma mcnjbmucof'bepmccyres Since the presence o r ASGI)R on
the sinusoidal surface could make ASG I'R-111cd iated endocytosis more efficiuu. it is
postu latedthat a change inthe polarity o f A.iGPR distributi on may influenceliver Ihnc tion
regarding the clearance ofASGP fromthe circulat ion
The distribution ofhepat ic ASGPR diners between mammalian species. Clmngand
Chang (1988 ) measu red ligand binding by hepa tocytes, as well as liver bomogcnarcs
origin a!ingfro mdifferentspecies. The re sultsshow ed[hat the amo unt of ASGI' Ron the
hepatocytes or inIhe liver fromdifferent s pecieshas theIbllo wing rank order: rahbit > rat >
guinea pig, indicating a species-difference of ASG P R expressionon hcparocytc s
During the past fcw years, the cl assical concept of "hepatic" ASG P H 1I11s becn
challenged by theobservations that ASGPR or AS GI'lt· l ikc substancesalso existin ot her
tissues . Stud ies in th is area initiated in the late 19805when investigators wer e trying to
identl fythe receptors onthesurfaceof spcrmaogcnlccells which could bind to the zona
pellucidaof egg s(Abdu llahand Kierszcnbaum, 1989 ). Results oreDN Asequenceanalysis.
mRNA detect ion.andanalysis of the receptor antige nicand ligandspcclnclucs(Monroe and
Huber, 1994b ; Muet al., 1993) showed thai rat or mouse genes en code RIII.· rehllcd or
MHL.re1atcd proteins in the sper matids and epididymalspermof rat and mo use. These
protein sare capable o f binding ligand of AS GIJR. In addition. rut peritoneal macop heg es
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also express Galbinding receptorswith 77%aminoacid sequence identity with RHL· I
(MClSa)tdciet aI.•1988; O,met aI. I992 ). Morerecen l1y. PacifICO et al.(I99 5 ) showed lhal
both RJIL-I and RilL-2/) mRNA were expressedin llleliver. kidney, br3in an d thyroid . bul
not dclCClable inlherat spleen. It isnot ex cblc:l that bcpario andextrahepatic ASGPRs may
bed iff<Jmtin lheirgene lfW'SCription,exp ressionand receptor biolog icalactivity. However,
clJrn:n1evidencedoes raise some doubts about the snict liver·spc'cificily of theASGPR·
deliverysystemrorgene anddrugtarget therapy.
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1.2. MATERIALS AND METII ODS
1.2.1. Anima ls.
Woodc hucks (IL1arlllofa mOl/ax. males and females), rnbbirs[New Zealand white.
adult female). rats [Sprague-Dawley, adultIClllales) and guinea pigs were used in this project.
All the animals were maiutnincd in the Animal Care Facility, Mcrunrial University of
Newfoundland . Experiments with animals were carried out according to the "Guide tothe
Care and Use o f Experimenial Animals" of thc CnnadinnCouncilon Animal Care.
Woodchucksfrom a woodchuckcolonymaintained inthe Liver Research Labamtory,
Facultyof Medicine.MemorialUniversity ofNcwtoumllandwe re divided into two groups:
healthy. WHV-noncxposcd woodchucks.andwoodchucks with c...perimentally induced WIIV
infection. Inoculationwith thevirus. and serological and histologies!evaluations of the sIalU S
ofW HVinfectioninanimals were donebyotherinvestigatorsfrom this lahorutory. according
to the methods anddiagnosticcriteria previously describedill detail(Michalak et at. I l)R9 ~
1990) .
1.2.2. Ct' lis.
1.2.2.1. Hepatocytcs Isola ted from Liver Tissue.
Hepato cytcs were isolated from woodchuc k and r;1I fivers using a coltagcunsc
perfusiontechnique (collagenasedigestion) or a mechanical disruptionmethod according to
previous descriptions (Michalak ct nl.,1988; 1994) with some minor modificmions
Materials'
(1) Phosphate-buffered saline (PBS): 150 111M sodium chloride (NaC!) in om M phosphate
buffer. pH7.4.
(2) I x Hanks'balanced salt solution (llBSS; Gibco BRL. Life 'rcchnol.. 1I1C. (immJ Island,
NY.)
(3) Wtihing solution: 0.2% (w/v) ethylcnediaminetetra3CC1ic acid(EDTA) (Baker Chemical
Cc., NJ.)in 1 " RPMI 1640medium(INC.. Diomediclls1nc., CostMesa,CA.).
(4) Perfusion solulion: ISOrn.\t NaCI, 5 mMpotassiumchloride (KCI)and 9 mM N. [2.
hydroxycthyf} pipcruinc·N'-{2-ethar'l.-sulfonic acid}(Hcpes,sodiumsalt;Sigma ChemicalCo.
St.Louis, MO.) adjusted10pI! 7.4 by I N 11(1
IS)Collaboenase solution: 0.05% (w /v) collagenase(type IV) (Sigma) in 1 • f1BSS
(6) Culturemedium: 0.1'/. (wIv)bovine aftxJmin (Sigma), 10 Jlglmlinsulin (Sigma),60 IlWml
penicillinaoo 100Jlglmlstreptomycin(leN Bicmedicals lnc., Horsham, PA.) in I • RPMI
1640medium (INC., Iiiomedicals lnc]
(7)Trypanblue solution: 0,2%(w /v) trypanblue (Sigl1l.1) in 0.85%NaCI
(8)Freshlivertissuesobtained from woodchuckbyliver blopsy or at autopsy, and rat autopsy
were storedin sterilePUS or HOSS onice for transfer.
Methods
(I) For mechanical isolation of hepatecytes, liver tissue WIS cut lore small piecesof0.25 to
0.5 em' and washed 3 times using about 10 vclc mcs of washingsolution.5 min for each
wash. Stbl;equently. lhe1r.,Cf tissue wasmiscd incold HIlSSandthen pushedIhrougha cell
dissociation sieve with SO meshscreensusing the plunger of a S·ml syringe. All these
JXlXedureswere done 00 icc. Ilcpatocyteswere collected from the resultingcellsuspension
andpurified2 to 3 times byccnlrifugation at 200 • g for 5 min incold HBSS. Microscopy
revealed jhat the purity of hepatocyteswasabove950/. and the cells had typical hepatocyte
morphology. Trypanblue staining revealed thatmost of the cellswere nonviable.
(2) For collagenaseperfusionmethod. thelivertissue wasalso cut into smallpiecesof I to
1.5 cnr' and washedonce withwashing solution for about 5 min. First perfusionwas
performed for IS min using 10 volumes of circulating oxygenated perfusionsolution
preheated 10 37°C. The perfusion wascarriedouton a celldissociation sievebyusinga 250
S/8" needle to puncture theliver tissueat different sitesand at a speedof 20 ml perfusion
so lution per min. Similar perfusion was performed twice using circulntingcollagenase
solution. JOvolumes offresh solution for 10min pereach perfusion. Subsequently. the liver
tissue was minced and gently pushedthroughthe sieveint\I IIBSS. Thecells were washed
and purifiedbycentrifugationas above. The purity of'hcpato cyrcs fromthis prepunuiou was
above95% according to microscopyexaminationandthe viability was9S t {l l}t~ o according
10trypanblue exclusion,
1.2.2.2. Hepatocyte Cellline.
The human hepatocellular ca rcinoma cellfine Il epG2 (AH'C l iB llOb~). kindly
provided by Dr. C. H. Ford (Faculty of Medicine,Memorial Universityor Newfoundland),
was maintained according to the instructions of the American Type Culrurc Collection
(ATCC). Culture mediumcontained Dulbccos' modified Eagle'smedium ( D-MEM)(Giheo
BRL,Life Techol, Inc., Grand Island, NY.) withfetal bovine serum ( lOYD), sodium pyruvate
(66 rngIL), 100)< nonessential aminoacids(6 milL) peni cillin (60 lUlL), and srrcptrunycin
(60 ~gfL) (all these materialswerepurchased fromICN l\iolllctlicali nc., ljorslnuu, \' 1\.)
Cellswere cultured in plastic tissueculturedishes111 :ire. in a controlledenvironment ors%
COl(v/v, in air)and 100% humidity,till fullmonolayer growth The cellswere harvested by
using trypsin-EDTA (10 < , Bibee DRL) digestion and washed with culture medium The
separated cellswere used for anotherseedingor tor fixation (sec sccncn 3.2,)
HepG2 cells cultured on tissueculture slid M~ (M i l es Sclcntltlc.luc.. Naperville,II,,)
underthe sameconditionsfor 48 hourswereused forlmmunorlucresccnr staining{sec section
1.2.11)
1.2.3. Hepatic Ptnsma Membrnncs.
Liver andhepatocyte plasma membranes(hepatic plasma membranes, III'Ms) were
isolated from liverho mogenate orpurilicd hcputccytcsusing a method describedby Aronson
and Touster (1974) andMichalaker el. (1988; 1989). Splenocyte and kidney plasma
membranes (SI'Ms and KPMs,respectively)used in control experiments were prepared using
the similar method and kindly providedbyother investigators from this laboratory
Materials;
(I ) Proteaseinhibitor solution: I mMphcnylmcthylsulfonyilluoride (PMSF, Sigma), 50,000
units/mlaprctioln{Calbiccltem-Novabiochcm Co., LaJo lla, CAl and2 mM e-amino-n-
caproic-acid (Sigma) in PIlS
(2) Sucrose solution A: 250 mMsucrose in5 mM Tris-HCI buff er, pH8.0.
(3) Sucrose solution B: 37% (w/v.) sucrosein 5 mMTris·HCIbuffer, pH8.0
(4) Sucrosesolution C: 57%(w/w) sucrosein 5 mMTris-HCIbuffer, pH8.0.
(5) Liver tissuesobtained from autopsies ofwoodchucks, rabbits and rats
(6) Woodchuckbcpatocyesisolatedfrom woodchuck livers using thecollagenase perfusion
technique(see section 1 ~.2 .1 .) .
Method:
Animal liver tissues were extensively washedwith coldproteaseinhibitor solution,
placedinto coldsucrose solutionAon icc, and then mincedinto smallpieces. For isolated
woodchuckheparocytcs. the cellswere washed twicewith cold solutionA. Subsequently,
tissucfragmentsor hc patocytcs suspended in5 volumesofsolution Awerehomogenized6
times, 15 seconds each time usinga knife homogenizer(Brinkmann Instruments, Rexdale,
Ont.,Canada). Thesuspension wasfiltered through three layersof prewettedsurgical gauze
(16threadslcm1). The solution wasagain homogenizedwith Ito 2 up-and-downstrokes of
a peste ho mogenizer (Con-torque, Eberbach Corporation, MI.). This homogenatewas
centrifuged at 1000 ><g for10 minto remove nucleiandcellulardebrisand thesupernatant
was recentrlfhged at 33,000 ><g foranother 10 min to pelletmitochondria andlyscscmes.
The resulting supernatantWllS spunat 78.000 ~ g for 100min and the microsomal pellet was
the n suspended in 2.5 volumes of solutionC and homogenized with three up-and-down
strokes of the pestle homogenizer. Tenml ofthe suspension waspla ced on the bouotuof
ultra-clear centrifuge tubes (Beckman). About20 mlof solut ionU W;lScarefullylayered
above the suspensionand thenabout 10ml ofsucrose solution ,\ was used III fill the tube
AfIer centrifugationat 75,500 ~ g for 16 hours, the plasmamcmurmc fractionW; lS collected
from the interface betwe en solution B and solution A ovcrtny. T he collected plasma
membranes were washed oncein sounon A bycentrifugationill 75,500 ~ g for I hour.
1.2.4. Liver Acetone Powd er,
Materials:
(I) Acetone precooled to - Io· e beforeusing
(2) Liver tissue: freshor frozen liver tissue fragmentskept at · 70"C.
(3) WhatmanNo. I file r paper (Whn tmnn lntcrnmional Lul., Maidstonc. Ellgland)
(4) Solidsodium hydroxide (NaOH).
Method:
Liver tissue fragmentswcre mincedwithscissors and thcnlunuogcnizcd threelimes,
30 seconds each time, in 10volumesof cold aceto ne using a kitchen h ili:blender. Tile
suspension was filtered through w hnrman paper under reduced pressure nnd washed with
another 10volumesorcold acetone. Adarkbrownliver mass formedOil till:lifter paper W;l S
blended again in acetone.filtered and transferred 10 a glassplate. Allcr evaporatingacetone
at4ce for I hour. liver powder was prepared bypushingthe liver mass tbrough n sievewith
60mesh screens. The powderwas allowed to dryin a desiccator over solidN,IOII fur4 days
at 4cC.
1.1,5. Prepnrmien of A ffinity Chr omatography l\1:ltrixes.
1.2.5. 1. Preparationof Asialofctuin-Scpherosc4B.
Asialofetuin (ASFN) was coupled to Scpharosc beads using CNUr·activated
)J
Scphamsc41l,accordinglolhcmanufhcturcr'sinstructions
Materials
(I) CNllr-activaled Scpharosc4B suppliedas freeze-driedpowder by Pharmacia LKB
m ;tltcdmol()gy All, Uppsala, Sweden)
(2) Asialofctuin (ASFN;Sigma)
(3) Ilydrochioric acid(1Iel) solution: I mfo"l l·ICl
(4) Coupling buffer: 500mMNaCI in lor mMsodiumcarbonatebuffer,pH 8.3.
(5) Tris-IlCIbuller: 100mMTris-lICI,pIl8,0 ,
(6) Alternatingpll buller A: 500mM NaCIin 100 mMsodiumacetatebuffer,pH 40
(7) Alternatingpl l buller B: 500mM NaClin 100mM Trts-Hcl buffer, pH 8,0,
(8) Columnstorage buller: proteaseinhibitorsolutionas describedin section 1.2.3 plus
0.02%NaN\in 100 mM Tris-IICIbuffer, pH 7.6
(9) 0.02%sodiumazide(NaN,) in water.
Method
15 g orCx nr-Scpharosc 41lwassuspended in 1001111of HC!solutionandwashed
withJ Lof thc Silnlel lCIsolutionon a sinitcred glassfinerfor 15 min, Thenthe matrix was
resuspended in80 mlofcoupling buffer. 250mgofASFNwasdissolvedin 20 1111of coupling
bufferand added to thennurix. The mixture wasrotated at4°C overnight. ExcessASFN
waswashed awaywith400 Ill ofCOLI piingbuffer, Theremaining activegroupson the matr ix
were blockedwith 'l'ris-llfll buflcrfor 2 hours at room temperature. The conjugate was
washedwith] cyclesofa hernatingpll buffers,eachcycleconsistedofa washwith ]00 ml
oraltcmating pl! buffer Afollowed by another washwith]00 mlof alternatingpH bufferB.
The preparedmatrixwaspacked into a columnin storagebufferaI 4°C. Ancr beingused,
the ASFN-Scpharosccallberegenerated bywilshing with] changesof alternatingpH buffers.
1.2.5.2. Preparation of D-Gal·Sepharosc-t1l
Preparation ofD-Gal,Sl.'pharosc-til was canted (lUI according 10 Fomstcd and l'orath
(1975) with some modifications
Materials:
(1) Sepharose4B (Pharmacia).
(2) Carbonatebuffer A: 500 mMsodiumcarbonate boner. 1111 11.0
(3) Carbonate buffcrB: 500 mM sodiumcarbonate bntfcr. pl l 10,0
(4) Bicarbonate solution: 500 mM bicarbonate in distilled wateradjusled t0 1l1111,5 hy I N
NaOH
(5) D·Gal solution: 200/0(w/v) Dcgalactosc ( D·Gal; Sigma) in carbonatebuller B
(6) Divinyl sulphone (DVS) (Sigma)
(7) z-mercaptoerhanot (Sigma)
(8) 0.02% (w/v ) NaN.\ indistilledwater
Method
100 011 of Scpuarosc4[3was washedwith 500 mluftlistil1edwater nil" glass flllel
and thenwith 200 O1l of carbonate buller 1\, lind immediately suspended in cmholl'.:e buller
A to a finalvolume of 100 ml. The Sepharosc was then incubated with 10 ml DVS under
stirring at roomtemperature for 70 min The DVS-:lctivall'tl gel was cnrcfuliy washed with
distilled water and resuspendedin 100 01 or D-Gai solution andincubated overnight at room
temperature. Subsequently, the Gal-coupled Scpharcsc 411 was extensively washed with
water and suspended in lOa mlof bicarbonate solution, The remaining DVS groups were
blockedby adding 2 rnl orz -mcrcaprocrhenclend stirring lilr2 hours at roomtempcnnurc
The resulting product was extensively washed with water andstored ill water with (j,02%
1.2.6. lso l ~l (ioq of ASGI'R fro m Liver Acetone Powder .
ASGI'I{ isolation was carriedout according to Hudgin et at. (1974).
1.2.6.1. Solubilization of Liver Acetone Powder.
Materials:
( I ) Liver acetone powder: see section 1.2.4
(2) Solubilization buffer: 200 mM NaC!, 10 mM EDTA and protease inhibitors (see section
1.1.3.) in 100 mM sodiumacetate-acetic acidbuffer, pH 6.0
(J)Distilledwa ter.
(4) Extractionbuffer: 400 mM Ke l, 1%(v/v) Triton X-lOOand0.02% (w/v) NaN) in 10 mM
Tris-HCI buITer,pl-l 7.8
(5) Solidcalciumchloride(CaClz, Sigma)
(6) Solid Tris base(Sigma).
Note: all the solutions werecooled at 4 C C before using
Method:
15 g of liver acetone powder was suspendedin 15 to 20 volumes of solubilization
buffer and homogenized with five up-and-down strokes of a pestle homogenizer. After
incubation on ice for 30 min, the suspension was centrifuged for 10 min at 20,000 " g. The
pellet was washed once with the solubilization bufferand then with distilled water by re-
homogenization of the pellet and rc-centrlfugatlon. The final pellet was suspended and
solubilized in 300 ml of extraction buffer at 4·C for I hour. Unsolubifized fragments were
removed by centrifugation at 100,000 " g for 2 hours. f inally, solid CaClz was added into
the crude receptor extract 10 a concentration of SOruM and the pH was adjusted to 7.8 by
addingsmall amounts of solid Tris base.
1.2.6.2. Isolation of ASGI'R by Ligand AninityChromatography.
Materials:
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(1) ASFN- or D-Gal-Seplmrose 4B matrix(see sections 1,2,5.1 and 1.2.5.2)
(2) Loading buffer A: 50 111M CaCI:. 1.251\1NaCi. 0.5% (vI\") Triton X- IOOnud prorcnsc
inhibitors (section 1.2.3) in 10 mM Tris-HC'Ibuffer, pH 7,8
(3) Loading buffer B: loadingbuffer A without Triton X- IOO
(4) Elution buffer A: 1.25 M NaCland 0.05%Triton X- JOU in20 1lIl\1 11 11111l0niutllacetate -
acetate acid (NH~AC-HAC) buffer,pH 5,0-5.2.
(5) Elution buffer B: 500 mM NaCIin 20 mM Nl-IlAc-IIAc buffer, pll 5,2.
(6) NnOH solution: 10 N NaOH in distilledwater.
(7) Solid Tris base.
(8) Saturated ammonium sulfate: 90!:l of nunuoniumsulfate, (NII,hSO. W:I S ndded to 100
ml of distilled water, heat-solubiliz.ed, cooled to roomrcmpcrarurc and adjllsh'd to pll u.S
with solid 'Ir is base
(9) PBS: section 1.2.2.1.
(10) Tris-HCI buffer: 25 mM Tris· I·ICI buller, p117.8
Method:
The procedure for ASGPR isolation and purification includes followingthree majur
steps:
(I) Isolation of ASGPR using a large ligand affinitycolumn. Ahout 50 ml of ASfN-
Sepharose 48 or D-Gal-Sepharose 4B gel was washed severaltimes with loading buffer A
on a glass filter. Thegel WIISimmediately transferred \0 the prepared crude receptor extract
(200-300 ml) and gentlystirred on a shaker at 4DC overnight. Aflcr careful washing with
loading buffer on a glass filter, the receptor bound gel in 100 1lI1 of the same buffer was
carefully packed into a chromatography column(50 Clll ~ 5 em (p) and further washed with
3 bed volumes of loading buffer till there was no protein washed out. Bound receptor was
elutedwithelution buffer Aand fractions ors-ml werecollected. Aflcr protein determination
by using Bicinchoninic Acid Assay(DCA,secsection 1.2.16), the protein-comnlning fractions
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were pooled and the Ca2' concentration was re-adjusted to 50 mM and pH 10 7.8.
(2) Purification of ASGPRusingsmallaffinitychromatographycolumn. Receptor-containing
solutions obtained from the large columnwere applied to a smallligand affinitycolumn (10
cm '" 1.5 cm «I) with about 5 ml of gel which was pre-equilibrated with loading buffer B.
Upon adsorption at 'lGCfor 3 hours, the Triton x-ton was removed by washing the column
with 50 ml of loading buffer B and the bound receptor was eluted with elution buffer 8 .
Fractionsof I· or 0.85-011were collected for protein determination by absorbency at 280 nm
or, in some instances, by DCA (section 1.2. 16). Fractions containing proteins were pooled
and pl-lwas adjusted to 6.5 by NaOH solution
(3) Concentration of purified ASGPR. Purified ASGPR obtained from the small ligand
affinity column was precipitated by adding an equal volume of cold saturated ( NH~ )ISO~
followedby incubation on ice for 2 hours. Receptor protein was recovered by centrifugation
at 50,000 x g for 30 min, dissolved in I 011 of PBS or 25 111M Tris-HCI buffer. dialyzed
against PBSor Tris-IICIbuffer, arid lyophilized usinga Freeze Dry-Sapparatus (Lebconco.
K .C.• MO .).
In someinstances. purificd receptor proteinwas dialyzed against 10-fold diluted PBS
or Tris-HCIbutler and directly concentrated by lyophilizationwithout prior ammonium sulfate
precipitation.
1.2.7. Isolation of ASGPH Subunit Poly peptides by Electro- Elution.
Materials
(I ) Materials for 50S- PAGE are described in section 1.2.16.
(2) Electro-elution buller: 15 mM glycine and 20 mM Tris base, pH 8.3.
(3) Dialyscrtubing lor proteindialysis (Fisher ScientificCo., Pittsburgh, PA.).
(4) PBS: section 1.2.2.1.
Method:
Affinitypurified rASGPR proteins (section 1.2.6) were subjected 10 SUS-PAGE
(section 1.2.17) in parallel with presraincd molecular mass markers. The gel slices containing
bands of receptor subunits with appropriate mol ecular Sil.CSwere cut out from the ge l and
placedinto preweued dialyzertubing with 2 1\11 of'clcctro-chnien buller. Then, themembrane
tubing was closed tightly and placed into the upper reservoir of n f\lini-I'ROTEAN II
apparatus(Bio-Rad). Aller addingelectro-elution buller to the upper and lower reservoirs.
electro -elution was carried out at 180 lilA lor about 45 min. Eluted subunitpolype ptides
were collected from the elution buffer in the dialyzer tuhing" dialyzed against PBS and
concentrated by lyophilization
1.2.8. Im Ollllliz:lti on of Aniruals with Purlfled H.l·("t'jllurs mnl Recepnn- S uIl,mil
Polypt'pt idcs.
Materials:
(1) Animals: healthyguinea pigsand woodchucks
(2) PBS: section 1.2.2.r: sterilized
(3) Adjuvant: complete and incomplete Freund's adjuvant ((FA ami II-'A, respectively)
(Gibeo).
(4) Antigens: affinity-purifiedrASGPR.wASGI'R. and electro-eluted 40-\.;1),1and 47-kDa
polypeptidesofrASGPR (see sections1.2.6 lind 1.2.7). Antigenswere dialyzedagainst PBS
prior10 immunization,
Method:
Before immunization. antigen in PBS in a glass syringewas mixedwith an equal
volumeof adjuvant (CFAor IFA) inanothersyringe. An emulsion was produced hy pushing
the plungers of the two glass syringeswhichwere connected through II three-way valve
For theimmunizationof'gulneepigswiththe affimty-purifled wASGJ'R,rASGI'R, 40-
kDa or 47·kDa polypeptides of rASGPR. three doses of antigen were administered
intramuscularly orsubcutaneously at multiplesiresfor the firstinjection. and intramuscularly
for booster injeclionsovera 6-10 g-wcckperiod. Eachdose contained SO).lgofwASGPR,
rASGPR or 40·kDa subunit protein, or 25)1gof 47·kDasubunit protein in 300)11volume.
Antigen emulsifiedinCFAwasusedfor thefirstinjeclion andinIFAfor the secondand third
injections. Animalswere bled OUI two weeks after thefinal injection,
For theimrramizrnionof woodchucks withaffinity-purifiedrASGPR, 50 ).lgof antigen
perdosewasused. Antigenwas administered in two doses withina j -week period. For the
first injection, rASGPR wasemulsifiedin CFA and for the secondin IFA Serial serum
sampleswerecollected before, duringandaller completion of the injections at weekly or
biweekly intervals. This Immunizanon washandledbyother researchers in this laboratoryand
the resultingantiserawerekindly provided and contributed topartof'thecurrentwork for this
thesis
Sera from healthy woodchucksandguineapigswereusedascontrols. All antisera
wereseparatedand storedinsmall volumes al -70QC.
1.2.9. Solid Pha se Enzyme -Link ed lmnmuosorbent Ass:lY(ELI SA) for Anti-AS GPR
Det ecti on.
ELISAwas carried out according to McFarlane ct al.(1983) andTreichel at al. ( 1990)
with some modifications
Materials:
( I) Affinity-purified rASGPR and wASGPR (see section 1.2.6,),
(2) PBS: section 1.2.2.1.
(3) Blocking buffer:3% (w/v) bovine serumalbumin(BSA)(Sigma)and 5 mMEDTAin
PBS,
(4) Loading buller: 25 I1lM NaCI,5 mMEDTA and0.05%{v/v}Twccn·20 in 10mMTris·
Hcl burtcr. pH 7.6.
(5) Reaction buffer: 250 mM NaCIin 10 1111\1Tris-llf't buller, pl l 8.0.
(6) Rabbit anti-woodchuck IgG and Igl\1: prepared by other researchers in this laboratory
(Michalaket al., 1990).
(7) Enzyme-labelledantibody A: alkaline phnsphatasc-cunjugutcdgoat antl-goincn pig IgG
(H+L) (Jackson lrnmunogcscarch Laboratories, Inc. WcstGrove. PA.)
(8) Enzyme-labelled antibody B: horseradish pcroxidnsc-conj ugntcd gl):!l umi-rnbbit IgG
(H+L) (Bio-Rad laboratories. Hercules, cA.)
(9) Alkaline phosphatase substrate: p-Nitrcphenylphosphate (pNPP tablets. Sigma FAST,
Sigma).
(10)Horseradish peroxidase substrate: TM13 pcroxldnsc EIA substrate kit (lJio-Rad)
(I I) Washing buffer (PBST): 0.2% (v/v) 'rwccn-znin PUS
(12) Woodchuck sera and guinea pig sera lor testing: see section 1.2,8
(13) I M H1S0 4
(14) I N NaOH..
Method:
In the preliminaryexperiments, purifiedrASGPR proteinswerediluted in I'I1S, 50 ng.
100 ng, 200 ng and I ~ g/50 ~ 1. and coated on the microplates (96 Ilat-bottnm wells plates,
le N Biomedical Inc., Horsham, PAl at SO IIIper well. Aner iucubntion llt 4QC overnight, the
plates were washed with PBST and then blocking buller was added, JOO III/well, for
overnight incubation at 4Q C. The plateswerewashed egnln. For the finalexperiments, plates
coated with 100 ng receptor protein/well were chosen
Subsequently, woodchuck sera or guinea pig sera collected from ilI1imnis immunized
with ASGPR and the receptor subunit polypeptide preparations (sec section 1.2,8) wcre
diluted to 1:50 or serially j -fold diluted from 1:50 to I:1,638,400 in loading bulle r. Diluted
serum(SOIlUwell) was added to the ASGPR coated plates and the reaction was carried out
at 4°C overnight. The plates were carefullywashed with PBS'!"three times, S min pcr wash.
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For the detection of woodchuck antibodies. the plates were further incubated with
1:50 rabbit anti-woodchuck IgGand !gM in loading bulTer (50 IJl/well) at room temperature
for 2 hours. After washing. SOIJIof enzyme-labelledantibody B at 1:250 in loading buffer
wasadded10 the plates for I hour reactionat room temperature. The plates were extensively
washed in PBST and the bound enzyme activity was determined by adding horseradish
peroxidase substrateaccording to the manufacturer's instructions. After stopping the reaction
by adding I M 11 2S0~, the product of the reaction was determined by reading the plates at
450 nrn, using a microplate reader (model 3553 , BIO-RAD).
The guinea pig antibodies were detected by enzyme-labelled antibody A at a dilution
of I:10,000 in reaction butler following the manufacturer's specifications. After 2 hours
incubation at room temperature, the plates were washed extensively in reaction bufferand
then developed by alkaline phosphatase substrate. accord ing to the manufacturer's
instructions. The reaction was ended by adding 1 N NaGH and the results were read from
the plates at 405 nm
Each serum sample was tested in duplicate. Mixtures of two or three sera from
nonimrnunizcdwoodchucks or guinea pigs were used as negative controls
1.2.10. Absor)ll ion of An ti-rAS GPR Anti serum Using Purilic d rASGP R.
Materials:
( I) Blockingbuffer: 3% (w/v) BSA in loading buffer (sec section 1.2.9.).
(2) Nitrocellulose membrane: 0.45 11m trans-blot transfer medium(Bio-Rad).
(3) Guinea pig anti-rASGIIR antiserum section 1.2.8. The serum was diluted 10 1:100 in
loading buffer (sec section 1.2.9) before absorption.
(4) PBS: section 1.2.2.1.
(5) BSA solution: I mg/ml BSA in PBS.
Method:
About 45 ~g of affinity-purified rASGPR protein was spoiled onto I C lll~ of
nitrocellulose membrane. The spots were air-driedand then incubated in blockingbutler at
room temperature for I hour. One mlof dilutedguinea Ilig llnti-rASGPR untiscrum was
incubated with the nitroc ellulose blot at 4°C overnight and then at ambient temperat ure for
I hour. Theaqueoussolution containingASGI'R·absorbed serum wascollected for further
testing. Antiserumwhichwas incubated with nitrocellulose membrane sportedwith USA
instead of ASGPRwas used as a control
1.2.1 t , Immunoflucresceut Staining.
Materials:
( I) Cells: isolated woodchuck hepatocytes andcultured IIepG2 cells(section 1,2.2).
(2) PBS: section 1.2.2. I.
(3) HBSS (l e N Biomedical Inc.)
(4) Antisera: guinea pig anti·ASGPR andanti-subunitsof ASGPR antisera (section 1.2.8).
(5) Fluorescein isothiocyanate(F1TC)-conjugated goat nntl-guincn pig IgG (IIH,) (Jackson
ImmunoResearch Labs, Inc" WestGrove, PA.).
Method:
To assess the expression of ASGPR on the surface of isolated or cultured cells,
approximately 1 x 104 of mechanicallyisolated woodchuck or rat nepntocytcsas controls in
s-ml glasstubes.and HepG2 cellsgrowingon tissue cultureslides were waslu...u with IIBSS
and then incubated with anti·ASGPR antiseraat I:I0 or I:20 dilution incold PBS for ]0 min
on icc. Afterwashing with three changesof cold PBS, the bound guineapig antibodieswere
identified by incubation with FITC.conjugated antibodies diluted to I:25 in PBS for 30 min
The cellswerewashed againin coldPBS andexaminedfor immunofluorescenceusing a Leitz
Diaplanmicroscope(LeitzCo., Germany). Sera fromnon-immunizedguinea pigs were used
as first layer antibody control. Cells incubatedwith PBS and thcn with n rC-conjugated
4.1
antibodies were also used as additional controls.
1.2.12. Rndioiodinal ioll or l'r ott ins.
Iodination of purified ASGPR. ASFN, HPM and hepatocyteswas carried out
according to the IODO-GEN method describedby Markwelland Fox(1978).
Materials:
(I ) IODO-GENsolution: 0.1%(w/v) of 1,3,4,6 tetrachlcro-Je.e e-diphenylglycohni l (Pierce
Inc., Rockford, IL.) inchloroform(Fishcr ScientificCo., Fair Lawn, N1.).
(2) PBS: section 1.2.2.I.
(3) Phosphate buffer (PO): 20 mM PO, pH8.0
(4) Tris-HCIbuffer: 25mM Tris-HCIbuffer,pH 7.6
(5) Nitrogen gas
(6)Carrier.free NalllJ: activity 100 j.lCi!J.11 (AmershamCanada Ltd. Lachine, Que., Canada)
(7) BSAsolution: 5% DSA in I'Dor Tris-HCIbuffer.
(8) SephadexG-25 (Pharmacia)
(9) Materialsforradiolabelling: affinity-purified ASGPRs, asialofetuinand asialocrsumucoid",
andpurifiedwoodchuck IIPMs asdescribed in sections 1.2.2 and 1,2.6,
(10)2% SDS in PO
(11)Cellculture rncdium: section 1.2.2
(12)TCA solution: 25%(w /v) trichloroaceticacid in PB or Tris-He l buffer.
'" Asialoorsumucoid (ASOR) was prepared by digestion of 7 Illg of orsumucoid (a RM,
Sigllla) with 0.6g insolubleneuraminidase(neuraminidase fromCtostridnan pe/j r illgell.f type
VI attached to agarosc bcads al 40unitslg agarose. Sigrna) in 10 ml of 0.15 M NaAc~HAc
bulTer(pH 5.0) at 37G C for overnight and then by removal of the beadsbycentrifugation at
500 xg for 10 min. Prepared ASORwasdialyzed against PBS andconcentrated before use.
Method:
( I) Preparation of samplesfor radiolabelling. Purified ASGl'Rs, Hl'Ms, ASFN and ASOR
weredilutedin PBS at a concentrationof I mg/ml. In some instances, ASGPRs lll1d IIPMs
were solubilizedby boilingin 2% SOSfor J min prior to labelling
(2) Preparation ofIODO-GENcoaledtubes. 10or 100 ~11 of frcsblyprepared IODO-GEN •
chloroform solution was used to coat the inner-surface ofn 5-mlglass tube, Coatingwas
carried out at room temperature under a stream of nitrogen gas lor evaporating the
chloroform. The coated tubes were stored in a desiccator III room temperat ure andused
within I year.
(3) Preparation ofSephndex0 -25 columns, Sephndex0 -25 beads were swollenill PBlind
transferred to a 10 011 disposable syringe with a glassfibrecushion. The preparedcolumnWlIS
equilibrated with I 011 of nSA solutionandthen washed with 10 mlof pn or Tris-11CIhuller.
(4) Iodination using JODO-GENmethod. 10 to [50 pg proteinswere reacted with ::!OO J.l Ci
or 500 J.lCi ofNa'"! at ambienttemperature for 10 to 15 min, in IODO-GEN coated lubes.
Thereactionwas stopped by adding I 01 of Pil or Tris-i-ICI buller. Labelled proteinswere
separated from free iodine bygel filtration on Sephadex 0 -25 columns, eluting with PB or
Tris-Hel buffer. Fractions of I 011 werecollectedand their radionctivities weremeasured by
a gammacounter (1277 Gammamastcr, Pharmacla). High radioactivity-containing fractions
were pooled together, dividedinto smallsamples and stored at 4°C.
Specificradioactivity for preparations ranged Irom 2.5 ~ 10-' to 2.5 ,. I O ~ crllling
protein. The concentrations of labelled proteins rangedIro1ll2.5 ng/J.l 1to 44 ng/J.lI
(5) Determination of radioactivity incorporated into proteins. The method used was
described by McFarlane ( 1984), Briefly, 5 ul of radiolabelled proteins, 495 J.l 1of IlSA
solution and 500 J.ll of TCAsolutionweremixedina lube. Afterincubation on ice for I hour,
the mixture was centrifuged at 1,000 Y g for 5 min. Then, 500 [.II of the upper supernatant
wastransferredinto another tubeandboth tubes, containing the upper and lower parts of the
solution respectively, were counted in a gamma counter. The percentage, calculated
according10thefollowing equation, representedthe radioactivity incorporated intolabelled
proteins: Radioactivity bound to protein > (lower- upper) + (lower + upper) x 1000/0
RadioabelJedproteinswere usedfor etherexperiments onlywhen the percentages(as
calculatedabove) wereebove90%.
1.2.13. Solid Phase Rcceptor-Ljgnud BindingAssay.
The ligand binding activityof purified wASGPRand rASGPRpreparations was
determined accordingto QuesenberryandDrickamer(1992)and Schwartzal al.(1981)with
somemodilications
Materials:
(I) "t -lebclled ASFNor ASOR {section 1.2.12): approximately20 to 44 ngflJI inTris-HCI
bufferwitha specificradioactivityo f l.36. 1.42>- 1O.1cpm/ng.
(2) Receptor proteins: affinity-purifiedwASGPRand rASGPR(section 1.2.6)
(3) ASFN, ASOR or ORM solution: 10·20 mg/ml asialoferuin (ASFN, Sigma),
aseloorosumccoid(ASOR)(section1.2.12) or orosumccoid (ORM, Sigma) indilution buffer
(seebelow).
(4)PIlS: section 1.2.2.1.
(5) Dilutionbuffer: 25 mMTris-Hel buffer, pH7.6
(6) Blocking buffer: 0.2% (v/v) Tween-zn and 5 mMEDTAindilution buffer.
(7) Washing buffer: 1.25 M NaCIand 25 mMCaCIJ indilution buffer.
(8) Reaction buffer(10 x): 1.5 M NnCI, 250 mMCaCll and 0.2% (v/v) Triton X·lOO in
dilution buller.
(9)Falconl1c:<iblcplates: oe-flat-bcuorn-wcllmicro-test assay plates(BectonDickinson Co.,
Oxnard,C A).
Method:
(1) In the preliminaryexperiments. to establishassay ccndulons, falconIlcxiblcntarcswere
coated overnight at 4°C with affinity-purifiedASGIIRat concentrations rangingfrom 25 to
125 ng per 50 J.ll of PUS per well. Aller rinsingwellswilh washing buflcr. fhc plates were
incubated withblockingbullerat o4 ·C overnight andwashedngnin. Then, increasingamounts
ofll'I·ASFNrangingfrom 40 to 100 ng was plpcued into the wells. The reaction volume
wasadjusted to 50 }.II per well by adding 1/ 10volumeofrcnction buller ([0 ~ ) anddilution
buffer to reacha finalconcentration of 150 mMNaCl. 25 tllto. l C'aq and 0.02% Triton X- IOO
in2SmMTris-HCI buller. Followingincubationat .t°C overnight.the unbound 11~t_ASFN
wasremoved in severalchangesofcoldwashingbutler. Subsequently. each wellwascui out
and the boundradioactivity counted using II gammacounter
(2) To determine the specificityof ASGPR·ligandreaction. a binding nssnywascarriedour
in the presenceof unlabelledASGPsor glycoprorelns. Oddly. llilinily-purilicd wASCi l'1l in
PBS was used for coating thc plates ( IOO ngfSO ~L1 /well ) as describedabove. 1ll1-ASOR
ranging from17t o 102 ng per 50 J.ll was applied for thebinding under similarconditionsas
above(I) , Parallel experimentswerecarriedout withunlabelled ASORor ORMIt! XSO ng
or 8500 nglwe1t; this was 5-10 450-foldexcess10labelled ASOR,
(3) To measurethe bindingkinetics betweenligandand purifiedASGI'R. platescoated with
100 ng/wellof ASGPR protein wereused. Increasing amounts of 11l1·ASFN from 2Sto 450
ngjwell were added. Non-specific binding was dctcnuiucd by parallel incubations in the
presence ofl OO-fold excessofun labcllcdASFN. Specific bindingof l!ll-ASFN10ASGI'R
wascalculatcdby subtraction ornon-spcclnc binding fromthe corresponding total binding
(4)AJl theabovedeterminationswereperformed at least iutripticatcs. A nonlinearregression
program (GraphPad InPlot, Grapbpad Software, Inc., CA,) was applied to lit thc data
obtained from the kinetic study. The data for saturation determination were lilted 10an
equation: Ligand bound = B...~ " [ligand]/Kd + [ligand],where K~ was the concentrationof
ligandat which half-maximal bindingwasobtainedlindB.....was the maximalbindingunder
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the conditions described in this assay
1.2.14. Rndielmmuno preclpltntl eu assay.
Materials'
( I) UlI_labe!Jed IIPM: section 1.2,12
(2) Loading buffer: 50 filMTris-HCI buffer. pH 7.6. containing 0.3 M NaCl. 0.4 M KCI.5
mM EDTA. I mM PMSF and 1% (v/v) Triton X-100
(3 ) Sera: guinea pigantisera and normal guinea pig serumas described in section 1.2.8.
(4) Protein A beads: 10% (w/v) staphylococcal proteinA immobilized on Sepharose CL-4B
(Sigma) swollen in loading buffer.
(5) Washing buffer: 50 mM Tris-HCI buller. pH 7.5. containing 150 mM NaCI. 1 mM
EOTA. 0.25% (w/v) gelatin. 0.1% (v/v) Triton X- laOnnd 0.025% (w/v) NaN).
(6) Samplebuffer: 3% 50S, 10% glycerol and 5% z-mcrcaptocrbenol in 62.5 mM Tris-HCI
buffer. pi-I 6.8
Method:
10Jcpm of radiolabelled HPMs in I mlof'loadingbullerwas precleaned by incubation
with 10 ~ l of normal guinea pig serumand 50 ul of protein A beads for 3 hours at ambient
temperature. Then. the samples were incubated with 10III of anti-ASGPR antiserum per
sample at4 D C overnight . followed by precipitationwith50 ~I of protein A beads at room
tcmpcmturc for I hour. Theresultingbeadswerewashed in several changes of loading buffer
and treated with sample bufferto release the bound proteins which were further analyzed by
50S- I'AGEand nutorediogmphy (see sections 1.2. 17 and 1.2.19)
1.2.15. Ligand Prl.'cipi ll\!ion Assay.
To examine the ligand binding activity of ASGPR in purified HPM. an affinity
precipitation aS5<'Y was carriedout accordingto a method described by Mu et al. ( 1993)with
somemodifications.
Materials:
(1) Dilution buffer: section1.2.13.
(2) Reaction buffer (10 x): section 1.2.13. Reaction buller (I ~ ) was diluted from
concentrated buffer withdilutionbuffer.
(3)Plasmamembranepreparations. woodchuck,mbIJitandrat IIPMs, andwoodchuck KllMs
andSPMsas controls. Seesection1.2.3 for details
(4) D-Gal beads: 10%(wlv) n -Gat-Sepbnrosc 4B(seesection 1.2.5.2) in reaction blink
(5) Ligand-freebeads: 10% (w/v) Scpharosc 4Bin reactionbutler
(6) Chaps solution (5 x): 50 mM 3-[(3-cholamidl1propyl) dimethylannuoniuj- l-
propanesulfonate(Chaps, Sigma)indi\\lliol1 bUITL'T.
(7) DOCsolution(5 x):0.5%(w/v) sodiumdeoxycholate (Sigma)and 150 111MNaClin50
IMf Tris-HCl buffer, pH8.4
(8)SamplebufTer: section 1.2,17.
Method:
Plasma membrane preparations(340 f.lg proteinper Sa1111)lc) were treated with 1/10
volumeofre.actionbutfcr(IOx), 115 volumeof Chapssolution(5 ,,) or 1/5 volume of nOC
solution(5 x)indilutionbulTer. Afterincubationat rocuucnpcraturc for )0 min, 100 IIIuf
D-Galbeadswereaddedto themembranesolutionandthetotal volume wasadjuslcd to I
mlwithreactionbuffer. Reactionwas carriedouta14°Covernight withgentlemixing ona
rotatingtray, followed bycentrifugation ar 320 ~ g for 10 sec and5 washes with reaction
buffer(1x,indilutionbuffer). Bound proteins werereleased byboilingfor3 min in50 III of
samplebufferandusedfor SOS-i'AGE separationand Westernblotanalysis
For control experiments. solubilizedwoodchuck IlI'Ms were prcincubatcd withan
excess of free D-Gal prior to the incubation with D-Gal bends, as well as membrane
preparationswere incubatedwith ligandfreebeadsinstead of f)-Gal beads
1.2.16. Blduehoninic h cid ASSllY for Protein Content Determination .
Materials:
( I) Bicinchoninic acid assay (OCA) kit (Sigma).
(2) Protein standard (IlSA, I mglml) (Sigma)
Method
The procedure recommended by the manufacturer was used. Fresh protein
determination reagent was prepared for each assay. Protein standards (BSA) ranging from
10 lISto 100 J.Ig weremade in PBS or in the solutionused forsample dilution (e.g., Tris-HCI
buffer) and tested to establisha standard curve. Tested sampleswerediluted in PBS, or in
original solution in which sample was kept, to 100 III and incubated with 2 ml of protein
determination reagent at Jrc for 30 min. Aller cooling to room temperature, the
absorbency was detected at 562 nm. Protein content was determined according to the
standard CUTVe established from the proteinstandards.
1.2,17. SO$-I·AGE.
The methodused was according [0 Ha rlow and Lane ( 1988).
Materials:
( I) Samplebuller: J% SDS, 10% glycerol and 5% [l-mcrcaptocthancl in 62 .5 mM Tris-HCI
buffer, pH 6.8.
(2) Samples for testing: allthe preparationsfor thedetermination of subunit compositionand
polypeptide molecular sizes or for autoradiography and Western blotting analyses.
(3) Protein molecular mass standards: low range standards containing rabbit muscle
phosphorylaseB (97.4 kDa). USA (66.2 kDa). henegg white ovalbumin(45.0 kDa), bovine
carbonic anhydrase (31.0 kDa), soybean trypsin inhibitor (21.5 kDa) and hen egg white
lysozyme (14.5kDa) (Bio-Rad); low range prestained standards containing phosphorylase B
(106.0kDa), BSA (80kDa), ovalbumin (49.5kDa),carbonic anhydrase(32.5 kDa). soybean
s o
trypsin inhibitor (27.5 \:Oa) and lysozyme(18.5 kDll) (Bio-Rad): high mng~ prestnincd
standardscontaining myosin(205.0Wa). p-g.11aclosidnse(116.0 kDa), bovine serumalbumin
(80,0 kDa)andovalbumin(49.5kDn) (Bio-Rad);l~-l1\~ hylat l"llJrOlei n standards ~llnlaini ng
myosin (200 kDa), phosphorylasc-b (97 kD,l), BS/\ (6()0 l.:Oa), ovalbumin (-16.0 kU.I),
carbonic anhydrase(30.0 W a) andlysozyme (14.0 kOa) (Amcrsham}
(4) 30010acrylamide mix:29.2% (wlv) acrylnmide (Bio-Rad) andOJ)% (w/v) N,N'-mcthylcnc-
bis-acrylamide indistillcd watcr.
(5) Lower Tris-HCIbul ler: 0.4% (wfv) 5DS and 1.5 MTris-fKlbu ffcr, pl l SS
(6) Upper Tris-HCIbuffer: 04% (w/v) 50Sand 0.5 MTris-l lClbuncr, pll 6X
(7) Ammoniumpcrsulfate(AP) solution: 10%ammonium pcrsulfato(llio-R:ld ) ind i.~t i l1cd
water. This solution was freshlyprepared before usc
(8) TEMED : N,N,N',N'-letramelhylelhylcnediaminc (Bio-It;\d)
(9) Running buffer: 25 mMTria-baseand 200mMglycine with2% SUS indistilled water.
pH S.7.
Methods:
(1) 12.5%separatinggelsolution was prepared by combining 4 mlof 30"10acrylemidc mix,
3.35 ml of'water, 2.5 ml of lower Tris-Hel buffer, 150 pi or AI' solllinn and 2,5 " I \If
TEMED. Upperstackinggelsolution contained SOOIIIofacrylmuidc mix, 1,25 mluf'uppcr
Tris-He l buffer, 3.17 ml of water, 75 JlIof AI' solution and 5111orTEM H} , The gel was
polymerizedin 0.75 or I rumz 7 ern z 10 emglassplates (mini-gel] nod ,lSSClIlhlcd for a
Mini-Protean II apparatus(Oio-Rad)orin J.5 mn " 15em' 20 ern(large gel) fo r a Protean
IIapparatus (Bio-Rad) followingthemanufacturer's instructions
(2) All samplesfor 5DS-PAGE analysis were treatedwithsample huller by boilingfor J· S
min and loaded into thegel wells using npproximntcly 0.2, 10 to l-\£ proteins P'-'f lanc for
mini-gelsand100 II!!proteins perlanefor large gels. Electrophoresis wascarried ourat 21KI
V for about 45 minor 4 hours inrunning buffer, Proteinstandardswere applied inparallel
for eac h run
I.:U8 . Cccmass ie lIIue Staining.
Materials
(I, Slainingsolution:0.05% (w/v) Coonrasstc brilliant blueR.250, 50%(v/v) methanol and
JO"Io (v/v)ace ticaci~indislilled water
(2) Dcst aioiog solution 5% methanol and7.5% acetic add in distilled water
(3) Prot einsseparatedon SDS·IIAGE gels:section 1.2.17
(4) filt e r paper (wlnnnan lntcnnulonalLtd.)
Method :
Proteins separated onSDS·PAGEslabgelswere placed in staining solutionfo r )0 min
nt room temperature with gentleshaking and then dcstaincdin dcstaining solution at room
temperature till the dyecolorofthe backgroundwas removed. Stained gels were stored in
destaining solution for photography or dried on filter paper usinga slab-geldryer (Hoefer
Scientific lnstrumcms. San Franciso, CA.) fo r long-ter m storage
1.2.19. AUlo.oadiogr:lphyo
Materials '
(I ) X- ray fikn: Kodakscienritic imagingfilm (XAR-5 ) or Kodak diagnosticfilm (XRP.] )
(Eastman Kodak Company, Rochester, NY. )
(2)WI_labelled proteins separated o n SDS-PAGEgels: section 1.2.17.
Method :
SDS·IIAGE slabgels weredried mid exposed10 X-raylil m for lite a ppropriate lengt h
of'timc (from 16 hours 10 severalweeks, dependingon the sampleradioactivity) at 4°C or
at -700 e ina light-proofcassette. The filmwas developedin a Kodakautomate de veloping
machine.
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1.2. 20. Dens itometer QlIlIlItil :ltion fur me Gels lUll! A IIIOl'lUliogrllll1S.
Wet 5DS·PAGE slab-gels and autorndiograuis were ana lyzed by densitometric
quantitation usingan UhroScnnXLlaser densitometer with :l u.:.n 2220 recording iutcgrntor
{Pharmacia-LKll Biotechnology) accor ding tot hcmanufacmrcr's instruction
1.2.21. West ern Btcutng .
Materials:
( I) Transfer buffer: 39 1111'0.1 g lycine, 4811I1\1'Ir is-base. 0 ,0.171% (w/v) SUS :lmI20% (v/v)
methanol in distilled water
(2) Nitrocellu lose membrane: 0.45 um tmns-blot transfer medium (li io-Rad)
(3) Other bulTers and reagents included leading bnncr. reaction buller, blocking huller,
PBST, rabbit ami-woodchuck IgG and IgM, euzyme-lahellcdantibodies Fur detail SI,'C
sect ion 1.2.9 ,
(4) Alkaline phosphatase substrate: brcmochlorcindoly l phospluu c-nitro blue teunzolium
(BCIPINBT) tablets (25 mg substrate/ tablet) (Sig11l il), According III the manufacture's
instructions. I tablet of nCIP wasdissolvedin 0.5 1111of dimcthyllo nnnmide(Sigma) and I
tablet of NBT was dissolved in I 1111of distilled Willer. [JClI'/N BT sokuionwas fr c shly
preparedby adding 330 IIIol'NBT solutionand33 III urnC1Ps olution into10 1111of 100 111M
Tris·HCl buffer, pfl 9 .5, containing 100 111M NllC l l1 l1d 5 mto.l magnesiumchloride(MgCl)1
(5) Horseradish peroxidasesubstrate: 3% (w /v) of'-t -chlor o-l-uauluhol (Sig ma) ln uhsohuc
etha nol. Before developing the reaction. 100 J-li or chloronaphtholand 10 [II of JO%
hydrogen peroxide (H~O~ l were mixed with 10 1111 ul'50 lllMTns-I lei buller, p1l7.6
(6) Samplcs for SDS-PAGE: section 1.2,17.
Method
Proteins separated on SDS-PAGE slab-gels were rmusferrcd onto nitrocellulose
membrane as described by Michalak and Lin (1 994). by using a semi-dry rransier unit
5,1
8ioTransMa~ i (GelmanSciences,Ann Arbor. M I,)
( I) After SDS-PAGE, theslab gelwas soakedin distilled waterfor 5 minand then assembled
in a sandwich in the followingorder: 3 layerso f f lltcr paper presoakedin tra nsfer bu ffer, 1
nitrocellulose membrane presoakedwith distilled water, the slabgcl andanot her3 layers of
transfer buffer-wet ted filter paper. The sandwich was placedin the transfer unit,w ith the
anodeon the membrane side andthecathodeon the gel side. Elcctrotrmsfer wascarr iedout
at 0,8mA/cml of gel for30 to 45 min. The efficiencyof transfer wasverified accordingto
the prcstainedprotein standardsor by the protein traceon the post-transferred gelvisualized
with Coomassicblue
(2) Aftertr ansfer. the membraneblots weredisassembled fromthe apparatus, air-dried for
about 10 min al room temperature, and then incubated whhblockingbuffer for I hour at
roomtcrnpcraure. Beingrinsedinr OST twicefor 5mineach,the blotswere incubated with
primary antibodies (forguinea piganti~ASGPR antisera,dilutionwas I:400 orgreater; for
woodchuck antisera, dilution was I: 10 or greater) in la nding buller at 4°C overnig ht and
followed by incubation at room temperaturefor I hour. Allerwashingthe blots in PBST,
goatanti-guineapig 19G(l-I+L)conjugatedwith alkaline phosphatasewasuse d to detect the
boundguinea pig antibodies, whereas a mixture ofrabbit anrisemrecognizing woodchuck IgG
and IgM and horseradishperoxidase-conjugated goat anti-rabbit IgGwere employed to
idcntifybindingof woodchuck antibodies.using the same conditions asdescr ibedin section
1.2,9. Aller extensively washingtheblots withPOST, the enzymeactivitywas develo pedby
addingthe corresponding substratesolutionto obtainan insoluble product . Reaction with
alkaline phosphatase substrate identified thcact ivityof guinea pig antibodies, whereas the
reaction with horseradish peroxidase substra te identified the activity of woodchuck
antibodies, Molecu lar massesofvisunlizcd proteins weredetermined usingcu rvesestablished
from the relative mobilities of prcnalncd molecularstandardsrun on eachge l.
1.3. RESULTS
1.3.1. Isolation lind C llllr:ldcriz :l!ion or \\'oodch mk1I1'1l:ltk ASGI'R (IYASGI'RI.
1.3.1. I. Purificationor wASGPR.
Accordingtoan criginlprocedure established bl'Illldginetal. ( 1974), ASGI'Rwas
extractedfrom acetoneliver powder with I% Triton X· IOO. Thecrude receptor prepa ration
was furtherpurifiedby ligand·aflinitychromatography, byusing two successive (OtiC large
andone small) ASFNaffinity columnsor, in some instances, D·G"lcolumns.lypiC<l1 lll'llfiles
ot the elution of binding receptor proteins fromtheASFNcolumns arc detailed illfig. 1.1.
Asshow"(Fig . 1,1 A and B), purified woodchuck rcecpror proteins were rec overed in the
secondarybedvolumeor clotcn bullerafter thechromatogruphyinthe smallcolumn. These
result s areingood a!V"eemcnl with rJ al a re [X>ned byl 'l ud~in e t <11 .( 1974). I:ig, 1. 1 (('a nd D)
also shows correspondingchromatography profilesofrabbit /\SGPR proteins. revealing
patternssimilar tothose ofwASGI'R
Fivepreparations ofwASGPIt,four of rl\SGPRand ol1eol'rtAS(JI'1{ were pariflcd
in the courseof the present work Theaverageyieldsor these receptor IlrCparaliulis arc
summarized in Table 1.2,which s110w tha t the yield or wAS(JJ'R is lower th.mlllat or
rASGPR, but similar to thelt or rtASGrR Considering the possible difference in the
interactionsbetween ligandandASGrRs derived from different species, a fewmodifications
to the receptor purificationprocedurewere made in anattemptto improve the yield of
wASGPR. Grant andKaderbhai ( 1986) reponed tluufactors, such as thccmccmruionof
Triton X·JOO andNaCI. markedlyinnencctheligand binding to thepurifiedrtASGPRnr the
plasma membrane-associatedASGrR. Ilasedon this report. iheoriginal procedure was
modifiedbyadjusting the pHof the elution buller From6.0 to S,Oand the cmcemmtiuns of
NaCI andTriton X-IOOI'rom 1.25 M to 150 mM andfrom 1'1. to 0,1%, respectively
However. despitethesemodifications, there wasno improvement in the yield of'wASGPR
ss
Figure 1.1. Puri llcnticn of ASGf'R by liglutl.1-atlillily chrom ntegra p by.
Chromatograms ofwASGPR(Aand D)andrASGPR (C and D) were obtained by usingtwo
successiveASFN·Scpharose 4B columns(A and C: large columns. approximately 50 ml
beads per column; Band D: small columns, approximately 101111beadsper column) as
described in the text(section 1.2.6,). The initialchromatographies were performed on the
largecolumns by subjecting200-300 mlof TritionX-l ooextracts of liver acetone powders
from normal woodchuck(A)and rabbit (C). The columnswere ehned withelutionbuffer A
(sec section 1.2.6.2.) at a flow rate 01'25 ml/h. Fractions (5 ml/each) were collectedand
monitored for protein content using the IlCA method (see section 1.2.16.). The protein-
containing fract ions(in A, fractions 5 to 20 and in C,Ii'aCliol1s 4 to 20) were pooled and
subsequently appliedto the small columns (8 and 0 , respectively). For the small columns.
theelutionwas performed withchuionbuller B (see section 1.2,6,2.) at a flow rateof 15
mllh. Thecollected fractions (3 mUcach) were assayed lor protein comcmby BCA for
wASGPR(13) and byabsorbanceat 280 11m lor rASGPR(D). f ractions zeroare thepoints
where elutionbuffers were applied ontilecolumns.
Thisfigure reveals that the affinity chromatographicprofiles or wASGPRaresimilar
to those ofrASGPR

Table I.:!. 't'idd~ "r n el"" e IIl'er powder alulll ffinll)'-pur lneLl
hepallcASG Plh rn'n1 wo",khu",k. , rabhib ..nd ~ n t
Nllllll",r "f
prcparnnons i\ cCI<lIl\: Jiwf M;{iI'Rp n'lcil1
!{"hhit
· ·l1 lcm l ± sl~llIl:lrJ ..J.. ..;"li'lIl{:-;l)
57
J7 ±2
19
711H: IXI
216
Thisconfirmed our initialobservation thai theoverallamount ofASGPRin woodchuck liler
was lower than that in rabbit liver.
1.3.1.2. Biochemical propertiesofwASG Pll
1.3.1.2.1. Receptor polypeptide composition.
Examination of the afllnity-purificdwASGPRby 50S- I)AGE and Clk11l111!'O!'Oie blue
staining(Fig. 1.2) de monstrated that the receptor wascomposed o ftwo major polypeptides
withapparent molecular masses of40 and 47 kDa, According to the densitometric so.::anning
of the gels, the approximate ratio01'2-3:1 was foundbetween lhe 40-kDa and the 47 -kDa
polypeptides inthe purifiedreceptor. RabbithepaticASGP Il also yieldedthesame pauem
of protein bands on 5DS-PAGE gel with a subunit ratio 01'40 kDa to 47 k1Ja at 2 : I. In
contrast, as described by other researchers(Table 1.1), purified rut ASGPR showed one
prominent polypeptide with molecular mass of about 44 kDa and minor h,lllds with
approximate molecular masses of 52 kDa and 65 kDa. In ncldition, several bands with
molecular masses of about80-105 kDa andabove 200 k Dn were consistcrulyseen on the
Coomasste blue-stai ned gels or both wASGPR lindrASGI'lt Long term stcruge of the
purifiedreceptor pro tein resulted inadditional bandswith approxluuucmolecularmassesof
25 to 35kDa which are considered10 be degraded receptor proteins (c.g , in Fig IJ and Fig
1.4). Overall,t he w ASGPR polypeptide profileclosely resembles that ofthe rASCiIJR, bUI
is distinct fromthe molecular patternof the rlASGPRsubunits
The high molecularweightspecies(higher than 100 kDil) seen inthe purified ASCil'lt
preparations arc most likelythe resultorrcccptor subunit scU:nggrcglllioll,as described by
Tanabe et al. (1979) and shown in Table 1,1. In thecourse urrhis study, tile presence of
prot ein bands with high molecular weight was also consistently observed in Ihe isolnred
ASGPR subunits. As shown in Fig. 1.3. 40-kDa subunits uf rA5G I'Risolatedbyelectro-
elutiondisplayedthe formation orhomc-oligomerpolypeptides with approximate mole cular
Figu l't 1.2. C Olllpllri so n ormolecul:lr 110IJl II'piid e Ilrolil" or lhe a ffinily· p u rifled
w ASGPR., rASGPR ,00 rtASGl'R protein by 50S- PAGE. IVASGPR(Iane2~ rASGPR
(l and ) and rtASGPR (lane 4) wa-c sepmted ar 10 11& protein per lane on 505· 12.5%
polyacrylamidegel and tilepolypeptide hands werevisuali2edby Ccomassie bluestaining.
Sccscdions 1217 and 1.1 1S fordetails ofthe methods. Non--preslair.cd protenmcleccle
massmarkers(laneI ) inkilodahonsare inditated onlhe len sideo f thepaneL
This figure showsthat lhemorecaer composition ofwi\SGPRis similarto that of
rASGPR and different fromthatofrtA5GPR.
m.wt.
kDa 2 3 4
97.4 -
66.2 -
45.0 -
31.0 -
21 .5 -
Fig. 1.3. The rt llttioll betwee n IlIOllOlllCl"iClUll! olil;Olllrr ic spt cit S or A5GPR
su h u nits an a ly:ztl! by w estern blollillg. RCCCPIOf subunilS were isolaled from alli nily-
rxtriflCd rASGPRby 50S-PAGE and gel eiecrro-eletion{secsection 1.2.7 for details), The
purified 4O-kDa subunit polYPCPliclcs (lane I. 0 2 jig protein per lane), 47-kOa subunit
polypeptides (lane 2, 0 .2 vs prolcin per 411I1:) and the allinilYilu rified rASGPR whole
prmcins (laneJ, O.SliS~cin perlane) weresubjCC1l-d10WcsI~n bIoI analysis using guinea
pi/; antiserum againstrA5GI'It. Sl"C sccnon 1.2 21lor details of'tbc l1k'lhad. The molecular
masses of prcslaillcd prolein standards [lane 4) arc shownon the rightof the panel.
This figure shows thai flurilied 40·kDa subunit polypeptides form homo-oligomer s
withthe molecular m.1ssof SO·kDlI, whereas the 47-kD3subunitpolypeptides self-aggregate
into <)()-kDa homo-ollgomcrs. Degradedspecies with approximate molecular massof 30 kDa
Ilrclilsoshowninthcpr cjlllniliollOf 40-kDasublillil.
m.wt m.wt.
kDa 2 3 4 kDa
90 106.0
80 - 80.0
47 49.5
40 -
30 - 32.5
27.5
18.5
Fig. 1.4. The inr era ction be tween constiluent subunits in affiuity purified
ASGI'H preparathms analyzed by SIlS-I'Ac.a: mill nutorndiogmphy, Surface Ilsl_
labelledafflnity-puntlcd native rA5UPR [lane I, 15ng prolcinl5~ lOs cpm per lane; lane 2,
6 ng prolcinl2>'lOS cpm per [Me) and 2% 50 S-solubilized rASGPR (lane 3. 6 ng
pf(l lc i n/S ~ 101 cpm per lane) were separated by 50S-PAGE and visualized by
autoradiography exposingovernight at -70·C _ Sec sections 1.2.17 and 1.2. 19 for details of
the methods. 'l'hcmolecular masses of l 'C-labdk.'dmolecular standards(lane 4) arc indicated
on the right sidc of th is panel
This figure shows thatthe47-I.:Oa subunit of the purified native rASGPR was poorly
labelled lIy surface iodination and became welllabelled ntlcr rrcauucm of the receptor with
detergent prlc r to mdiolabching
m.wt . m.wt.
kDa 2 3 4 kDa
- 200
- 97
- 69
47 -
<l - 4640 -
- 30
- 14
massof8 0 kDa, whereas the 47-kDa subunits self-aWregated into 9O-kDa polypeptides.
The presence of self-aggregates in the purifiedreceptor preparations raised some
concern about the immunologicalproperties of the native (or detergent untreated) ASGPR
macromolecules, as these preparations were usedas antigen for immunization of animalsand
for antibody detection. During the investigation of tile physical relationship between the
subunits, it wasnoted that the 40·kDa polypeptides ofr ASGPR were preferentially labelled
after surface-specific iodination of tile purified, native rASGPR (Fig. 1.4). Densitometric
tracingof tileaUloradiograms ofthcsereceptor preparations showed that the 40-kDa and47-
kDa subunit hada ratioof7 ; I. To disruptthe intact receptor macromolecules, receptor was
solubilizedindetergent(2%SOS) prior to the radiolabclling. Results showed that under such
conditions,40·kDa and 47-kDasubunits ofr ASGPRcould be labelled at an approximate ratio
of2 : I. This ratio closely resembled thai found for the subunits from the native receptor
separatedbySDS-PAGEandstainedwith Coomassicblue. Theseresultssuggest that the 47-
kDapolypeptidesarc partially hidden in the purifiedintact rASGPR macromolecules. Since
there is a strong similarity between the woodchuck and rabbit receptors, we proposed that
the same structure relationship may exist between the polypeptides of isolated native
wASGPR.
1.3.1.2.2. Ligand binding activityand kinetic studies of tile purifiedwASGPR.
The ASGPR purified by affinity chromatography from woodchuck liver or. as a
control, from rabbit liver was examinedfor the ligand bindingactivity using solid-phase
bindingassays. In the initialset ofexperiments, optimalconditions for ligand-ASGPR binding
were established by using microtiter plates coated with increasing amounts of purified
wASGPRandsubsequently exposed to increasing amounts ofml ·ASFN. Fig. 1.5 shows the
amounts or ml·ASFN bound 10 the immobilized wASGPR. At a coatingconcentration of
100ng ofwASGPRproteinperwell, fhcbindingvalues tilllinto a region in whichthe binding
Figure 1.5. Determination or ASG I'I~ co:lting couceuuu rlcu ror solid Ilhllst'.
ligand binding assay. Flexible plates coaled with affinity-purified wASGlll{ in PBS at
different concentrations ranging Irom 25 ng to 125 ng/50 IIIper well wen! incubated with
increasing amount of \lSI~ASFN (1.36>\ io' cpllI/ng) rangillg from --10 ng to 100 ng. Aller
washingout excess1ll1.ASFN, theboundradioactivitywas counted and presented as amount
of llSl·ASfN bound in ng. See section 1,2.13 lor details or the method. Elich point
represents the mean or triplicate determinations(mcane SD).
This figure shows a dose-dependent ligand binding by wASGI'R contcdat 100 ng
protein per welt
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kinetic profileshowed a linear relationbetween the concentrationsorc oated wASGPR and
bound 12S1_ASFN. Therefore. this coating conccntrnticnllOOng per well)wn~ chosen as a
standard for the studiesof ligand and purified ASGPRbinding
The specificity of the ligand binding to the purilied wASGPR or rASGI'1l was
determined by adding 5· to 425-foldexces orn n unlabelled ASOR (asiafylotcd glycoprotein)
or ORM (sialylated derivative of ASOR,control), as competitors, to the reactionof ASGI'R
and ml_ASOR. As shown in Fig 1.6, results revealed Ihat ASGP (ASOR), hut not
salog lycoprotein (ORM)inhibited (>80"10)the interaction between !HI_ASOR aud ASGPR
This result demonstrates that purified wASGPR recognizes lUI asialylatcd glyeoprctcin Iignrnl
but not a sialoglycoprotcin, indicating 11strict ligand Sllccilicilyof'the purilied wASGPR
To access theligandbindingcapabilityof theaffinity -purified wASGI'R, the kinetlcs
of mI-ASFN bindinL were examined. Incubation of incrcasing amounts () rl~' I.ASFN with
a constant amount of immobilized wASGI'R gave a monophasic,conceutmtiou-dcprndem
curvilinear pattern of the binding kinetics This pattern suggests th"t the interaction is
mediatedbya single classofsalurable receptor. Fitting the durnto a one-site binding model
by a computerized nonlinear regression programproduced the ligand-binding kinetic curve
(Fig. 1.7) andScatcbardplot (Fig. 1.7, insert), which showsthe dissociation constant (Kd) for
thebinding was 7.4 " I O·I~ M and the maximum binding(Il,...,) was 1.2 ~ 10.11 M under the
assay conditions used. These data support the conchrsionrhata single classot'r cccptor is
involved in the interaction between wASGPR lind its ligand. ASFN.
Under the sameassay conditions.binding betweenpurified rASGI'Rand ASI'N gave
an estimated Kd and BOlO, value of 5 ,. IO· I ~ M and 2.3 ,. Iffll M, respectively Comparison
of these data with those for wASGPRsuggests that altlmugh the wASGPRdisplays 11100-
foldlower number ofl igand binding sitesthan rASGPR per umuunt ofr eceptor protein, ns
ligand binding affinity is approximately Ino-foldhigher than uuu uf thc rabbitreceptor.
Figure 1.6. Speti ficity of ligand binding 10 the llffinit)··lluri fied wASG PR and
rASGPR determined thr ough ccmpetitlon of ml·ASOR a unchment by nslnlylated lind
sialyll ted glycoproleins. Immobilized wASGPR (A and B) or rASGPR (C and OJ was
incubated with IllI_ASOIt (1.42" 10.1 cpmrng) ranging from 17 ng to 102 ng per well
(controls). Parallel experimentswere carried out under the sameassayconditionswiththe
additionalunlabelledASOR(Aand C) or ORM(13and D) present. Theboundradioactivity
ontheplates wascountedand presented as theamount ofml ·ASO I~ bound(ng). See section
1.2.13for detailsor thcmethod. Eachpoint represents the meanof triplicatedeterminations.
This figure showsthat bindingbetween theaflinity-puriflcd ASGPRand l2l1.ASOR
is specifically inhibited by an asialylated glycoprotein. ASOR. but not by a sialylated
glycoprotein.ORM
ss
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Figure 1.7. Bindingof l15J·ASFN to lite alnnity-purifird wASGPR as a function
of ligand ceneenrratren. Increasedamounts of radiolabcllcd ASFN( 1.36>< 10) cpm/ng)were
incubated withconstant amounts of immobilizedwASGPR (coated at 100 ng protein per
well)with orwithouta l00-fold excess ofunlabcllcd ASFN. Eachpointrepresents the mean
of triplicate determinations of specificbinding / II.I'I,!((, Scntchnrd plol of binding data
indicatinggraphicaJlyt he presence ofa singlesaturablereceptors ire. Thelinesof best fit to
the data points wasdetermined by a computerizedprogralll. See section 1.2.13 for details
of themethod
This figure shows a concentration-dependent pattern ofrcnction between purified
wASGPR andits ligand, suggestingthat the bindingis mediatedby a singleclassof saturable
receptor.
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1.3.13. Immunological properties of ASGPRs
In thecourseof currentstudies.guineapigs were immunized withpurifiedwASGPR,
rASGPR and its subunits (40-kDaand 47-kDapolypeptides) in order to prepare specific
antibodies for the detection of receptor subunits and the analysis of receptor antigenic
properties. In addition, two woodchucks werechallenged with purified rASGPR,and their
seraweretestedto determine whetherrASGPR wasimmunogenic inwoodchucksdespite its
apparent structural andantigenic similarities to wASGPR. A reference guineapigantiserum
to rASGPR was kindly provided by Dr. B.M. McFarlane from the Institute of LiverStudies,
King's CollegeSchool of MedicineandDentistry, London. U.K. This serumwasusedas a
posluvc conuol.
1.3.1.3.1. Immunogenic and antigenicproperties of wASGPR analyzedby usingguineapig
anti·ASGPRantisera.
Titration of the antisera from immunized guinea pigs using microplates coatedwith
rASGPR (Fig.1.8) showed that challenge with both the entire ASGPRpreparations and
isolated receptorsubunits induced highlevels of specificantibodies.demonstratinga high
immunogenicity of the receptor preparations derivedfrom eitherwoodchuckor rabbit liver.
The titers of theseantisera wereas highas I:819.200.whilethe non-immunizedguineapig
scm(NGPS) usedas controls were negative. Titrationof theantisera againstrASGPRwas
alsoperformed by radioimmunoassay (RIA)(this methodis describedand discussed inPart
II of this thesis). Both assays, ELISA and RIA. gave similar results.
Usingtheseguineapig antisera{l.e.,anti-wASGPR,anti.rASGPR,anti·40·kDa and
anti-47-kDa). the antigenic properties of theaffinity-purified ASGPRs and their subunits were
analyzed byWestern blotting. Thefollowing resultswereobtained:
( I) Atltheconstituentsubunits of ASGPRpreparations derivedfrom differentspecies were
recognizedby bothantj·rASGPRand anti-wASGPR antisera
Figure 1.8. Titmtion or guineu Ilig llll l i- ,\SG I' I~ lllllisl'ra by I::Ll SA. Scm from
guineapigs immunized with theaffinity-purified rASGPR. wASGI'R, or isolated 40-kDa- and
47-kDa·subunitsofrASGPR were seriallydilutcd Iiom 1:50 to 1:1,6] 8,400. The sera were
testedfor the reactivity with rASGPR by ELISA,as described in section 1.2.9. Results arc
presented as the absorbance at 'lOSr un. A pool of sera from nOll-immunizcd guinea pig."
(NGPS)were used as a control. Each point represents Ih~ mean ofduplicntc dctcrmimuions
(meane SO).
This figure showsthai all theanti·ASGPR nntiscmriscd illguinea pigsagainst the
entire ASGPR molecules (anli.wASGPR and anti·rASGI'!t) or the isolated subunit
polypeptides (anti-40.kDaand anti-47-kDa) react with purified ASGPRwith similar titers
Serum DIlut Ions (log)
10-1
Allthe polypeptides ofwASGPR, rASGPRand rtASGPR wererecognized byanti-
rASG/'Rantisera, indicating thata strongantigenic cress-reactivity existsamongtheaffinity-
purified ASGPRs derived fromthese three different species (Fig. 1.9A). The ASGPR-
spcciflcuyofanli-rASGPRwasconfirmed (Fig, 1.10,lane10) bycompleteelimination ofth e
antibody activitiesafter absorptionwith purified rASGi'Rperformed as outlined insection
1,2,10
Essentially identical results to those found with guinea pig anli-rASGPR were
obtainedwhenguineapiganti-wASGPRantiserum wasusedfor imrnunoblotdetection(Fig
1.913), Both subunit polypeptidebands orchhcrwASGPR or rASGPR wererecognized with
a comparable densityby this antiserum, furtherdemonstrating the strongantigenic cross-
reactivi tybetweenthese tworeceptors.
(2) Distinct antigenicspecificity of ASGPR subunitswere recognized byami-40-kDaand
aml-ar-kna annscra
The antigenic specificity of ASGPR subunits wasalsoanalyzedbyWestern blotting
using guinea pigantiseraraisedagainst 40· or 47-kOa polypeptidesof rASGPR. Results
revealedthat immunization withthe40·kDapolypeptideled to appearanceof antibodies with
exclusive reactivitytowards the40-kDapolypeptides of eitherwASGPR or rASGPR«s..
Fig, 1.10,lane 5). Thisantiserumalsorecognizedthe 44-kDaproteinband or thertASGPR
preparation (not shown), Also,antiserum raisedagainst the47-kDa polypeptidedisplayed
a specific rencnvity towardsthe47-kDa of both wASGPRandrASGPRat a dilution higher
than 1:400 (e.g.. Fig. 1.10,lane 8) and recognized 52-kDaand65-kDapolypeptidesof the
affinity-purifiedrtASGPR(dntanotshown), Thus, theseresultsdearlydemonstratedthat the
40- and 47·kDa subunits orwASGl'R or rASGPR are antigenically distinct by using the
5Ubunit mono-specific antisera. Ontheotherhand, thecorrespondingsubunitsof wASGPR
and rASGPR with thecomparable molecular massesappearto have verysimilar antigenic
properties This conclusion is in goodaccordwith the reportson the protein sequence
Figure 1.9. The sJlccificil)' of gllim'lI Ilig lllu isl'ni ngainst ntlinit)'-pllrilil'd
ASGPR preparations analyzed b)' Wcstr l'lI hlolling. Affinit y purified wt\SGI'R (laue 2).
rASGPR (lane 3) and nASGPR (lane4) were scpamtcd m 0,2 II ~ proteinper lane on 5\)5 -
PAGE. electrct ransferred onto nitrocellulose and idcnrificd by innnunoblouing with guinea
pig antisera againstaffinity-purified hepatic ASGI'R from rabbit (Al and woodchuck (11), Sec
section 1.2.21 for details of the method. The molecular Ill<lSSCS of prcstahrcd protein
standards (lane I) in kiloda1tons (kDa)are indic.llcd on the ld\ silk uf'jhc p;lllcls
This figure shows that guinea pig antisera against either rASGJ'R or wASOPR
recog nize all the constit uent subunits of the allinily-purilk u wASGI'R, rASGI'R aIHI
rtASGPR.
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Figure 1.10, The snbunlt-spcrlflchy Ofg llilll':1 p ig :llllb l'r :1l'iSl'd against :tllin ity-
purified ASGPR and isolated AS G I'R 1'01)']ll'{Itidl's :lI1 ;1 I~,Z\' t1 h~' W l'Sh'l'll hlulli llj:.
Affinity-purified rASGPR (OJ Ilg protein per nne: lanl'S :!, 5, S and10) anti woodchuck
hepatic plasma membranes (HPrvls)( 10 Ilg protein per Ianc ~ luncs 3 , 6, () and II) were
separated by50S-PAGEand analyzed by inununublonlng lI~ i llg guinea pig antiseraagain~l
wASGPR (lanes 2 and 3), the 40-kDa subunit (lanes 5 and ll) o r Illl',I7-kD:!subunit(lanes
Sand 9) or with antiserumagainstrASGI'R prcnbsurbcd with purified r/\SGI'R (lane 10 and
11). See section1.2.21 for delails o fthe method. Prcstuiucd pnnc iu standards nrc showu in
lanes t, 4 and 7 and their molecular masses indiclll'd on the Id i orthc puncl
This figure shows that guinea pig anti·i\SGI'R subunit lllollospecilie antisera
recognize relevant receptor subunits in the purified receptor and woodchuck IIl' M
preparations. and that antisera against the entire ASGI'Rsreact with both 40- und 47-kDa
subunit polypeptides of'afflnity-purified ASGI'R. II is nlsc shown thatneithe r <l nli-wASGI'R
nor anti·47·kDa antibodies recognize the 47-1.:1):1polypclllides in woodchuck [II'M
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homology between ASGPR subunits Irom different species (Drickruatucr et ul.. In84;
Bezouska et al., 1991)
1.3.1.3.2. Immunogenic propertiesof ASGPR analyzedusi ll~ antiSertl tfl\ll\W\llldehuch
immunized with rASGPR.
The above immunoblot analysesusing guinea pig antisera haveshown the srroug
antigenic cross-reactivity between affinity-purified wt\SGPR and rASGPR. II is olint crcst
to know whether rASGPR is immunogenic to woodchucks. Sera Irom tW~l woodchucks
injected with two dosesof rASGPRwerecollected at different limes before, during and utter
immunization. Titration of these woodchuck sera by RIA (for method, sec section 2.2..1)
revealed that the titers of anti·ASGPR in these sera ranged between 1:800 ;1I1d I:IhOO As
the immunizations of woodchuckswerecarried out at a lowerantigen dose per IXldy-wciglll
than those of guinea pigs. it is difficult to preciselyevaluate the strength of the inmnme
response to ASGPRby comparing thetiler of woodchuck anli-ASGPR antiserawith that of
guineapig anti·ASGPR antisera. However, these two woodchucks did showthat rASGPR
was immunogenic to woodchucks. despite the antigenicsimilarity betweenwASGI'R and
rASGPR. This result indicates that rASGPR canbe used as an antigen to stimulate anti-fiver-
specificantibody responses in woodchucks. Therefore, immunization of woodchucks with
purified ASGPR may provide a convenientexperimentalsystem to study the autoinunnnc
responseto hepatic ASC.PRand viralhepatitis in the saute auimals. Thissystem muy be or
significant value in the study of the pathogenic role ofolnti-ASGPR autoimmune responses
in the woodchuck modelof hepatitis B
Receptorsrbunit-speciflcity of'thcwoodchuck antiserawas also analyzed hy Western
blotting. Results are summarized in Table 1.3 and illustrated in Fig. 1.1' . Tbcse results
revealed that challengewithrASGPRled to the appearance of'antibodicsspecificfor both40-
and 47-kDa subunitso f rA5GPR. indicating that both subunits of rASGPRare hnmunogcnlc
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Figure 1.11. The ASGPR subunit s Jl.'c ifid t ~· ol':llllist'r:1rist'd ill woodchucks by
immunization with rASGPR. Atlillity-purilit'l! rASGPR(OJ Ilg protein per laue. lanes 2
and3) wereseparatedby SDS-PAGE, trnnstcr cd 01110 nitrocellulose and separatelyanalyzed
by Westernblottingusing sera ( I:10) [romwoodchuck A (sec Table1.3) obtained at 10 days
(lane 2) and 42 days (lane 3) after administration ofthe first dose ol'rASGI' R. Sec section
1.2.21 fordetails onh e method. The molecular masses of'prcstniucdprotein staudnrds (lanes
I,l ow range; and lane4, high range) arc indicated 0 11theJell arulrighl sides orthe panels
This figure shows that immunization ora woodchuckwithpurified rASGI' R produced
a specific antibody responsewhichinitially was directed aguinsrthe receptor <I0·kDa subunit.
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to woodchucks. Interestingly, antibodies with reactivityagainst rho .JO_kDa polypeptide
could bedetected within 10 days after immunization with the first dose, whileunnbodlcs to
the 47-kDa polypeptideemergedapproximately 2 weeks afterttrebooster inununizntion. This
result may be interpreted as showing that the major 40-kDa subunit of rASGI'R is more
immunogenic than the minor 47·kDn subunit when the ntllnity-punflcd. whole receptor
macromoleculesare used for immunization
1.3.2. lIepaioeyte Sur face Expression or wASC1' lt
1.3.2,1. ImmunocYlOchelllicall ocalizatioflof thc wASGI'R on hepatocytcs
Expressionof wASGPRon isolated woodchuckhcpatocvtcs wasexamined by indirect
immunofluoresecent stainingwith guinea pig antiseradirected to the entire wASGl'1lor
rASGPRmolecules, or to the subunit polypeptides of rASGI'Il, Fig, 1,12/\ shows rhnr the
guinea pig antibodies 10 ASGPR are granularly deposited on hepatocytcs. indicatingthe
reactionbetweenanti-ASGPRantibodiesand wASGPRon hcputocytcs. No differencein the
pattern of the ASGPRlocalizationwas observed bystaining woodchuck bcpntocytcswith
either anti-ASGPR antiseraor anti-subunit specific antisera. Incubation or tile hcpatucytcs
with a pool of sera from non-immunized guinea pigs resulted in no immunofluorescent
staining(Fig. 1.12B). confirming the specificity of this reliction
ASGPRexpressionwasalsodetermined on the surface ofcuhurcd IIepG2 cells, a cell
line derived fromhuman HCC. The results showedthat the ASGPR displayed(Ill IlcpG2
cellswasvel)' wellrecognized by ourguinea pig anti-/\SGI'R antisera (e.g. Fig, 1.12C), The
specificity of this reaction wasconfirmed by incubationof'thc Ile[1G2 cells with u poolof'scra
from non-immunized guineapigs (data not shown), These results imply 111;11an antigenic
cross-reactivity not only exists between w/\SGPR and rASGI'R but also exists between
wASGPR and humanASGPR.
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Figure 1.12. Expression of ASGI'R 0 11 hcpntccytes detenulned by Indirect
fmmuncnuorescent staining. Isolated woodchuck hcparocyrcs{AI and culturedHepG2
cells (C) wereincubatedwithI:20guinea pigantiserum against rASGPR, After washing,the
cells were stained with Fl'FCcconjugatcd goat anti-guinea pig IgO (1:25). As a control,
woodchuck hcpatocytes (8) were incubated with a pool of normal guinea pig sera (I :20)
instead ofa nti-rA$GPRantiserum, Sec section 1.2.11 for details ofthe method. Original
magnifications. A and 8, )(400 andC. )(250
This fig..re showsthai both woodchuckand human hcpatocytes express ASGPR on
the cellsurfacewhichis readily recognized by illlli-rASGPR antiserum.
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1.3.2.2. Hepatic plasmamembraneexpression ofwASGPRsubunits.
1.3.2.2.I. Immunologic properties of hepatic plasma membrane-associated wASGPR.
Although results from immunoflaorcscent staining have shown the presence of
wASGllR moleculesat thesurface ofisolated woodchuckhcpatocytes, it was necessaryto
determinethe receptorsubunitdistributionin the purified hepatic plasmamembranes (HPM),
since the immunocytochemical staining docs no! provide the opportunity for suchdetailed
analysis. For this purpose, plasmamembranes were purified from wholeliver homogenate
or from isolatedhcpatocytesof healthy woodchucks, as well as WHY-infected animals which
developed ell or BeC (see section 1.2.3). Subsequently, the purified membraneswere
analyzed by Western blotting for the expression of the membrane-associated wASGPR
subunits
Results from Western blot analysis showed that only one band with eppn..xinate
molecularmassof 40 kDawas consistentlydetectable in the purified HPMs from healthy
woodchucks, using guinea pig antisera against wASGPR, rASGPRor against the 40-kDa
subunit (Fig 1.10, lancs3 and 6; Fig 1.1J, lane5) Identical results were also obtained when
HPMs fromwoodchucks with WHY-inducedCH or Hee wereexaminedbyusingthe same
antisera (Fig. 1.14) Ascontrols, plasmamembranes purified from woodchucksplenocyte
(SPM)and kidneyhomogenate (KPM) wereprobed. Results revealed norecognition of SPM
(Fig I.IJ, lane 2) or KPM (not shown) bythese antisera, suggesting that the protein bands
identified in woodchuck HPMwerein factliver specific. Inaddition, the specificity of this
inuramorcactionwasconfirmed bythe elimination of recognhionof the HPM-associated40-
kpa-band following the absorption of the anti-ASGPR antiserumwith the affinity-purified
ASGPR(Fig. 1.10lane I l). This indicates that the 40·kDa polypeptide band in woodchuck
HPM is antjgenically closelyrelated, itnot identical, to the 40-kOasubunitof the affinity-
purifiedwASGPR.
It was surprising that a protein band corresponding to the 47·kDa-subunit of
17
Figure 1.13. Ccmpnrlson of molcculaI' 1101)']lrptidc l'J'oliks ofASGr R in hepntlc
plasma membranes:isolated from woodchuck, rabbit and n il. Isolated IIl' l\ls (10 Ilg
protein per lane) from a healthy woodchuck (laue 5), rabbit (lane .1) and rat (lane 4), and
control plasma membranesfrom woodchuck splenocyte (lane 2) were separated by 50S-
PAGE, electrotrensferredonto nitrocelluloseand analyzed by humuncblcttingusingg,lIinell
pig antiserumagainst rASGPR, Seesection 1,1.21 for details ofthe method, The molecular
masses of prestained protein standards (lanes I lind 6) arc indicated on the len side of the
panel
This figure shows that in woodchuck j-II'Monly the 'lO-kDn polypeptide. which is
liver-specific and corresponds to the nmjor subunit of the atliuity-purificdwASGPR (sec
Fig.1.2, lane 2) was recognized by antiserum against rASGPR, Nevertheless, the sante
antiserumidentifiedthe polypeptidescorresponding to nllrhc constituent subunits of rASGPIl
and rtASGPR in HPMs from the respectivehosts, This result indicates annppnreru lack of
the 47-kDa subunit reactivity in the purified woodchuck 111'1\'Is when unnlyzcd by a
conventional Western blotting.
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Figure 1.14. IdtntiCicatlon or wASGl'1t subullits inlitll:lIit plasma membranes
rrom healtb)' woodthucks and woodchucks with chro nic br)J:ltilis :lud \\ 'IIV-inducrd
htpaloctllularc arcinol1ll l b)' w esteru blotting. Isolated }\PfI,bfrom healthyanimals (lanes
6 and7) andanimals withexperimenla.lly inducedCII (lanes 1,2 , 3 and "') or with lice (lane
5) wereseparated by SDS-PAGE at I0 ~g proteinIX'" lane. rrensfcrrcd onto nitrocellulose
andanalyzed byimm.Jnoblottingusing guillC3 piganti-rASGPRilluiS4.wm. Sec section 1.2.21
for detailsortlle method. The molecular massesof prestaincd protein standards (lane 8) arc
indicated on the right side of the panel.
This figure reveals that only the 40-I.:Da subunit polypeptideof wASGPIt was
detectable by Westernblot using anti-ASGPR antibodies ill the Il[>f\t s thlill woodchucks with
or without WHY-induced liver pathology.
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wASGPR could notbe detectedinany or tlle I-lI'M preparations (Fig. 1.10. f ig. 1.13 andFig
1.14). Increasing the amount or the membranestested by Iu-Icld (from 10 Ilg to (00).lS
membrane proteinsper lane) for Westemblot analysis did notlcud to [hedetection ofthe 47M
kDa-band(Fig. 1.15, lanes 1, 2 and 3), In contrast, thc samepanel of alltibmlics clearly
demonstratedexpression of allIhe constituent ASGPlt polypept ides in either rabbit nr rat
hepatic plasma membranes when 10 pg or membrane protein per lane wasused for the
immunoblolling test (Fig. 1.13, lanes 3 and 4 and Fig. 1.15, lane 4).
In an attempt to detect the 47-kDa subunit of wASGPR in woodchuck III'M, a
radioimmunoprecipitation assay was employed to analyze I!ll-Iabdled native (detergent
untreated) HPMs or SDSMsolubitized woodchuck LPMs Allcr precipitation by antisera
against wASGPR, 40·kDa or 47· kDa polypeptide. the precipitates of horh native or
solubilizedHPMs displayedthreebandswhhapproximatemolecular masses or30, 40 and 47
kDa,as it isshown for native IIPM in Fig, 1.16. Polypeptides ofsimilar molecular sizes to
thesebands had beendetected in purifiedASGPRpreparationsby protein staining ofSDS-
PAGEseparatedgelsand by anliMASGPR antiserain Westernblotting, as shown in Fig. 1.2
and Fig. 1.9. Therefore, these plasma membrane bands ruost likely representedthe wAS(iI'!t
subunits in the membrane preparations, In addition, controls prepared by precipitation of
radiolabelled-Hl'Ms withproteinAMSepharose beadsalone or with non-immunized guinea pig
seradid not revealsuch polypeptide patterns, Fig1.16also shows that ldcnncalpcucrns were
obtainedwithallthe antiseratested, irrespective of whether the antiserum was raised against
thewhole receptor or against the isolatedsubunits. It is possible that there arc cross-linkages
among the subunits ofwASGPRin the nativeplasma membranesand therefore, these subunits
could be co-precipitated by antibodies specific for any aile of the subunits, Such cross-
linkage of ASGPRsubunits hasbeen observed inthe receptors fromother species(I larford
et aI.•1982). Taken together. these observations suggest thatbot h 40- and 47·kDa subunit
polypeptides ofwASGPR arc expressedin the woodchuck hepatic plasma membranes.
H<'
Figur e 1.15. w ester n blot nnalysis of wASG plt subunit expression in
woodchuck I lpM! using guinea Ilig llllti-ASGPR antiserum. rWMs isolated fromhealthy
woodchcks (lanes I, 2 and3)and rabbit (lane4.control) were separatedby 50 S·PAGE at
100 I!Hprotein perlane, transferred one nitrocellulose and analyzedby imnamoblctring using
anti-rASGPRantiserum. Secsection 1,2,21fordetailsfor themeihod The molecular masses
of the detected polypeptidespecies areindicated on the right sideof the panel.
This figure shows that only the 40·Wa subunit polypeptide was detected by
antibodies against rASGPReven when relatively large amounts ofwoodchuck HPMs(100
II!! membrane proteins per lane)wereemployed for determination
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Hgur~ 1.16. RadioimnJullol1rccillitlltioll unalysis elthe exp ression orwASGPR
sub units in woodchuck "P~1s using lllllj.. \\'ASGI'1tnud monospeclfi~ anti·rASG PR-
sub unitantisera. I O~ cpmofl1S!.labc!led nafivc (non-detergenttreated) woodchuckH PMs
(specificactivity, 2.5'"IOJcpm/ng) were preclca nedbyincubationwith norma]guinea pig
serumu d then incubatedwith guinea pig.antisera againstwASG I'R (lane 3), 40-kDa (lane
2) and 47-kDa (lane l) subunits ofrA SGPlt Subsequently.the irumenocomplexes were
prccipila1cd by protein A-Sepharosc41l lrnnnmo prccipitatcs wereseparated by 50S-PAGE
and the radioactivity on the gel was dCICC I~d by autor<ldiography. Precleaned HPMs
prccjpitared withprotein Abeads alone was used<IScontrol (lane4). S~ section1.2.14 for
detailsofthe method, Themolecular masses of the precipitated polypeptides arcindicated
on the rightsideofthe panel
This figureshows lhat both 40- and 47·kDn subunit pOlypcpl idesofwAS GPR were
detectedby guinea pig antisera against wASGlI!t or against subunits of rASGPR
1 2 3 4
kDa
- 47.0
- 40.0
- 30.0
1.3.2.2.2, Biologicalpropertiesof hepatic plasma membrane-boundwASGPR.
To determine whetherthe ASGPRbound towoodchuck HPMsis biologically active,
purifiedmembranes inthepresenceof mild ionicandzwitterionicdetergents wereexamined
byusing a ligand affinity precipitationmethod. Afterincubationof woodchuck HPMs with
Scphrosc-an beadscoatedwithO-Gal followed byextensivewashing, prote insbound to the
beadswerereleasedbySOS-PAGEsamplebufferandanalyzedby Western blotting. Results
presented inFig, I.17Ashow thatthe 4o-kOa subunitpolypcpfide ofwASGPRin the purified
woodchuckI-IJlMs wereprecipitated byp -Gal-Sepbarose and then recognizedby antisera
against ASGPR. Thisresult indicatesthatASGPRexistedinthe purifiedwoodchuck HPMs
hasbiologicalactivity. Results also showthat therewere no differences between the HPMs
treated withvariousdetergents, suggestingthat theligand bindingsiteson ASGPR molecules
withinthe purified native plasma membranes are readlyaccessible for binding of ligand. The
specificity ofthisreaction wasconfirmedinthe controlexperiment performed inthe presence
of free D-Galwhichactedas a competitor to theD-Gal immobilizedon Sepharose. This
control experiment revealed that the precipitationwas extensivelyinhibited byfree O-Gal
(data not shown). In additional controlexperiments. incubation ofnat ivc andsolubilized
woodchuckHPMs withSepharose-4B beads. or incubation ofwoodchuck KPMs with D-Gal-
Sepharoscbeads didnol result in the recovery ofany proteinspecies with ASGPRactivity
(data not shown).
Interestingly, the membrane-bound 47-kDasubunit became detectable when the
HPMs wereprecipitated with D-Galbeadsand theblots carryingreleasedwASGPR proteins
were probed with monospecirlcantiseraagainst receptor subunits. As illustrated in Fig
1.1711.lh e woodchuck HPM-bound47·kDapolypeptide bandofwASGPR wasunveiledby
antiserum against the47-kDasubunit (lanes5 and6).whilethe40-kDapolypeptide band was
recognized by anti·40·kDa·subunit antiserum (Innes 1 and 2). In a control experiment.
incubation ofwoodchuck KPMs with D-Gal beadsdid not show any detectableprecipitates
Fig ure 1.17. Identification or ASGI' R subunits ill Il uul!churk IU'II:uic pl :lSl1l3
membr anes by ligand-affinilYprtcipit:tlioll. IIPM prl-paraliolls (3·10 IJYper assay) in
0.02%Triton X-IOO(lanes AI, 0 1, 82. BSand B6), 10 111M Chaps (bllc A1) orO. I%. OOC
(laneAJ) wereprecipitated with O-Gal-Scph:1rosc beads. I'IasnJ:lllll'lllbrancs purified from
woodcbJ ck lOOney (KPMs) werealso precipitat ed by O-G al beads, as controls (lanes Il J and
B7). Bead -bound proteins were released by sample buffer, separatedby SDS-I'AGE and
analyzed by lmmunoblonjngusing guinea pig amiscra against rASGllR(Illnes AI, A2 and
AJ), the 40-kDa subunit (lanes 9 1, 82 and OJ ) andthe 47·Wa subunitof rASGPR (lanes
as.B6 and 87). See section 1.2.1S for details of the method. The molecular mass es of
prestained protein standards (lanes A4, 94 and 08) arc indicated Oil the right side or rbc
panels.
These figures showthat both 40- and47- I.;Da subunitsllf wASGI'R arc detecta blein
woodchuck HPMby antibodies afterprecipitation of the membraneswith D-Galconj ugated
to Sepharose beads.

with ASGPR specific activity (Fig. Ll 713. lanes3 and7). This result indicates that the
functional active 47-kDasubunitof wASGPR is expressedin woodchuck lll'Ms and thnt, in
fact, it appearsto presentinnumberscomparableto the40 klja subunit species
Taken together. the above findings indicate thatbiologicallyactive40- and 47-kDn
subunits ofwASGPRarc expressed inwoodchuck hepatic plasmamembranes. Additional
evidence tosupportthis conclusion willbe provided in Pm lfl of'tlusthesis. which willshow
thai ligandbindingactivity ofwASGPR on thesurfaceofisolated woodchuck hcpatocytcs
can be inhibited by monospcciflc antibodies to both 40 and 47-kDareceptor subunas. The
evidence will confirm that both subunits of wASGPR aTC expressedon the surface (If
woodchuck hepatocytcs and nrc accessible to both natural ligand us well ns specific
antibodies
1.4. DISCUSSION
Numerous studieson the characterization of mammalian ASGPRs have revealed that
ASGPRsfrom rabbit. rat and humanlivers contain '.,J"l-binding sites which can interact with
the terminal Gat residues of ASGP. Aminoacid sequence comparisons and immunological
analysisidentifiedtheevolutionaryhomology betweenthese receptors. Takingthese common
biochemicalandimmunologic properties of mammalian ASGPRs into account, we employed
ligand affinity chromatography to isolate and purify ASGPR from woodchuck livers. This
method was firstestablishedfor the isolation of ASGPR from rabbit liver and later widely
appliedfor ASGPR isolation from rat and human livers. Using wASGPRs affinity-purified
bychromatography on an ASGP(i.e.• ASFN) or D-Oalcolumn, we were able to analyze the
biochemical and immunologic properties (If woodchuck hepatic ASOPRs. The receptors
were analyzed both in the purifiedwater-soluble form and in their natural environment as
plasmamembrane-associated proteins, The data presented here demonstrate that wASGPR
consists of two subunits with apparent molecular masses of 40- and 47-kDa, respectively.
Oath polypeptides arc immunogenic to guinea pigs and arc immunologicallyclosely related
to the rA$OPR and rtASOPR. The wASGPR is specifically expressedon the surface of
woodchuck hcpatocytes and is delectable in purified woodchuck hepatocyte plasma
membranes Althoughboth 40- and 47-kDa subunits of wASOPR exist in the HPM, mainly
the 40-kDa subunit polypeptides were detected directly by Western blotting.
Amajorfindingin the present studies is that wASGPR is closely related to rASGPR
in terms of receptor subunit constitution, immunological properties and ligand binding
specificity. Very similar, if not identical, molecular masses of receptor subunit polypeptides
(i.e., 40- and47-kDa) are consistentlyseen in allthe preparations purified from woodchuck
and rabbitlivers; purifiednASGl'R displayed three subunits with molecular masses of 44, 52
and 66 kDa aller separating the receptor proteins by 5DS·PAGE (Fig. 1.2).
However. wASGPRdiffer s fromrASGPRbychamcrcrisricsot'ligandbindingkinetics
TheK..and B_ ofwASGPRis lower 11.111that ofrASGI'Runder theconditionstested. TIle
classical method for the kinetic analysisof receptor-ligand Interactionis usuallycarriedout
in liquid-phase. Thecritical step in thisncmodis III scpnmtc receptor bound lignnd fromfree
ligand(8 and F. respectively). For ASGPR analysis. the receptor-ligand complex can be
precipitated by (NH' )lSO, and harvested on glass-fibre discs (lI11dgin ct al., 1974), The
disadvantage of thismethod is tbat thc non-specinc background can bc 100 high(Grant.
1986). Solid-phaseassayfor receptor andligand reaction is abo used for the bindingkinetic
studies of membranereceptors (Quesenberry andDriekamcr, 1992). The principle fur the
separation of B and F is simply by pre-inuuobiilzatien of receptor on plastjc plates
Obviously, if'rhe conformationoftile receptor is changedwhencoating the receptor OIll O the
so1id phase. t hebind ing between receptorandlig:llldwill\Jcinllu cl\c~'<I. Dnc toourinabilay
to decreasethe backgroundin the liquid-phase assay, weused a solid-phaseassay for the
kinetic analysis of wASGPR and usI_ASFNimcraction Therefore. it is possible Ihat our
valuescouldbesomehowlower thanthetrue kineticvalues lor wASGl'R. Thispointwillbe
further addressed in Part 1IIof this thesis (sections 3.3.2 nnd 3.3.4). That wASGllR had
lowerK..andB.....thanrASGPRcanbearesultdue 10 the species spccillciry. In this regard.
it is clear that hepatic ASGPRdistribution is different amongmammals(Ch,Ulg and Chang.
1988). Wealsofoundthat therecoveryofwASGPRfromwoodchuck livers wasmilch lower
(approximately6-10 fold)than that fromrabbitlivers. According 10 Changand Chang. the
totalASGPRconcentrationinthe livercfdiflcrcntmammals vanes with a rank order of rabbit
(423.4 ± 24.8 pmol!g tissue) > rat (300.2± 26.6 pmol/g tissuc)> guinea pig (159.8 ± 7.I
pmoVg tissue). Fromour experience.wASGPR ismore likely close 10 ASGI'1{fromrat or
guineapigratherthanfrom rabbit.
With respectto the anti~cnic cross-reactivitybetween wASGPRandrASCjIlR. it has
been shown, assummarizedinTable 1.4. that notonlycan ami-rASGI'R or anti-subunitsof
T.b k I.... Sumn'aI,· or lh~ m ulti uf Wulun blun in" 'lIl1 l) .b
or ru rir~d A,SGP R . nd m~mbr~n c-bel", nil ASG PR
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rASGPR recognize wASGPR, butalso that anli·wASGPRreacts with rASGr R. These
resultsindicate thatwASGPRand rASGPRshareantigenic epitopcs. Suchcross-reactivity
exists between the corresponding subunits fromdincrclIl species, but Ilul betwecn the
subunits fromthesamespecies: anti-4Q..kDa·subunit spccitic antibodyrecognizesonly40·kDa
polypeptide while the antibody to the 47 kDa polypeptideonly reactswith the 47·kDlI
polypeptidesof ASGPR. Theseobservationsare ingood agre mentwith previousfindings
that ASGPRs are very conserved molecules with high homology amongrecept ors from
different species. According to thelIminoncidscqucnceanalysis(Drickamcret at.,1984:
SpiessandLcdish,1985b). thereis 70·80%homologybetween the correspondingsuhunits
ofrat andhuman(RHLIversusHHLIandRHL2/JversusIIIIL2)while onlyappro ximately
SO%homologybetweendifferent subunits fromthesamespecies. Thus, it isnotsurprisin~
thatwhenthecomposition ofrASGPRandwASGPRarc similar, they willalso have similar
antigenic epltopes end, likely, havehomologous primary structure. Inaddition,asidentical
ligandbindingspecificity exists inall ASGPRs, thestructureofthe ligandbinding site itself
or structuresrelatedto thebindingsill' maybesimilar. Thispointwillbeaddressed rorther
inPart IIIof this thesis
Surface expression of wASGPR on hepntocyres was demonstrated by
invnunofluorescent stainingasweltasby ligandbinding assay(sec Pari IIIfor moredetails)
Tounderstandin detailthesubunit distributionandreceptor functioninwoodchuckIIPMs,
purifiedwoodchuck HPMswereanalyzed byWesternblollingusingguinea pig anti·ASGPR
or anti-subunitantisera. Resultsshowedthatonlythe polypeptide bands withmolecular
masses corresponding 10those ofthc affinity purified wASGI'Rwere recognized by these
antisera, Thespecificityof theimmunoblolreactions were confirmed byseveralcontrols. It
wasfound thatrecognitionofthe purifiedASGPR andthepolypeptidesin woodchuck I-IPM
was abolished when the antiserumhad beenpre-absorbedwithafhnily-puriflcd ASGI'R
proteins,indicatingthatthisantiserum wasspecificallydirected against ASGPRand Ibat the
recognized polypeptideband in woodchuckHPM was antlgenical cross-reactive with the
purified ASGPR (Fig, 1. 10, lanes 10 and 11). It was also found that the ASGPR-related
polypt:ptide band recognized by anti-ASGPRantisera was present only in HPMs, but not in
the plasma membranes from other organs. Woodchuck KPM and SPM were not reactive
with antisera against ASGPRor ASGPRsubunits(e.g .• Fig. 1.13 and fig. 1. 17).
The biological activity of the IIPM-associated wASGPR proteins was examined by
D-Gal bead precipitation. The ligand-boundproteinswere analyzedby Western blotting
using anti-rASGPRandanti-subunit antisera(Fig. 1.17). Controls for the D-Gal precipitation
assaywereset up by using ligand-free beads or addition of'Trcc D-Gal as a competitor. Based
on the results of these experiments. we conclude rhmfunctional wASGPR molecules are
presentin thepurified woodchuckJ-1PMs, Sincebeth subunitswere detectable in woodchuck
HI'Mby thismethod. both 40- and 47-kOa subunitsare most likely involved in the ASGPR
function for ligandbinding. Alternatively, it is possiblethat at least one of the subunitsis able
10 bind ligand. but because of the cross-linkage betweenthe two subunits, both of them can
beprecipitated by the D-Gal beads
Interestingly. analysisof the woodchuck HPM directly byWestern blotting showed
only the expression of 40-kOa subunit. The 47-kOa polypeptide could not be directly
detected (Fig, 1.10. f ig. I) , Fig,14, and f ig,15), unlessthe membrane-bound receptor had
been precipitated from l-lPMs by D-Ga! beads (Fig. 1.1711). At thispoint, this result may
suggest that ASOPR subunit-distributioninwoodchuck I-I PMs is differentfrom that in HPMs
ofotherspecies tested, since all the subunits of ASGPR in rabbit and rat HPM preparations
weredirectly delectable by Western blotting.
It is worthy of mention that the antigenicityof the 47-kDa subunit in wA$GPR
prepared from liver homogenate appears to be different from that in membrane-bound
wASGPR. The 47-kDa subunit inaflluity-purifledwASGPR preparations could react with
anti-rASGPRantibodies (Fig. 1.9), while the 47·kDa subunit in woodchuck HPMs could not
(Fig.I ,17A) although the HPM had 1llSQbeenexpoS\.'111Q ligand on beads. Thisditlcrcnce
maysuggest that the changein the cxprcsston of the antigenic cpitopes \11 the 47-kDa
subunits (e.g , due to a conformational modification in the course or the receptor
transportationfromthecytoplasrnato the cellsurface)
Ligand-coatcd bendsnppearcd to luvc rbeabllhy 10 enrichthe 47-kDnpolYPcl'tide
fromwoodchuck HPM (Fig. 1. (713). Thus. wecanspeculate that thc higher ratioof47-
kDa:40-kDasubunits thantheirinitial ratioin ligand-free membrane preparations is due to
receptorsubunitre-organizationwhcnrcceplorbirlds tothcl igandonbcads_ Theligandmay
funetionasabridgetolinkscveral47.klla subunitstogether I'rnbably. llie -47-kDnsulJuuilS
ofwASGPRhavehigh amnity forthcligandalthough theyarc present inlow i11t1111llltSin thc
membranes. lfthis speculation holds trueill l'i l'O, the 47-klJa subunit mayfunction us a key
regulator, at the level of theplasma membrane, to comrolthcrateof ASGI' hindingaswell
as thcspeedof'cndocytosis Ofnoteis thatpre-fixedbcpntocytcs arc alsoublcto hindligand
(fordetails,seePart Ill). Thismaysuggests that someof the specific ligand binding docsnor
requiresuchre-organization. According10 theliterature. subunit rc-orgnnizntkmhasbccn
observed inbothhumanand rat ASGI'Rgenetransfectcdcells[Bmhemumct al , I l) R!) ~ Hcnls
et at, 1990). It is postulated that re-orgauizaucn is responsiblelorthe formation ofa high
affinity ligandbindingsite. Our observation in wASGI'R mayprovidenew evidence 10
supportthisnotion.
On theotherhand,according to the rcsrhs frollllherudiohunumeprccipitnuonOlSSllYS
(Fig. 1.16), both40- and47-kDa polypeptidesweredetectable ill woodchuck IIPMs and hlld
comparable densities inlhe autoradiograus. afterbeingprecipitated or co-precipitated by
antisera against wASG?R, 40-kDaor 41-kDa polypeptides of rASGllR These results
indicatecomparable iodizationson both subunits of the membrane-bound wASGJ>R and
suggest thatequal amounts of 40- and 47-kDa subunitsmayexist in thewoodchuck III' Ms
Therefore. attematlvcly, theobservation thallhe47-kDa poJ}'IJCj1l idcinwoodchuck
'11
HPM becamedetectableby anti·47-kDa antibodies after precipitation by ligand (Fig.I.17B)
could suggest that thc 47-kDa subunit undergoesa ligand-dependent conformationchange
during this precipitation. Such a conformational change could expose the antigenic epitopes
whichwere recognized byour antibodies. Inether words, our antisera to the entire ASGPR
molecules or ASGPR 47·kDa subunit might not recognize the 47-kDa polypeptide of
membrane-bound ASGPR,unless the receptor's structure has been modifiedby ligand. Such
modification couldbe achieved by using ligand (ASFNor D-Gal) conjugated on beads, but
not by free D-Galsince after treatment of woodchuck plasmamembranewith free D-Gal the
47-kDasubunitofwASGPRin I-IPM wasstillnot recognized byanyof our antisera (data not
shown), Just as configuration is important to the activity of an enzyme, so a change in
configurationor conformation ofa receptorcouldbecriticalfortheactivation of the receptor.
It has been found that receptor-ligand bindinginvolves ligand-dependent conformational
changesof the receptor [Lenget al.,1993; Ryuct al., 1993; Zanolariet at , 1992), which may
lead to the conversion of tile receptor from aninactive (or less active) to an active formand
induce some other functions of the receptor, such as signaltransduction. In the studiesof
ASGPR,it has been foundthat Cal ' concentrationand pHinfluencethe ligand binding activity
of chickenASGPRbymodulating receptorconformation (Loeb and Drickarner, 1988). This
conformation change is found to correlate with the rareof protease resistance of ASGPR.
It is, therefore, likely that such a changemay also introduce new antigenic epitopeswhich can
bedistinguishedby antibodies. Our observations suggest such a ligand-dependentchange(s)
in the antigenicity of the HPM-bound wASGPR
1.5. CONC LUSIONS
The work on the molecular composition and immunologic propertiesufthe allillily-
purifiedwASGPRreveals that wASGPR is composed or two subunits. with approximate
molecularmassesof40-kDaand47-kDa. Both subunits111"1..' immunogenic andshare antigenic
cross-reactivities with the corresponding subunitsof ASGPR from other rnnmmafinn species,
It is also demonstrated that both subunits of wASGPR expressed on the surface of
woodchuck hepatccytes or purified HPMs are accessible to ASGPR'Sllccitic antibodies
Further, despite close structural and antigenicsimilarities between woodchuck and rabbit
ASGPRs, woodchucks are able to produce an antibody response ngnhtstrASGI'R. This
observationcan beutilized in further studies on the dctcnninarlonofthe contnlnnionuf nnti-
ASGPRspecificimmune responses 10 the pathogenicity of hcpuduavirus-imluced liver injury
in a woodchuck modelof hepatitis D
These studies also suggest that the structure ofthe 47-kDa-subunit in woodchuck
HPM maybe important for theantigenic properties and function ofwASGPR. Thcantigenic
propertiesof the hepatocyte membrane-associated ASGPR could be 11\Ollilicd due 10 liglmd
binding. This could be the first demonstration of a ligand-dependent change in the
antigenicityof the hepatocyte surface receptor. Further work remains to bedone In clculy
understand the biological nature of the47-kDa-subunil in its natural cnvlrcumcm and 10
reveal the differences of the mechanisms for the induction of antibody responses to the 40-
kpa-and the 47-kDa subunits
I'ARTII
INDUCTI ON OF AUTOANTIDODIES AG AINST ASGPR
IN EXPER IM ENTAL WOO DCII UCK VIflA L II EPATITI S
1.1. INTRODUCfION
2.1.1. G~nual Mtcllllllisl1l5 of Autoimmune g espcn se In d uced by vlra t lnreeuc n.
Many factors.such as environmental.genetic and hormonal factors, contribute to the
induction of autoimmune responsesandthedevelopmentof autoimmune disease. Viruses are
usuallyconsideredimportant environmental agents related to thepathogenesis of autoimmune
diseases in their host. Evidence to support this concept has been collected from several
experimental animal models of virus-induced autoimmunity, cs wellas from various clinical
investigations. Based on these findings, mechanisms for virus-induced autoimmunity have
beensuggested (for reviews. see McFarlane. 1991; Schallncr and Rager-Zisman, 1990).
Theinitialstudies on this subjectbegan inthe 19705. Clyde and Thomas (1973) found
that turkeys infected with mycoplasmadeveloped disease which might be generated by an
autoimmune reaction between best antigen and anlibody against mycoplasmal antigen.
Kuzumaki et aI(1974)also found that rats infected with leukeni agenie viruses would develop
enosnmu ne hemolytic anemia. Following these observations. several experimental models
of virus-induced autoimmunity have been established 10 study the pathogenesis of
autoimmune diseases. such as insulin-dependent diabetes mellitus (10 0M ). myocarditis.
polymyositis. demyelinating disease and chronic active hepatitis etc. One example is that a
hightiter ofr ctrovirus was found in the New Zealand black (NZB) mouse model of systemic
lupus erythematosus. The involvement of'this virus in the pathogenesis of this autoimmune
diseasehas been demonstrated (Theofilopoulos and Dixon. 1985). Another example is that
experimental inoculation of young mice with coxsackie UJ virus induced persistent
myocarditis (Roseet al., (988). In thesemice,heart-reactiveautoantibodiesdirected against
cardiac myosin heavychain. but not againstthe virus.weredetected in the circulation and
heart . suggestingan autoimmune mechanism for the induction of myocarditis, lnhlrcslingly,
the cardiac myosin did not cross react withcoxsackievirus, However, imnnnuznnon of the
susceptible animalswith cardiac myosin antigen could induce syndromes similar to that of
virus-indoced myocarditis, suggestingthat exposureof this nutcaruigcn ntlcrviral infection
might be responsiblefor the induction of autoantibodies in myocarditis
In additionto studiesusinganimalmodels,clinical investigationshave indicatedthat
viral infectionsor even virusvaccinations in individualsarc associated with the development
of autoimmunity. Autoantibodies (c.g., antibodies against nuclcnrantigens.lymphocytes, and
smoothmuscle)arecommonly detectablein the serumorpnrlcnts with some viralinll.'CtinllS
(e.g.• Epstein-Barrvirus,cytomegalovirus, HOV, HAV, IICV, intlucnza virus,measlesvirus,
coxsackievirus, human immunodeficiencyvirus, ctc.) (Schauncr and Ragcr-zisman, II}I)O)
Some autoimmune diseaseshavebeenround 10beassociated with the admtnisuntionof virus
vaccines. For example,the Gulllaln-Barre' syndromedeveloped in some individuals nflcr
vaccination with influemaor measles vaccines(Grose <II1d Spigland, 19 76 ). Uveitis and
myasthenia graviswere alsoobserved in individuals after hepatitis 11 vaccinations (Fried cl
al., 1987). On Ihe other hand, a past or ongoing viralinfectionin patients with autoimmune
diseases is commonlyobserved,such as persistent measles vlms genome <111<1 high levelof
antibodyto measlesinpatients with Hllv- ncgativc autoinununcchronic hepatitis (Robertson
et al., 1987) . 11 was proposed that rheumatoid arthritis is associated with injection by
Epstein-Barr virus, parvovirus B19, or retroviruses(Schauncrand Ragcr-Zismnn, 1( 90)
However, a definite demonstrationthat viruseshavea primaryrole in the pathogenesis
of autoimmune diseasesis still lacking. In addition, it is still a mailer of debate as \0 how
virusesareinvolvedin the processoreutoimnunhyin their hosts One possibility is that host
autoimmune responses aretriggered by virus through polyclonall3cell activation, effectson
immuno regulatorycells(e.g., T suppressor) or generationofcytokines (IFN, TNF, etc.). For
example,it has been demonstrated that Epstein-Barr virusinfected 8 cells are functionally
activated and can produce autoantibodies recognizing autoantigens in multiple organs
(GarzeJli et at , 1984). Another important mechanism of viral-induced autoimmunity is
molecular mimicry. Antibodies against viral antigens recognize self-antigens due to the
antigenic cross-reactivity between virus and host components. The appearance of cross-
reactive antibody couldlead to tissue injury, formation of immune complexes withselfand
viralantigens, and generation of anti-idiotypic antibodies. For example, a sequcnce of 8 to
10 amino acids in the encephalitogenicsite of myelin basic protein is found to be identical
with a segmentof measles virus P3 and HBV polymerase. This myelin basic protein
determinant has been identified capable of eliciting autoreacrlvhyand autoimmune disease
(i.e., experimental allergic encephalomyelitis) (Fujinami and Oldstone, 1985). Finally,
infection by viruscan slsomodify the expression of autoantigensby exposure of sequestered
autoantigens, modificationof antigen on the cell surface and induction of novel antigens.
Suchalteration mayinduce the induction of autoimmu ne responses and lead to the damage
ofinfected cells. For example, a cell surface proteinwas found to be modifiedby influenza
virus and then recognizedbyinfluenza virus-specificcytotoxic T cells(Bennink ct al., 1982)
Changesin theplasmamembraneof skinfibroblasts were alsoobserved after coxsackie virus
B3 infection (Lutton andGauntt, 1986)
2.1.2. AlltOlllllibotJy Response in Liver Disorders.
In 1957, Gajdusek found that antibodies in the seraof patients with liver disorders
could react with the extract of normal human liver (Gajdusek, 1957). Since thcn, many
researchgroupshavestudied theoccurrence and pathogenic role of autoantibodies in hepatic
and other disorders. Autoimmunehepatitis (AIH) (Johnson and McFarlane, 1993). which
wasalso calledautoimmunechronic active hepatitis (ai-CAl-I), and prinml)' bilim)' cirrhosis
(PBC) are the typical autoimmunediseases ill which the liver becomes thc primary target
organ for the autoimmuneresponses induced by unknown etiologic factors. Liver-specific
or non-organ-specific autoantibodiesarc associated with these diseases and some of thcsc
antibodies have been used as diagnostic markers. although their pathogenic rule l\mttheir
relation to the severity of liver injuryarc not clear (Meyer zum Buschcnfcld ct al., 1( 90)
Autoantibodies are also frequently detected in patients with viral hepatitis, ill paniculur.
induced by HBY infection (Mcjtnrlanc. 19( 1), These uutuuntibudies, generally, call be
divided into two categories according to their antigenic spcciflchy: non-organ and liver-
specific.
2.1.2.1. Non-c rgan-speciflc autoantibodies.
Non-organ-specificautoantibodies identified in the scm of'pnuents with liver disorders
mainlyincludeantibodiesto nuclearantigens (anti-nuclear unnbodics. ANA), smooth muscle
(snti-emoothmuscle antibodies, SMA), liver-kidney microsomal nmigcus(mal-liver-kidney
microsomal antibodies, LKM antibodies) and mitochondrial antigens (anti-mitochondrial
antibodies,AMA). Most ofthese antibodies react with intracellular antigens whichl i re not
accessible to the antibodies, unless they are occasionallyexhibited on the cell surface or
releasedinto the circulation. In the fblluwing paragraphs, II generaldescriptionor these nun-
organ specific autoantibodies observed in patientsand, relevant to the present study, in
woodchucks with WHY infection will be given accordingto several reviews (Meyer ZUll1
Buschenteldeet al., 1990; McFarlane, 1991; Peters et <II., 19( 0) lind report [ljzwnnkowsk i
and Michalak, 1990).
ANA is one of the autoantibodies most frequently detected in scm or y-gluuulin
fractions from patients withdifferent liverdisorders, such as Ali I, IIBe, viral hepatitisand
some drug-associated hepatic disorders A high frequency of ANA is UISIl observed in
systemic lupus erythematosus (SLE). Double-stranded DNA. RNA and histone have been
identified o..s the autoantigcn for ANA. So far. there is no direct evidence that ANA can
induce aUloimmuneliver diseases.
SMA were lirsl detected in the sera of patierus with chronic active hepatitis . Since
lhen, they have beenfou nd in patients with dilTercm hepatic or non-hepatic diseases. Up to
80% of patients with acute and 50% of patients with chronic HBY infection were found to
be SMA-positive, while 50% of palienls with AIHdeveloped SMA It hasbeen demonst rate d
thai the major autoantigen recognized by sera of patien ts with AIH type I is F- actin (actin
filaments), a microf llament protein. Because these antibodies are commo n in the sera of
patients with a variety of autoimmune diseases, it is unhk.elythat there can be a liver-spec ific
etiologic factor involved in tile pathogenesis of liver injury.
LKM antibodies have been found in patients with different liver disorders.
Microsomal antigens, cytochrome P-450 2D6 or cytochrome P-450 2C9 , were identified as
the autoantigens for LKM- I and LKM-2 autoantibodies. Another microsoma l antigen in
family I undine diphosphate-glucuronosyI transferases (UGT) is recognized by LKM-J
autoantibodies. Appearance of LKM antibod ies is co nsidered a mar ker for a particu lar type
of autoimmune hepatitis. t tcwcver. the role of LKM antibodies in the pathogenesis of the
disease rcmains controvcrsinl. TIle presence of cytochrome P-4S0 on isolated rat HPMs was
detec ted by Loeperet at ( 1990), suY,gcsting that LKM antibody-mediated hepatocyte lysis
may contribu te 10 the li\'cr injury. In contr ast. Yamamot o ct at (1993) found that the
cytochromc P-4S0 206 reacting with LKM- I autoantibodies could not be expressed on the
surface of the hepaocyrcs. Therefore. the mechanisms of LKM antibody-mediated liver
damage remains to be clarified
A high frequency (80.95%) of AMA was detected in POC and connective tissue
disorders, while a low frequency ( 10-25%) was observed in chronic active hepatitis, and
occasionally in patients with acut e hepatitis A 70-kDa protein identified as the E2
component of a pyruvatedehydrogenasemahienzyme complex or mitochondria and a 48·kDa
protein on the inner mitochondrialmembrane were lourid to be the uutoauugcus Ior AM"
These autoantigensarehighlyconservedduring evolutionandcross-react with enterobacteria
Therefore.it is suggested that bacterial, parasitic or viralinfectio n may induce AMAdue to
antigenic mimicry.
Although all the above mentioned autoantibodies have beenencountered in liver
diseases induced by HBV infection. the spectrum. prevalence,and dynamics of related
autoimmune responsearc difficult to assess in patients. 'l'hiais mainly because of inability
to determine precisely the momentor virus invasionand thestatus of ,lu!oimlllunityprim to
infection. and to conduct longitudinal studies in a clinical situation. In 1990, Dzwoukuwski
and Michalak evaluated the significance of the non-organ specificautonmibodies (c.g . SMA.
AMA. ANAandantibodiesIlgninst the brushborderof'proximal kidney tubules}in predicting
the occurrenceand outcome of viral infection in a woodchuck modelorhcpatftls n, In this
investigation. the authors analyzed 646 sequentialserum suuptcs lhull It! animals with
experimental WHY infectionand 8 with natural WIIV infection Resultsdeillonstwh..sltlnu
WHY invasion alwaysinduced non-organ spcciric nutoinnnuncresponse. especially SMA
The appearance of SMApreceded the occurrence of screlogicalnrarkcrs or virnl intccuon,
suggesting that the induction of the autoaruibodics is unlikelya consequence of WIIV-
induced liver injury, but is mediated by other mechanisms(c.g , virus-induced polycloaaln
cell activation). In addition, it was found that the SMAdynamicsdid not correlate with virul
serological markersanddiseasedevelopment.indicatingthatthedynamics or SMA, as well
as other non-organ-specificautoantibodies nre not good predictors orl he llUlI.::llIl1e ofacule
infection or the progression to chronicbepntitis
2.1.2.2. Liver-specificautoantibodies
Asmentionedinthe abovesection, antihodies againstnon-orgnn-spccitlc autoantigcns
'N
aredetectablein a variety ofdisorders. It is therefore unlikely thattbese antibodies maybe
responsible for liver-specific injury. When the autoantigens arc liver-specific, the
consequence of having autoantibodies may be different. Appearance of liver-specific
autoantibodies could be a marker for the damage of liver cells or for the disorder of
immunoregulation. On the other hand,liver-specific auroaruibodles maycontribute to the
pathogenesisof hepatocyte injury, especiallywhen they are directed to an autoantigen
expressedonthe surfaceoffivcr cells. In an attemptto identify liver-specific eutoantigens,
isolated hepatocytcs, purified hepatocyte plasma membranes and purified hepatocyte
cytoplasmiccomponents havebeen used as substrates to lest the autoimmunereactivities of
sera frompatients with variousli...'cr disorders [eg, Hopl'et al., 1974, 1975). So far,only
a few liver-spe cific componentshave been describedas important potentiallypathogenic
autcanugcns
Oneof the liver-specificcomponents is"liverspecificproteins"(LSP), whichhasbeen
purified fromhuman liver homogenate(Meyeret nl, 1972). Antibodies specific for such a
preparationwere correlated with the clinical severityandhistological changesof liver tissue
inpatientswith acuteandchronic liverdiseases(Maims et nl.,1980). High frequencyof anti-
LSI'autoantibodies has beendetected in patientswith autoimmune hepatitis, viral hepatitis
and other liver disorders. Theautoantigcns in LSI' preparations were identified as a mixture
of compoocnrs. so called jvcr-spccltlc membrane lipoproteins. In this mixture, the
macromolecular antigens couldbe species-specific, speciescross-reactive. liver-specificand
non-organ-specific [LebwohlandGerber, 1981; Manns et al., 1980; McFarlaneand Williams,
1980). It has also been shown1I1at nnti-LSPcanserve asa serologicmarkerto predict the
ongoing relapse of AlI·{aftercancellationofiuununcsuppressivetreatment (McFarlane et al.,
19Mb). Sotar. ASGPR is theonly component inthemacrceoleculemixtureof LSP that has
been identified. Anli-ASGPRautoantibodies willbediscussed later in detail
In addition, a protein in purified hepatocyte plasmamembranes was proposed as a
nn
candidatetargetautoaruigcnlor antibodies in the seract'parleu s withAlii (Swansonet at ,
1990). This protein hasallapparentmolecular nmss 01'60kOa and seemsto be liver-specific.
but not species-specific, Anotherprotein in purified liverplasmamembralies has a molecular
mass of 26-kDa. and it isalsorecognized by antibodies in SCTll from patients wilh All l lllopf
et at , 1990). This protein was idennflcd as a species cross-reactive antigen without any
relation to other known autoantigcns in liver. The role of these proteins in the
immunopathogenesisofliver disorders is unknown and the characterizationof'thcsc proteins
remainsto be done.
2.1.3. Aut oimm un e Resp onses Agai nst ASG J'n.
2.1.3.1. Autoantibodies against ASGPR
The relationship between autoimmune responses against cellular receptors and
autoimmune diseases has been a very interesting subject, because rcacrkms between
antibodiesandreceptors may inhibit receptor biologicalfunctions (e.g., ligand binding, slgnal
transmission), induce destruction of cells (c.g. antibcdy-mcdinted cytotoxicities Callbe
induced when antibodies react with receptors expressed un thesurface or cells)or induce
stimulation. Studies inmany autoimmune diseases sllgyesil lmlami-receptor nntoamibodics
do playImportant pathogenic roles. For exmnple, it is pes' luted that antibodies 10 thyroid-
stimulating hormone receptor in thyroid diseases (Graves' hyperthyroidism).antibodies 10
acetylcholine receptor in myasthenia gravis, and antibodies 10 insulin receptor in insulin-
resistant diabetesmellitus play the primary roles in the pathogenesisof these autninuuune
diseases(Abbas, el 011., 1991). lt is well known thathcpatocytes lire not only the producer
of a variety ofph ysiologieatlyimponant compounds,but also the target and the metabolic
centerof manysubstances. Thus, a large number of receptors arc presentedon 111esurface
of bepatocytes.such as receptors for vitamins, hormones and manymetabolites, Since LSI'
wasidentifiedas the plasma membrane protein complex!Horf ct al.• 1974), it would contain
lUI
some orue hepatocyte-specific receptors. ASGPR becamethefirst candidatein the search
forthcsclivcr-spccificaooautoanligenic receptors,because itwas a receplor clearlyidentified
3S being present on thesurfaceof heparocytes and appeared 10 be expressed mainlyin the
liver. McFarlane etaI.(1984a) addressed thissubject and identifiedASGPRas a component
of LSP. They purifiedASGPR from rabbit and humanliversand tested theirantigenic
propertiesusingantibodies fromguineapigsimmunized withhumanorrabbitLSP. Results
frombothRIAand ELISAindicated that anti-LSPantibodies reacted strongly with purified
ASGPR. This reactivitycouldbe abolishedaflerabsorption of theantibodies with eitherLSP
or ASGPR proteins, butnot withkidney homogenate, Indicating that ASGPRwasa liver-
specific, species cross-reactive antigen anda constitutional component ofLSP. Subsequently,
ASGPR WlIS shown to bean autoantigen whichcouldbe recognized byautoantibodieswith
LPS reactivity from patients with liverdisorders (McFarlane et al., 1985; Treichel et
al., 1990). Of note is that111.1'1(11 perfusionofisolatedrat livers withpolyclonal antibodies
against purified rASGPR showedthaI ASGPRon the hepatocyte surfacewas in fact
accessibleforrccognitiOl1 byspecific antibodies in invivo conditions (McFarlane et al., 1990).
Furthermore, thedeposition of antibodies showed a localizationpalternwhichwassimilarto
that ofpiecemealandinualobctar hepa tocellularnecrosis observed in AIHandchronicactive
hepatitisB, suggesting thepossibilitythatanti*ASGPR autoantibodies maycontributeto these
hepatocellularinjurys
In thepast few years,theoccurrence of anti-ASGPRantibodies in patientshasbeen
extensively investigated. Usingpurified rabbit ASGPR. McFarlane et al.(1986) detectedanti-
ASGPR activity by RIAin sera from 129Europeanpatients with acuteor chronicliver
diseases. 83% of patientswith AIHhad anti·ASGPRin their sera. The liter of these
antibodiesappearedto be relatedto the lnlfammatory activityof the disease, basedon the
histological examination of liver biopsies, A similllf frequency (73%)ofanti-ASGPR was
detected inpatients withchronic active hepatitis B. Thelitersofanti-ASG?Rinpatientswith
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chronicactivehepatitisB werefoundtobe lower than thosein patientswith Ali i, Also.anti-
ASGPR antibodiesweredetectedin theseracrpetlents withacute I-HlV hepatitis (3S%) and
other liver disorders(22%) (e.g.• PBe). Anothergroup ofpatients (421 individuals with
ditrerent forms of inflammatoryliver diseasesand 288 individuals with other extrahepatic
disorders) were investigated byTreichel et at. (1990) usingau ELISAwith purified human.
rat and rabbitASGPRsas targetantigens Theyfounda highoccurrenceofumonmibodics
against human ASGPR in patients with AIH (SO%), especially in those with high
inflammatoryactivity(88%). Only4 to 15%orpaucnrswithother liverdisorders [c.g.• pnc .
viral hepatitis and alcoholic liver disease)had antibodiesto hOlllan ASGPRdetectableby
ELlSA. Onthe otherhand.antibodiesto rator rabbit ASGPIlwere detected morefrequently
inpatients with non-All-l liver disorders, Their occurrenceappeared 10 becorrelatedwith
inflammatory activity and was not related 10 the diseuse enology. In respect 10 IIllV
infection. the occurrenceof autoantibodiesto human.rabbitand rat ASGPRswas 4%. 21%
and 26%inpatients whowere HBsAg-pc~i llve . In addition.til 10 10% orpatlcms withnon-
hepaticautoimmunediseases (e.g.• rheumatoid arthritis, systemiclupus erythematosus and
systemic vasculitis) were found to be anti-ASGPR-positive_ The authors suggested tlnu
different epitopes on ASGPRsfromdifferentspecieswere recognizedby theanti-ASGI)R
autoantibodies from patients with different liverdisorders. Thus, il is speculated that the
mechanisms for the induction ofanti-ASGPRantibodies inAll-I must differ nomthur in other
liver diseases(Pora1la et al., 1991)_ Since antibodies to non-spccics-spcciliccpitopcs on
I.SGPR weredetected in patientswithliverdisorders without ctiologic-specificiry. it ismore
likely that these autoantibodies could be induced in 11 non-specific manner, such as by
polyclonal B-cell stimulation. Incontrast,anti-ASGI'R. specificfor humancplropcs.appears
to be more restrictedto a specificdisease(i.e.• AUI) and thus,more likelyinducedby immunc
responses to specificstimulation, such as hepatocytedamage. This speculation may be
indirectlysupportedby a recent observationtha t the immunoglobulln subclassof anti-human
ASGPR anrbodies areIgG2inpatients wilh AIHand IgG4 inpaticntswith HBY or hepatitis
Cvirus-relatcdchronichepatitis(Treichel ct al., 1993}.
Thespecificity ofanti·ASGPR autoantibodies from patientshasalso been studiedby
Westernblotting (Treichel Cl al.,1990). Resultsshow that these autoantibodies recognized
the46-kDasubunit ofhuman ASGPR. One interesting observation (Treichelet al, 1992) is
that anti-ASGPR antibodies in patients with different hepatic diseasesare heterogeneous
Thus, the autoantibodies frompatientswith AlHand viral hepatitisappearto recognize
different antigenic ephcpcs on thehumanASGPR. This finding may further suggeststhatthe
mechanisms of the processingof ASGPR antigens and the gereatton or anti·ASGPR
autmmibodes could bedufcrcnr in diffcrent liverdiseases
2.IJ .2. Cellular immune responses to ASGPR
In contrast to thestudieson humoral immune response to ASGPR,there hasbeen
much less progress inthe investigationof the cellular immune responsesto this receptor.
O'Brien et aI.(1986) first detected circulating T lymphocytesspecificfor ASGPRin patients
withAIH byusing a lymphocyte migration inhibition assay. ASGPR.specificT cellclones
werelater establishedrrom thelymphocytes of'patients withAIH (Li et al.. 1990).
ASGPR-speciJic T cells were alsodetectedill intrahepaticlymphocyte infiltrations
(Lohret at, 1991; Treichel et al,1992a). :.\Iggesting that localT cells might playarole inthe
induction orspecificimmune responsesto ASGPR. In this respect, it is worthnotingthat
mosl of theestablished Tcell clones wereCD4-positi....e cellsand someof themwere able10
inducespontaneous anti·ASGPRantibodyproduction. Someof the 'f-cellautoactivities were
HLAclass ll-rcstrictcd, since recognitionof autologousantigen-presenting cellsby these T
cellscould beblockedbymonoclonal antlbccy to 1-ILAclass 11 molecules{Lchr, et al. 1991).
The role of ASGPR-specific T cells in the pathogenesis ofhe patocellular injury requires
extensive studyboth intn vmo and ill lim experimental systems.
1.2 . MATERI Al.S A NI> l\IET IlODS
2.2.1. Woodchucks 3,111.1Seru m Samples.
Woodchucks (n=55, 20 male and 35 female) were maintained as describedin section
1.2.1. Woodchucks (0=43) were cxpcrimcntally Infected with WilY by huravcnous
inoculation witha WHV infectious pool (Michalak andChurchill. 1988). According to the
criteria described previously, the diagnosis of the status or viral infec tion and disease
development werebased onthe serological investigations of' the WHY DNA, WIlY surface
antigens(WHsAg). antibodies to WI-IsAgandWHY core amlgcn(WIIeAg) (nnti-WIIs and
anti-WHc. respectively), as well asthe histological cxmninntion of livcr biopsies (Michlliak
et al., 1988; 1990; Pardoe and Michalak. 1(95). AcuteWIIV intcction wasdinguoscd whcn
WHsAS and ann-wl tc were detected in the circulntiou or unirunls nflcr inoculation with
WHY. Resolutionof acuteWHYinfection upon clearanceorW l lsAg from the circulation
withinsix monthsafter viralinoculationwas classified as self-limited acute hepatilis (S1.AII)
(n=32). Chronicviral hepatitis (e l-I) (nell) was diagnosed when Wl lsAgremained in the
circulationfor morethan six monthsafter thefirst nppcarnncc of the antigen. ('II W<lS also
confirmed by histopathological examination of liver biopsies obtained at 6- to 12-month
intervalsor at autopsy.
Serum samples (n;55) collected from the above group of 55 animals before
inoculation ofWHV were designated as zero samples, All these scm were WIIV DNA
negativebya nestedpolymerasechainreactionwilh WIIVcore gene specificprimers[Pardoe
and Michalak, 1995) and nonreactive lor anti-Wllc by specilic ELISA (Churchill and
Michalak, unpublished). Serum samples (n = 218)of 13animals from thc above group. were
collectedsequentiallyat bi-weekly or monthly intervals for a period orup 1022 months (62
±20 weeks) afterexperimental inoculation withWHY. Amongthese 13 animals. 7 (3 male
and 4 female) displayed SLAH and6 (3 mille lind 3 lcmalc) developed e l l All sera were
IUS
storedat -20·Cuntill tcsling.
2.2.2. Protein A Doublt·DifTusion Am y,
Accordingto Jensen et a1.(1978)andMcFarJance el al.(1985), insolubleproteinA
couldbeusedtoprecipitate the hnmunocomplexesofASGPRand anti·ASGPRantibodyin
a radioimmunoassay. This method was originally developedto determine anti·ASGPR
activity in human sera. To identify whether protein A can be used to precipitate
immunoglobulins [Ig] in woodchuck sera, the binding betwcen protein A andsera from
different speciesweretestedby a modifiedOuchtcrlnnydou ble-diffusionassay (Harlowand
Lane,1988).
Materials
( I) Sera fromwoodchucks, humans. guinea pigs andrats werecentrifuged at 300 " gfor
10 minto remove possible aggregated debris. Proteinconcentration was determined(see
sectionl.2.16)andadjustedto 1,0 ntg/ml usingPBS. In someinstances,sera were two-fold
dilutedin PBS from I mgproteirJml
(2)PllS (section1,2.2)
(3) BSA solution: 1.0 mglml BSAin PBS
(4) Protein A solution: 0.2% (w/v) soluble proteinA(Sigma)in PBS
(5) Agarose solution: 1.4'/0(wlv ) agarose(Sigma) inPUS.
(6) Staining solution: Coomessiebrilliant blue solution(section 1.2. 18)
(7) Dcstainiog solution: section 1,2.18
Method
An Ouchterlonyslide was preparedby pipcuing 3 1111of meltedagarosegel onto a
cleanglas slide(76 ><26mm)to fbnua layerof about2 mm thick. Aflerthe agarosegelled
at roomtemperature, slllull wellswere carefullycored in the gelina pal1em of equal distance
between the center welland the surrounding wells
WC,
Serumsamples(5 ~l each) wereadded incnch ofthc surr ounding wells. w hile 5 ,11
ofprote in Asolut ionwasappliedin the ceracr. PBSand IJSAsolutionwere used3S cmurols
and added in the surroun ding wells. After incubation at 37<> ( in a lnunid au uo spbc rc
overnighttillthe appearance ofprecipitinlines. proteins on thegel were washedand slaiucd
byCoomassie brilliantblue (secsection 1,2.\ 8 ). The gel was stained for I S min,then gently
rinsed using three changes of destainingsolutionlor about30 min, and air-dried at mom
tempera ture.
2.2,3, R adiehumunnassuy (HlA) for Iktcct ioll of Woo tlrhuck '\ uli·,\SGI'U '\ntiblldil'5.
Thisassay wasemployedto detectanti· ASGPR antibodie s inwoodchuck scrnor in
theantisera from guineapigs immunizedwith wASGP I~ or rASGl' R,followingthe mcihod
described by lensen er011. (1978) and McFarlancct al. (1985)
Materials:
(I) Reactionbulfer: I MNaC!, 5mM EDTA, O.l%(w/v) BSi\, 0.'2% (v/v) TritonX· 100alld
0.02% (w/v)NaN) in50 mM Tris-Hf'l buffer, pll 7.8
(2) Sucrose solution: 250 mM sucrose inreactionbuffer.
(3) Insoluble proteinAsusp ension: 1% (w/v) staphylococcaldried cells (So (/llr4.'11." Newman
DlC. Sigma) inreactionbuffer. The cellswere suspended in100 volumesofnacrion buller ,
washed twice and adjusted to 1% (w/v) with the same buller. Suspcnsio ns were prepared
immediatelybefore use.
(4) Serum samples: 10 ~I of woodchuck serum was diluted to I:SU in relictio n bulle r.
Samples werepreparedon the day orthc nssny andwere hcut-inuctivatcd at 56"C for 30 min
beforethe assay. In some instances, serumwas serially diluted in reaction huller Irnm 1:25
to 1:800 .
(5) Po s itive cont rols: gu inea pig anli·rASGPR antiserum[sec tion 1.1,8) , guinea pig anti-
rASGPR anliserumkindly provided by Dr. 13.M , McFarlane(lnslitute of Liver Studies, King's
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College School of MedicineandDentistry, London,UK)and woodchuck sera found anti-
ASGPRreactivewhenpre-testedby Dr. D.M. McFarlaneusing thesame RIAprotocol.
(6) Negat ivecontrols: a pool of sera from two healthy guinea pigsand woodchuck sera
withoutanti.ASGPRantibody reactivitywhich hadbeen pre-tested byDr. B.M. McFarlane.
(7)llsl_rASGPR solutions: I ng 1HI_rASGPR withspecificradioactivity of I " lOs cpmlng
protein (section 1.2.12) was diluted in 2S ~l of reaction buffer. In so me instances, the
concentrationof IllI·rASGPRranged from0.5 ngto 2 ng/2S Ill.
Method :
2S IIIof tested serum samples,control serum samples or reaction buffer(as blank)
wereincubated with 2S 1-1 1of I1'I_rASGPRin a S·m[ plastictube at 4°C overnight. Then,
allcradding100 IIIof insoluble protein Asuspension, the reaction continued I hour at room
temperature. Finally, the reaction volumewas adjusted to I ml withadditionof 850 II of
cold suc rosesolution, After centrifuging at 1,130 x g for 5 min,500 IJI of the upper
supernatant (U) of the reaction was transferred to another tube andboth the upper and
remaining solution wifh pellet (R) were counted in a gammacount er(LKB).
Total ant ibody activity in each sample was expressed as percent of I!SI_rASGPR
bindingaccordingto thefollowing calculation: percentbinding(%) ::.: (R - U)/(R+ U) " 100.
All serum samples and con trol samples were tested in triplicate. For each
determination, the backgrou nd radioactivitydetected ir- theblanks containing only reaction
buller was subtracted. Theintra-and inter-assay variation of'the meanvalues obtained from
positiveandnegative controls were 10% or less inthe experiments performedat each time.
1.2.4. Wtst crn and Dot BIoi Analy ses.
To dcterminespccjflchyof wo odchuckanti·ASGPRautoantibodies against ASGPR
subunits,a Western bloting technique wascarriedout as described in section 1.2.21.
A similarwcscrnblot procedurewasemployedfor theanalysisof the cross-reactivity
ms
between ASGPRand WHY proteins. For this purpose. 0.25 j ig rASGPR protcinllane, O.5
I1JY1ane ofWH sAg o r WIIV virion proteins we re applied jor analysis. Th e affinny- punrcd
wA SGPR and rASGPR were prepared as desc ribed; 11 section 1.2.6.2, The WIIsAg and
WHYvirionswere isolatedfromthe sera ofchronicWI,IV carri ers by other researchers inthis
laboratory (Michalak et al., 1988; 198 9), A dot -blot assay was also performed III examine
the possible cross-reactivity betweenASGPRand WIIV antigens. The assay was carriedout
in the same wayas described for Western blotting, with the exceptionthat the samples were
immobilized onto nitrocellulose membranes by microflltration usinga Bio- Rudepparnus.
Briefly, 0.36 -0.8 J.I£ proteins of wASG PR, rASGI'R, Wl lsAgor WI-IV virionsin 100 II of
PB S were spottedper dot. In theseexperiments , the nhro cclelcsc membranes were probed
with guinea piganti~rASGPR antiserum (1:400) or rabbitanti-Wlls anliserum ( I:400), The
reaction conditions andreagents used in Ihis expe riment weredescribedin section 1.2.21.
2.2.5. Sta tistical AIHllysis_
Student's nonpaired I test was used to compare the mean values of allli-AS(iI' R
antibody activity for tested woodchuck groups. Wilcoxon signed rank test W<lS used 10
co mparethe dataofa nli-ASGPRantibody activity in the samplesat each lillie point during
the course of follow-up of animals with WIIV inlcctiou, Fisher's exact lesl W,l5 used 10
comparethe raro of disease development indiffcrumgroups. Inall tests, two-sided I' values
les s than 0.05 were considered significant. Analyseswere performedusing the Gruphlud
InSlat software package(Grap h Software, San Diego, CM
Ill ')
2.3. RES ULTS
2.3.1. Det ection of Anli·ASGP R A u tol'nl ib otJics in Woodch ud l Sera by RIA.
2 .3.1.1. Establishment of the assay co nditions.
R IA was originally developed for the d etection of human anti·ASG PR (McFarlane,
et cl. 19&5)andwas adopted in the co urse of the present study for the identification o f anti-
ASGPR ac tivity in ....oodc buck sera . In one o r tilepreliminary e xperiments . the rea ctivity
betweenwoodchuck serum and protein A was d etermined by using a double -diffusio n assay
in whichse ra from woodchuck andother species were tested. The results. fo r example in Fig.
2 . 1, show ed that protein A recognize s woodc huck, gulnea pig and human serum (po sitive
con trols ) wilh similar efficiency, while . as ex pected, it did not recognize the ral sera (the
negative coorrol). The results frorn protein A afllnhy chromatog raphy ex perimen ts (see
section 3.J.I ) further confirmed the highly efficient binding between protein A and
woodchuc k IS fractions. To determine the appropri ate dilution of woodchuc k serum and the
optim al co ncentration of radio'abe lled ASG PR for the RIA. another l WO preliminary
ex periments were performed. First, th e anli-AS GPR.posit ive and negative woodchuck sera
at dilutions ranging from I:25 to I;800 and the m j.ASG PR al co ncentratio ns rangi ng from
0 .5 10 2 ng perassay were tested. S ome of the scta u sed in these expe riments had been
pret ested by Dr. Barbara M. McFarlane (Institute of Liver Studies. King's Colle ge Sc hool of
M edicine and Dent istry, London. U.K. ) using a RIA for human anti-AS GPR det ection
(M cFarlan e eI al., 1985) and served as positive or negat ive controls. The affinity-p urified
rA SGPR radiolabelledwith Nall' l (2.5 >< !Ol cpm lng. sec section 1.2) was u sed as the target
an tigen Th e rcasons for choosing rASG PR instead ofwASGPR were that rASG PR is more
rea dily available than wASGPR and that both receptors nrc highly ant igenically cross-r eactive
( scercsuhs in section 1.3.1, Table 1.2and Fig. 1.2). Results of these prelimina ry experiments
re vealed tha i RIA 'WIS a rciiablc metho d to identify anti-ASGPR activity in woodc huc k sera,
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Figul'"C2.1. Th e reliction between woodchuck serumand prctctn A detected by
double-.diffusion assay in agaro se. Serum samples (I mg ser um proldnJmJ) nudprotein A
(0.2%. w/v) wereaddedto the wells(5 ~ l/each) o n theOuchwlolly slide. 0, solubleprotein
A; I, PBS (blank); 2, human serum(positive control):3, rat serum (negative contro l); 4.
woodchuck serum; 5. guinea pig serum (positive control); 6, I.lSA (negative control. I
mglml) . Afte r incuba tion at 37°C overnight. the gel was stained withCocnn sslc blue.
destained and dried. as described in section 2.2.2.
Thisfigure shows that protein A recognizes a componentin woodchuck serum with
an efficiency similar to thatof the reliction betwen proteinA andIgG fhlcliolls in human and
guinea pigsera.
"'
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since th e positive andnegativecontrolserum samples hadbeen well distinguished and the
obtainedvalues were highly reproducible. On thebasis ofthese evaluations. staudnrdnssay
conditio ns forthe testingofanti·ASGPRillwoo dchuck serawere used (sec section 2,2.3 for
details). In general.these assayconditionswere similar llli hosc determined fbr the detection
of anti-AS GPR in human sera [Mcltnrlanc ct al., 19$5). thus 1 Ill; uf 11'I_rASGI'1tami
wcodcbuck serum at a dilutionof I :50 were selected
2.3.1.2 , Determination of the prevalence o f llllti·ASG l11t antibodies in a healthy. WIIV-
noninfecte d woodchuck population.
T o evaluate tim prevalence of llnti·ASGI'R nutcnmibodics ill woodchucks with
experimental WHY infection. we rucasun..xl t he i\nti-ASGI' R activity;1\healthy WII V·free
animals to establisha normalvalue as a cut ai rli ne, r ig 2,2 givesthe disHilllllio l\ of'umi-
ASGPR autoantibodyactivity in the SeTiI(zero samples ) 01'55 woodchucks at dillercnt ages
without previou s exposure to WHV. The mean of anti-ASGPR activity in this gn,up or
animals. as detec ted byRIA and expressedas percentage {\r l~' I - rASG I' R bound. W ,lS 3,;1%
± 1.2 (mean ± 2 x standard error of mean. SEMI, On thisbusis, IYC defined vnlucsahovc
4.5% (me an + 2 SEM)as anli·ASGl' R autoantibody positive, As shown illl'ig . 2 2. the
majority ofhealthy. wllv-nonefcctedanimals (39 of 55 animals; 70.9"10)were lmti-ASGI'R
autoantibody negative. Sera from these woodchucks gave values below 45%. which
correspon dingto an antibodytiterbelow I:50 (o r grade 0). Some animals(10of 55; 11t. 2%)
weremod erately positivefor nnti·ASGPR ranging between4.5 and 8.0%. correspondingto
titers below 1:200 (orgrade 1+). Four woodchucks (7 . 6%) c~hib i t ed strong ASGPR-binding
activity ranging between8.1 and 1511/0. corresponding tu titers bciow 1,<100 [ur grade 2,1)
Two ot hers (3.6%) showed very high anti·ASG PR activitywith values above 15% which
correspon ded to titers above 1:400 (or grade ]+ ), Overall. the results revealed that the
prevalence ofanti·ASGPR autoantibodiesin WIIV-noninlcctcd animalswas29. 1%
" 2
Figure 2.2. Distribution or;lnti-ASGI'J{numnntlbody activity ill the sera or55
htlllthy woodchuckswithoul previous rxpcsuretu WIIV. Anti-ASGPR antibodyactivity
in woodchuck sera was determined by RIA llsillg , ~sl ·rASGPR as a target antigen, as
describedin section 2.2.3. The blank bar represents thenumber oranimalswhose sera were
anti·ASGPRnegative (gradc 0) and thespeckled barsrepresentsthenumber of animals whose
sera wereantj·ASGPRposinvetgradcs 1+ 10 3+), as assessed according to the cut off'value
ofant;-ASGPR activity (4.5% of ASGPR binding) as defined in section 2.3.1.2.
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2.3.1.3. Determination of the induction anddynamics of anli·ASGPR autoantibodies after
WHY inoculation and in the courseofWHV infection
To study the relation between WHY invasion and the appearance of antj..ASGPR
autoantibodies, serial serumsamplesfrom 13 animals collectedbefore andafter inoculation
with WHY were analyzedby RIA for the activity of anti·ASGPR autoantibody. These
animals wereal differentages. Basedon diseasedevelopment. theanimals were divided into
twogroups. Onegroup included1 woodchucksthat displayeda serologic pattern indicating
recoveryfromacute WIIVinfection(SLAI-I)andtheother included 6 animalsthat developed
ell (Sl,.'C section 2.2, I for dctails of tile animals).
Table 2.1 summarizes the characteristicslind occurrenceof autoantibodies against
ASGPR in relation to theappearanceofWHsAgin these animals. Examples of the changes
over time in the activity pattern of autoantibodies against ASGPR in individual animals are
illustrated in Fig. 2.3. The comparison ofanti·ASGPR activity before and610 8 weeks after
WHVinoculation in the sera of all Ihe animals is shown in Fig. 2.4. Theoverall pattemsof
serumanti-ASGPR aelivity in animals with SLAH and those with CH duringthe follow-up
periodare showninFig. 2.S which are the computer generated graphs of the mean values of
anli·ASGPRautoantibodyactivity. The following issues were revealed
( I) Asshown inTable2.1and Fig. 2.4. amongthe 13tested animals. 9 (i.e.• WM.I to WF.6.
and WF.8 to WM.I0) were anli·ASGPR nonreactive before WHY injection. After WHV
inoculation. anti-ASGPR became detectable in 8 of these animals. the other one (WF.6)
whichdevelopedSLAB tested negative throughout the entire follow-up. In general, in these
woodcbocks, anli-ASGPRresponsewas inducedafter WHY infection at a ratio of88 .9% (8
o(9 ). In addition. the overall difference betweenthe values of anti-ASGPR activity before
inoculationand thilt frompostinoculation wasstatisticalsignilicant (I test, P < 0.05)
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Figure 2.3. Dynamic patterns of an ti-ASGPR nutouurlbudy during follow-up
of four woodchucks with eJlflerimcntally induccd WIIV infection. WM.! and WF,3,
animals with a self-limited episodeof'acureinfection (SLAH), WF.8 anJ WM,IO,animals
wilh acute WUV infection whichprogressedto chronic hepatitis (e U). The values of anti-
ASGPRantibody reactivity weredeterminedby RIA, as described in section 2.2,3, Values
at point zeroreflecttheanli·ASGPRantibody reactivity intheserumsamplescollected before
inoculationwith WHY. Horizontal bars showthetimeofthe appearance anddurationof
WHs.antigenemia
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Figurt2.4. Compar ison of uUli-ASGPR llClivit)' before WIIV inoculation and
6108 weeksafter in thesera of 13 woodchuckswith expemneuutlacute hepatitis. Open
symbols showthe mean valuesdetectedineachof 1 animals which tinally recovered from
acutchepatitis,whcreasshaclcdsymbolsrcprcsclll lhclllcanvalucs foundineacho f 6 animals
in which acute infection progressedto chronic hepatitis
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Fl€ure 2.5. Cemputer gCllcrllt cd gr:lllhs (If the means of anti·ASGPR
auto antibod y reactivity in wecdchuc ks witli eaperimcnta l WI IV lufectlen . Anti·ASGPR
autoantibodies in woodchuck sera were determined by RIA, as described in section 2.2.3.
Graphspresent themean ofanli·ASGPR autoantibody reactivityin the seraobtained from
woodchucks with SLAH(n .. 7) and animals with CH (n '" 6) after experimental WHV
inoculation. Values shown at zero represent the meansof anti-ASGPR autoantibody
reactivity in sera collected before inoculation with WI-IV. Horizontalbars show the mean
lime oft he appearancelindduration of WHs-;uuigclIcmia Comparison of the data at each
timepoint of the follow-up betweenthese two groupsbyWilcoxonsigned rank test didoct
shown significantdifference (/' >0.05)
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(2)Table2.1alsoshowedthat in5 (WM.l toWFA, andWF,B)of the Sanimals (62.5%) with
anti-ASGPR response induced afler viral inoculation. the anti-ASGPRactivity emerged
concomitlU1t1y with (WF.2) or 2 10 18weekslater (WM.I. WF.3, WF.4 and WEB)than the
appearanceof WhsAg. Since WHsAg appearancein thecirculationis an indicator of well-
established viral replication andlor viral hepatitis and is accompanied by active liver
necroinllammationin themajority ofanimals. thepresent finding may suggest thatthe anti-
ASGPRautoantibodyresponse dependson thedamageorhcpaocv tes due to WHYinfection.
In threeother animals (WM.5. WF.9 and WM.10) (37.5%). anti-ASGPRautoantibodies
appeared between 210 6 weeks prior to thatof WHsAg. AsWHYDNAhad beendetected
in these animals10 to 20 days after WHYinoculation by peR (data are not shown). the
emergenceofanti·ASGPRin thesegroups stillfollowed theestablishment of viral replication.
Therefore. WHYinfection was necessaryfor all these 8 woodchucks to produce ASGPR-
specific autoantibodyresponse
(3) Further. Table2,I and Fig. 2.4 revealed that in 4 (WM.7. WF.I I. WM.12 andWM,I3)
of these 13 animals. the zero samples(preinoculation sera) were positive for anti-ASGPR
activity. However, WHYinfection in2 (WM.7 andWM,12) of the4 animalswasassociated
with a moderate rise in the autoantibody activity during the first 8 weeks post WHV
inoculation(Fig. 2.4 andFig. 2.5). The remainingtwowoodchucks displayed no change in
the autoantibodylevelsuntil in the late phaseof follow-upwhen increases in the levelof anti-
ASGPR were finally observed. Therefore. itappeared that WHYinfectioninduced a riseof
anti-ASGPR antibody levels in the majority ofanimals, even inthose that had preexisting anti-
ASGPR antibodies, Most interestingly. 3 (WF.II , WM,12 andWM.13) of these4 animals
developedchronic viral hepatitis. while only one (WM.7) recovered from acute infection
Thisobservationraisesthe possibility (hat animalswith preexistingautoimmune response to
liver-specific ASGPR may be at higherrisk to progress to chronicWHYinfection, Further
analysisof thisissuewillbe presented in section 2.3,2.
Ill)
(4) As shownin Figs.2.3 and 2.5, anti-ASGPR autoantibodiesremaineddetectable through
the entire follow-up period in 12 of the 13 animals(WF." did not generate anti-ASGPR),
evenafterthedisappearanecofscrologicalll1urkersof activeWIIV infcxtio n (c.g. Wl lsAg)
Thepatternsof anti-ASGPR accurrenceshowedalternate periodsof increases and falls which
did not parallel the fluctuationofWHsAg and progression or recoveryfromacme hepatitis
(e.g., in Fig 2.3, WM.I and WF.3). In the animals that recoveree from viral infection
(SLAH), the clearance ofW HsAg from the circulationand the appearanceof antibodies
directed to WHsAg (anti.WHs) were typically detectable, us determined by other
investigators in this laboratory. This indicates a complete serological resolution ofW IIV
lnrecnon. Statistical analysis,by comparisonsoflhe ,mti-ASGPR activity data at eachtime
point during the whole follow-up period. showed thai the dynamic difference wus not
significant(Wilcoxonsignedrank test, l' = 0.47) betweenSLAII and (' II animals (Fig. 2.5)
It appearedthat theactlvhiesofanti -ASGPR autoantibody ntlcr 50 W,I1.i tended to decline.
even to undetectable levels,more frequentlyin animalswithSt.Allthnn in those with e l l
(Fig.2.5). However, the differencein the autcnntibody dynamics between these two groups
in the late observationperiod was still not quite significant(Wilcoxon signed rank rest. /' ""
0.063). Theseobservationssuggest that evaluationofnnt i·ASGPR autoantibodypatterns in
the course ofhepednaviral hepatitisdocs 110t have a prognostic value in the predictionof the
outcome of acute hepatitis, Lc. progression to chronic diseuse or recovery from acute
infection.
2.3.2. Investigation of tile Relationship Between Anli·ASGl'l t Respons e and Diseuse
PaUern s in WH V-Infecled Woodchucks,
As mentioned in the previous section (2.3.1.3), the occurrence of unti·ASGPR
autoantibodies prior to WHY inoculation appeared to predispose to the development of
chronic liver disease in 3 of 4 woodchucks. Thisobscrvaricn led us to explore in a larger
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woodchuckpopulationwhether there is any relationship between pre-existinganti-ASGPR
autoantibody activityand the diseasepattern ofW HV infection. Among the 55 healthy
woodchucks whose serum samples were used to establish the normal anti~ASGPR
autoantibody reactivity value (section 2.3.1.2.). 43 animals. including 13 woodchucks
describedindetail insection 2.3.JJ, hadbeenexperimentallyinfectedwith WHY. The serum
and liver biopsysamples had been evaluatedfor WI-N infection markers and morphological
status offivcr injurybyother investigators in this laboratory. Therefore,the available data
were retrospectively reviewed forthe purposeof tile presentstudies.
Table 2.2 summarizes theoutcomecfW HVinfection in these43 animals, in which
II (25.6%) were foundanti-ASGPR autoantibody positiveand the remaining32 (74.4%)
wereanti-ASGPR autoantibody negativepriorto WHYinoculation. It was foundthat 32 of
the 43 woodchucks (74.4%) developed AH and finally recovered fromhepatitis(SLAH),
while 11 animals (25.6%) developed CH. Interestingly again,amongthese ' I animals that
developed CH,6 (54.6%)wereanti·ASGPR positive priorto WHY inoculation. In contrast,
the rate of the Cli development in 32 animalsthat wereanti-ASGPRnegative beforeviral
inoculationwasonly 15.6% (5 o(32). Statisticalanalysisrevealeda significant difference in
the CH development ratebetweenthese two groupsofanimals(Fisher'sexact test, P < 0.05).
This resultsupports ourpreliminaryobservationdescribedin section2.3.J.3andsuggestsa
possibility that anti~ASGPR autoimmunity existing prior to hepadnaviral infection predisposes
10 thedevelopment ofchronichepatitis in woodchucks.
2.3.3. Receptor Subunit SIll'cil'icity or wuv-luduced Autoantibodies to ASGPR.
Todeterminethe ASGPRsubunit specificity of anli·ASGPRautoantibodies induced
by WHY infection and detectedby RIA, Western blot analysis was performed by using
purified wASGPR and rASGPR. Fig. 2.6 showsthat both the 40- and47·kDa subunitsof
ASGPRfromwoodchuck and rabbitliverswerespecifically recognized by the an t i~ASGPR
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positive sera from WHY·infecled animals. This result indicated that both subunits of
wASGPR and at least the cress-species-reactivedeterminants inwASGPRand rASGPRwere
autoimmunogenic in the animalswithWHY infection. Interestingly, identical results were
obtained by usinganti-ASGPRpositive sere fromdifferent periods ofWHVinfection, even
using the sera in whichanti·ASGPRbecamepositivefor the first time by RIAafter WHY
inoculation (data not shown). This result indicatedthat the anti-40-kDa and anti·47·kDa
activity appeared at the sametime following WHY invasion Thisfindingvaried from our
previous observation that tile anli-40-kD appeared prior to anti-47-kDa in woodchucks
immunizedwith atlinity-purifted rASGl'1l(Table 1.3 andFig. 1,I I), Thisfinding maysuggest
that induction of autoantibodies to ASGPR by WHYinfection could involve a mechanism
different from that throughactive immunization
2.3.4. Assessment ofW IIV·ASGPR lnuuunclogienl Cross-Reactivity,
To test if there is any antigenic cross-reactivity between w·ASGPR and WHY
proteins,immunodot blot andWesternblotanalyseswere performed byusingaffinity-purified
wASGPIland rASGPR preparations, and isolated WHV envelope (WllsAg) proteins and
complete virion panicles as target antigens. In these experiments, guineapig anti·ASGPR
andrabbit anti-WHs antibodies were used.The obtained results revealed the lack of antigenic
cress-reactivity between ASGPR and WHV proteins. as summarized in Table. 2.3. In
addition,there was00 correlation between thepatterns of anti-ASGPR andanti-viral antibody
(ie., anti.WHs) responses inthecourseofWHVinfection (see section 2.3.1.3.). This further
suggests that it is unlikely that there areantigenicdeterminants sharedbywASGPRandWHV
structuralprotcins.
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2.4, DISCUSSION
Two immunodctection methods, RIA and ELISA. have been established for the
detection of human anli·ASGPRautoantibodies (Mcf'arlnne cr al., 1985; 1986; Treichelet
al., 1990; 1994a). There arc several disadvantages o f lhe ilntj·ASGPR EUSA method,
compared with the RIA method. Firstly, a relatively high amo unt of pu rified receptor is
required as an antigenlor antibodydetection, Considering thetime-consuming procedureof
ASGPR isolation and the relatively limited yields of puri llcd ASGPR, it is more convenient
tochoose a method in which lessASGPRproteinis consumed Secondly, ASGPRmust be
immobilizedonthe plasticplates in anli-/\SGPR ELISA. However. isolated native ASGPR
occurs in highly aggregated formsin aqueous solutions , Deterg entscan notbe applied to
dissociate these aggregates during the coating of tile ASGPRonto the ELISAplates, since
they interferein the clllciency ofproteinattachmentto plastics. In addition, conformation
changes of the ASGI'R molecules may take placedue to theinteraction between ASGPR
proteinand plastic. 111us. it is possible thatsome important domains (c.g., antigenic epltopes
or ligand binding sites)may notbe accessible to antibodies. As an example. our finding
(section 3.3.2)showed that subunlt-spccltk antibodies against the 47-kDa sobunit did not
inhibit ligand binding to ASGPR immobilized on plates. but did inhibit ligand bindingto
ASGPR on hcpatocytes. T his suggests that the binding siteon the 47·kDa polypeptideof
ASGPR maynotbe accessible tospecific antibody when purifiednative ASGPRis coated on
plasticplates. Therefore, co nsidering thesefactors, a liquid-phase RIA was mainly used in
the course of the present stu dies. In RIA, purified ASGPIl.reacts with antibodies in the
presence of a low concent ration of Triton X-IOU. Therefore, it is likely that ASGPR
aggregates canbe dissociated andthe majority of'entlgcnic cpitopcs onASGPRare available
forantibody recognition. T he possible drawbackof RIA is that proteinA has10be usedto
precipitate ASGPR-anti·ASGPR imuumocomplcxes. although the affinity of different Ig
l :!f,
classesandsubclases to protei n Avaries Withregards 10 the prcscru smdy. theOIllinity uf
different woodchuckIg classes or subclassesto protciuA remainunid~nt ilied Therefore, it
is possible that some anti-A5GPR autoantibodies limy not bedetected in this ussay system
However, according to the results from our douhlc-tlitrusion assay, the reactivity of
woodchuckIg withproteinAappearssimilar10 that of'hamun orgulucu pig Igs , Inaddition,
ou r results have shown that woodchuck 19 can be isol.ucd by using a protein A-al1illilY
columnand that the purifiedwo odchuck 19behaves as IgO (sec sccti unLk. L;~ 1id \ll l ak ct
a1 ., 1990). So, it is likely that ant i-ASGPR RIA used li)f the slmly ot'woodchuck scm may
be as sensitiveas that used for the study orhuman scm
Comparison of the rate s ofal1 t i~ASG rR detection inthe same group uJ'patientshy
the liquid-phase RIAusingprote in Aand bythe solld-phasc EI,IS/\ ha s been dune in a recent
study (Treichel et at.. 1994). The results of this study ShOW ;1 hig h dcgrce cragrccmcm
betweenthese twoassays. The finalcouclusionofrhesc authors is that lnnhRI" and 1 ~ I .1 SA
are highly reliablefor thedetecti onofa nti-ASGI'R nutoan ubody
Inthe ecorseof thisstudy. wefound that anti·ASGI'H. autoantibodieswe re deteetahle
in the sera of some healthy, Wl-lv-nonlnfcctcd animals. Occurrence or autO,lI\libmlies 10
ASGPR in these animals may suggest somephysiologic Ilillctiull o f these uuronntibodics
Natu ral autoantibodies in thecirculation arc thoughtto be involved in theclearance of free
autoanugens {e.g., following cell death) (Cohen and Couke, 1986), Wilh regard to this
scenario, it has beenlbund lhata solubleA$Gl'll exists in humanseru m (Yago et al. 1995)
This human serum ASGrR was identified. alter being absorbed on ,111 ami·ASGI'R
monoclonal anlibody affinkycolumn, us protens wilh molecular masses of) 5 to 40W ;. The
ASGPR levels in the serum appear to be related to the st"lus of liver degeneration or
regeneration . Thus. it is quite possible th,llallli-ASGPR maybe induced by these soluble
ASGPR proteins under both natu ral and pathogenic conditions
The normal level ranges ofhuma n autoantibodies against ASGI'R ill scmhas heen
investigated insmall yrollps of peficnts byusiny boll' RIA and ELISA, McFarlane et al.
e1985)determined the anti-ASGPRautoantibody activity by H[Ain 12 patients without liver
disorder or organ-specific autoimmu ne disorders. Treichel crat. ( 1990) analyzed serum
samples fromJI healthycont rols, In beth ofthescreports, the mean of the normal values
plustwostandarddeviation (SO) was used asacut oll'valuc to determinethe activity of anti-
A5GPR in thetested samples. Unlike our result obtained in healthy woodchucks, [henormal
valuesof autoantibody against ASGPR inhuman control serawere wilhin a narrow range;
all the values were below the cut 011' value. In the presenl study, the prevalence of
autoantibodiesagainst ASGPR wasfou nd\0 be 29,1%in healthy woodchucks, This high
incidence of anli·ASGPRantibody in apparently healthy woodchucks may be a species
specific event. Apreviousstudyinthis laboratoryhasshown that the prevalenceof ron-
organspecificSMAin healthy woodchucks isas highas 55%, whilethe prevalenceof SMA
among normal human subjects is only 12% [Dzwcnkcwski and Michalak, 1990)
Nevertheless, since all thewoodchucks werewild-caught. it isalsopossible that someof the
woodchucks with high anti-ASGPR activitymay have had a previousexposure to some
pathogenic factorsctbcr tlm WI-IV(e,y_. bacterial orparasitic ierccnons. or chemical toxins)
The important finding in thisstudyis that autoantibody respunseto ASGPR was
induced(in 8 of9 animals, 88 .9%)or boosted (in 4 of 4 animals) due to WHYinfection
(Table 2.1). This findil1!,\ provides, for the first time,IIdirect evidencethat hepadnevirus
invasion triggcrsliver-spccflcautoimmune response. Inaddition, observations inthepresent
studygive some new insightson therelationshipbetween bepadnavirus infectionand anti-
ASGIIRautoimmune response . Firstly, theinductionof anti·ASGPR antibodiesin WHV-
infected animals appearedto be IIconsequence of well-established WHY infection. The
appearance of anti·ASGI'Rurtoanibodics usually followed the emergenceof serumWHsAg
whichisan indicator of progressing WHY infect ion. Incomras to this observation. WHY·
infcclioninducednon-organspecificautoantibodies, inparticularSMA, usually appear prior
tothe serumWHsAg(Dzwonkowski andMichalak, 19lJO). Therefore. it islikely thatanti-
ASGPR response is a consequence or vsus-tnduccd liver damage rather limna di recteffect
ofhepadnavirus on theimmunesystem, nmechanism postulated inthecase ofWIIv-lndnccd
SMAresponse. Second, the levelsof auto.1nti\.>odics to ASGI'R showedrapid changl,.'Sduring
theco urse of follow-llp. The dynamic pnncrns ofanti-ASGI'Rau toantibo dies lunnlmals with
SLAH couldnot bedistinguished from that in animals with('J I, which also showed a strong
resemblanceto the dynamics ornon-organspectre autoantibody responses inWil Y-infected
woodchucks (Dzwcnkowski and Michalak. 1990). Fur thermore. like the ncn-orgau-spcifl c
autoantibody response. WI·IV-ind uced ant i-ASGPR nutoam ibodics per sisted in Sl.A I I
animals. Thistype ofvira l-related autoimmune responsescould bethe resultIll' a "hit-and-
run" event (Oldstonc, 1987), in w hich autoantibodies remainwhenviruses had been long
removed. This typeor autoimmune response could abo be the outcome Ill' continuous
stimula tion of the immune system due to life-long persistence of WIIV replicationand
residual livcrnecroinflammaiioninsomeSl.Al l woodchucks[Michalak , c t ul.,11)94; Pardoe,
etal., 1996).
Tbeoccurrerce rate (88.9%) ofanti-ASGIIR in experimental WI IV infec ted animals
wason ly slightly higher than that in parlcors with Illl V infection (73% ) (McFllrl,mccl al..
1986)_ This findingmay Sll££CSIsimilarpath waysleadingto the ,U1li-ASGI'1{aut oimmune
responses inWHY and HBY infections. Onthe ocher bnndrhcr c is npossibilitytha t <Ihigher
rate of response in woodchucks may be due 10 infection unde r experimental conditions
Inoculation of animals w ith WHY was ca rriedour by huruvcuous ,ldillinistra tiun or a
relatively highdose of viru lent viru s. Thereby. infectioncould be more severe than under
natural conditionsand induce more efficiently autcinuuune response to AS(WR
One of th e most in teresting andunexpected observations inthis study was thatthe
presence of anti-ASGPR in preinoculation sera was associated with the higher nrc of
developmentof chronic WH Y hepatitis IIwas lound that b of I I woodchucks(S4 .S%) with
12')
anti·ASGPll autcanubodybefore inoculation of WIIV developed CH, while the rate orCH
development inanti-ASGPR non-reactiveanimals wasonly 15.6% (Table 2,2).
Viralpersistenceis one of the major subjectin the study o f viral pathogenesis. The
balance between viral invasion and host defensecontrols the outcome o f viral infection.
S".eralmechanisms have been suggestedbased on Hnv research (for review seeChisariand
Ferrari, 1995a). With regards to virus, production of defective viral particles and
spontaneous mutationsare commonly observed inpatients with HBVchronicinfection, It
is thought that this alteration of viral replication may help HE V escape from immune
surveillance. Also, as for the hostimmunedefensemechanisms. immune surveillancecanbe
influenced byviral infection sinceHB Vnot only attacks hcpatocytesbut alsocells olthe
immune system(e.g.• lymphocytes and macrcphages). Therefore, thefunctionsof immune
cellsmay alsobedestroyed. Mennwhile, highconcentrationof l-lBsAg in serumis thought
10 beable to induce a stareofirnmcne tolerance in thehost. Moreover,cytokineproduction
(e.g. v-interferon) CM besuppressed in patients withchronichepatitis. One of'theinteresting
st udies on anti-viral CTLresponse have shown thatpatients with chronic HBVinfection
usually have weaker (evenundetectable) virus-specific CTLresponsestha n those patients
who successfulyrecover from acuteHBYinfection(Ferrariet aI., 1990). Takentogether,
the current sodlcs indicate that the host immune system may significantly influence the
development ofchronic viral hnccdon. Relevant to our observation,anti·ASGPR activity
occurring prior (0 WIlY-inoculation couldbe oneof the signs o f anabnormal responses
induced by thehost immune system. Under suchabnormal conditions, it would nOI be
surprising if ahigher rateof vimIpersistenceoccursin theseanimals(Table 2,2), Further
workshould continue to investigatethe courseand the outcomeofWHV infection by using
anti·ASGPR positive woodchucks inoculated with WHY. The anti·ASGPR antibody
reactivity in fheexperimental animals couldbeinduce t,y JlIIlllunization with purified ASGPR
or-pos ibly bysome"nuumlagents" (e.g . bacteriaor parasite infection). Suchexperiments
DU
are in progressinthis laboratory andIheresultsmay provide some clnnficntion( In this subject
in th e future.
Accordingto Porallaet al. (1991), inpatients wilh AlII. species-specific upltopcs ill
human ASGPR are thought to be the major cpitopcs recognized by tlnti·ASGPR
autoantibodies. Incontrast,ncn-spcccs-speclnccpa opcs or ASGIIR are mainly recognized
by ant i-ASGPRautoantibodies from patients with I-IDVinfection Our results indicated that
at least non-species-specific epitopes exp ressed 011 bothwASGPR and rASG PRcould hc
autoimmunogenic in the animals with WI IV Infection (Fig. 2.6). This observ ation appears
10be comparable10the results fromclinical studies. Whether ruerc is li ll y strictly wASGPR
speci fic autoantibody response in woodchucks with WIIV-infection still needs further
investigation.
Inaddition,sera fromanimalsindifferentstagesor WIIVinfection(i.c., Al l lind e ll)
showed identical patterns of ASGPRpolypeptide reactivity (Fig. 2.6), including thesera in
which anti-ASGPRwas detected by RIA lo r thefirst limeliner inoculation with WIIV. This
result is different from our observation in woodchucks challenged withlllli nitY'rurilicd
rASGPRrr abie 1.3and Fig. 1,11), where an i1 nti-40-k[) response occurred prior to anti-<! ",
kDa response. Thisdifference suggeststhat the pathwayof allti-ASGPR antibody induction
inWHV infection could be different from thatthrough theimmunization route s
Molecular mimicry between vira l peptide and scff peptide is one of the hnporunn
mechanisms for theinductionof'autoinnuuncrcspcnses (Oldsrouc. 1987). With respect to
the autoimmune phenomena occurring dur ing B UY lulcctlcn. there has been nu reports
regarding the cross-reactivity between HBV andASGPRproteins. According to computer-
assisted multiple sequence comparisons using the PC G ENE progr<lI11 ( In telliGcne l ies,
MountainView, CA.), we found that the ide ntity between the DNAor aminoacid sequences
ofHBV proteins and humanA.SGPR protein is very low. At rue nucleotide sequence level,
tile overall identitybelween HBY genes and the genu or thc human I\SGPR II I subunit is
II I
36%md that bdwccnthcl l8V gClle and the112 geneof human ASGPRis 37%. Although,
at the amino acid~levcl. l he idcntitybetwetn H13Vproteins andHI or H2 is 3%01"
40/.. respectively. Our results showed a lackof cross-reaeti\; IYbetween antigenic domains
of ASGPR ardWlisAt: (fable 23) . Ho~. it m Id be noted that inductionof antibody
prodactic n requires antigen-processing byantigen-presentingcells. This processinvolves
proteolysis ofantigens, and thus,some cpitopes of cross-reectivity and hiddeninside the
anIigm moleculescouldbeexposed To verifythis, funher study of cross-reactivity between
WHVand ASGPR shouldincludelimiteddigestionof ASGPRand WHY withproteolytic
en zymes, tr eatment withdetergents or denaturation of the ASGPR or WHV proteins
Whether WHVand wASGI'R share co mmonT cellcpitopcs also remains to beelucidated,
2.S. C ONCLUSION
Themajor observation from this part of'the work is that experimentalhcpaduavinu
infection evidently triggers an autoantibody response ag:lillst host hepatic ASGl'lt These
WHY-induced autoantibodiesrecognized both constituent subunits ofw ASGl' R. suggesting
thatboth receptor subunits expressed 011 the hepatocyte surUICCmay serve as ur gers for liver-
specific autoimmunereaction. WHYand 1\SGPRseemingly do not contain cros s-reactive
epitcpes, suggestingthat induction of the nnti·ASGPR muoamibody response is unlikely to
be a consequence of viral antigenic mimicry. Since autoantibodies against AS(iI'R were
usually detected afler the establishment of WIlY infe ction, it is more likelythat generation
of these antibodies is related to hepatocyte damage. Thus. the induction of llnti·ASGPR
autoa ntibodies may be caused by exposure of autonntigcnic ASGI'R cpiropcs to the host
immune system after WI-IY infection. ruther than through a virus-induced pnlydollill
stimulationwhichmaybe responsible for the induction cfnon-orgunspecific uutonntibodics
Theexistence ofa nti·ASGPRautoantibodies in preinoculation seraof woodchucks
appeared to be associated with the development of chronicwnvinjection. Th e apparent
relationship between the pre-existingami-ASGI'R autuuuulxnlics Hnd the development of
chronichepatitis inwoodchucks needs further study. In addition, judl;ing fium current data,
it is poss iblethat a similar situation may occur inpatients with chronic Imy infection since
thediseaseprogresses similarly allcr WI-IV and lIBV invasion (Summers et nl., 1978). Thus,
clinical studies of the incidence of chronic hepatitis B in patients with pre-Infectionanti-
ASGPR positive autoimmune responses may beof considerableinterest. lft his hyputhesis
is correct. strategiesdesigned to controlor terminate ASGI'R.specificautoinununu responses
in patie nts with non-viral-related liver disorders (C-b-. Ali i) lIlay prevent or reduce the
developmentofchronic HOY infection
PAIn III
PAT IIOBIOLOGICAL EFHCTS OF ANTI-ASGPR ANTIBO DIES
3.1. INTRODUcnON
In comparison 10 the considerable progress whichh3.S beenmade intherecognition
of bioc hemical properties of ASGPR, current understanding of the physiological and
pathological roles ofASGPRis very limited. Becauseof this ]imitation, the pathogenic
significance of autoimmune responses specific for ASGf'Risalso limited. Inthe following
sections, a summaryof our knowledgeon the physiological function of ASGPR and the
ASGPR behavior inpathologicalconditionsare presented. Finally thepostulatedmechanisms
of the pathogenic action of antibodies 10 ASGPRare discussed
3.1,1. T he Physiological Function s of ASG PR.
Theoriginallhilking about the physiological!h nctionor ASGPR is thatthis receptor
system mediates the homeostasis of biological macroeclecules. It is accepted that
gI)o>prOlcins after desialylalM:.n need10 murn fromthe circdation tothe liver forcatabolism.
These g1yoJ1:1'Olcin moIcculesincUde protein complexes(e.I_. heptoglobin), carrier proteins
for smaller molecuks (e.g.. ceruloplasmin. thyroglobulinand transferrin), modulatorsof
cellular responses (elh interferon, folliclesrimdation homlOne), andimmunoglobufin or
immunocomplexes (see reviewby As welland Harford. 1982). It isthoughtthat the major
function ofthe ASGPRsystemisto perform specificrccepror-nn..xliated endocytosis and, in
tum, to regulate the lifetime, metabolism and biological activity of these molecules
(Drickamer, 1991).
Be sides the desialylatl.'d proteins, some cells call also becleared by ASGI'R·involved
phagocytosis , Studies on programmed cell dea th show lhat immature glycanstructure s
without ter minal sialicacid moieties are exposed Oil li lt: surfaceof npoptotic cells(Sa villct
al., 1990). More recent studiesemployingbo th invitro nudill \'/In systems. indicute that
ASGPRs are involved inthe removal or npoptotlc cells iuthc liver (Diu!cr al., 1992; 1993).
By using pr imary cultures ofn conalal rat liver cells (w hich mainly conta in hClliltocytes and
stromal cells), it was found that apoptotic liver cellswhic h expressed dcsialylutcd glycans
were reco gnized by ASGPR. These apoptot ic cells co uld be cleared by bystande r cells
th rough ASGPR-dependent phagocytosis, since llllli-ASGI'1{amibndy and the ASGI'R·
specific ligands (e.g .• Gal, GalNAc and ASFN) inhibited thecell cleurunce. FUl'the r, in till
experimentalliver hyperplasia induced by lendnit rate ilticcti{lIlSin mrs.it W;IS also round thaI
apoptotic hepatocyteswere intc mnlizc d by hcpatocytcs as wellas sinusoidal celts, including
KuplTer and endothelial cells, In addition, AS G PR expression<I t both mRNAand protein
levels were greatly increased during the apoptosls. suggesting lhat c:>;hibilion ofA SG PIl can
bemodulated to respondto the celldeath or damage. [I is well-knownthat apoptosis is one
of the features of programmed cell death unde r physiologicalconditions, Thus, receptor-
mediatedclearance or apoprottc cells shouldbe c on sidered one urt hc physiologicalIl mctians
ofASGPR.
The function ofASGPR in some pathological conditions has been examinedill " lew
laboratories. Sawamura ct al. (198I) found that accumulationorASGI' in St-~\1I1l could be
experiment ally produced after the induction of acute hepatocellular damage inrats treated
with galactosamine. Later,Sawamura et al.(198-1) observed thai paticnls with cirrhosi s and
liver ce ll carcinoma have high levels of plasma llsialoglycoprnlcins
{hyperasialoglyccproteincmia). In both huma n and rat systems, the authors fo und a
significant correlation between the accumulation of ASGP inthecirculation and the decr ease
of ASGPR activity in theliver (about 28% of the normal activity) These fmdings indicate
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thatASGPRplaysan important physiological roleand suggcst that inacute or chronicliver
diseases,the receptor functioncan be disrupted
However, oneofthe mostrecent reports reveals somecontradictory evidence on the
physiological relevance of ASGPR(Ishibashict al, 199.:1 ), UsingASGPR-delicient mice
which were establishedby targeted disruption of the MI-IL-2 gene. it was found that the
expression of MIIL-l in the liver was extensively decreased and the injected
asialoplycoprctcin (Illl-ASOR) couldnot beremoved fromthecirculation. Nevertheless, the
accumulationof plasma ASGPor other proteinswas notdetected in thecirculation of these
knockout mice. Althoughit is not excluded tbm the expressionofM HL-1 may stillbe
sufficient to remove someof thegtycoproteins, this result stillappearsto argueagainstthe
possible functionof ASGPRin the homeostasis of'glycosylarcd plasma components
3.1.2. ASGI'R :I~ n Putentlal Cell Receptor for Viruses.
Based on the evidence that hasemergedduringthe past two years,it has become
apparentthat ASGPRmayfunction asa porcrealllvcr-speclfic receptor for viruses. It is well
knownthat the envelopeof manyviruses ccmninssialoglycoprotcins which originatefrom
host cells or are the products of vimI gene transcription. These glycoproteins playan
important role in recognitionofhost cellreceptors. As the sialoglyccprctcinscan be easily
desialyhtcd by acid or enzymes under normal blologjcal conditions,the Gal or GalNAc
residues on viral surfaceproteinscanbecomethe potentialligandsrecognized by ASGPR
To examine this possibili ty,Treichel cral. ([994) tested whetherHBV paniclescan bind10
purifiedhumanASGPRor culturedhepatocyte celllines. Theyfoundthatonedomainon the
preSI region of tile virusenvelopecould be recognized by ASGPR. This binding site
appeared to be sensitive to a detergent(Lubrol),lindwasonlyexpressedbythe native viral
particles whichwereisolated fromtheseraof chronicH13 V carriers, In addition, two human
hcpmocytecell lines, HepG2 and Hul-l7. expressing ASGPR were ableto internalizeHBV
particles, suggesting that ASGPRcould be a hcptocyte-spccitlc receptor for 11U\' . Another
hepatotrcpic virus, Marburg(MBG)virusisolated Item patients with hacmorrhngic fever.
was investigated by Becker et at ( 1995) The envelope of this virus contains highly
glycosylated proteins. Unlike other glycoprotcins, Ihc Icrminill sugar residues ofnntivc MUG
virus glycoprotein lack sialic acid (W ill ct al., 1993) . Becker cl a1.(19 95) demonstrated that
such an unusual glycosylc tlcn pattern could lead to the SIK'cilic binding of 1\IBG virus 10
ASGPRon cells and sub sequently resultedill the intcnmlizationnf'virus by 11c11G2, as well
as by ASGPR-transfectcd fibroblasts, Alt11O\lgh these experimclIls were carried Illlt i ll \ ';11'0,
it is poss ible that ASGPR may also have the ability to bind somevirusesund facilitateviral
invasion of thel iveri ll l'illJ
3.1.3. T he 8 iologiclll Efrects of Alltibud ics Against ASG I'It .
The common o ccurrence of <l mi-ASGPR autounnlxxlics in patient s with liver
disorders, particularly in AIHand viral hepatitis, raises an assumption about their pathoge nic
releva nce. Since the antibodies arc dire cted 10 a receptor naturally occurring Oil the
hepa tocyte surface , ihe binding of antibody to ASGI' R may lead 10 several pathological
outcomes. In the follow ing paragraphs. a lew potcutialmcclmuisms by which these antibodies
could be involved in the hepntocyre dysflmcrion or dnmnge will be addre ssed
3.1.3.1. Inductio n of ASGPR loss from thecell surface by allli·ASGI' R antihodies
Schwanz er a1.( 19S6) revealed that ASGI'R expression onthe surfac e of ! IcpG2 cells
would be rapidly decrea sed after exposure of'the cells to anli-ASGPR antihodies at IR'T
This investigation showed thai tile loss or ASGPR was nor caused by pro tein degradation in
lysosome, but byan unknown non-lysosonmlme chanlsm. Whole antibodies In ASGPR, hut
nOI their Fab fragments . could induce cress-linking of ASOJ'R amI clustering of ASGPR
molecules on the plasma membranes Sud ' linkage miglll lead to a reduction in the recycle
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rate of ASGPR and the surfaceexpression of ASGPR Although the mechanisms of these
processes remainunknown, theseobservations suggest thatanti-ASGPRantibodies mayplay
a role inregulationof ASGPR expressionon thesurfaceofhepatocytes
3.I.3.2. Anti-ASGPRantibody-mediated inhibition of receptor-ligaud binding.
It is well recognized that monoclonal antibodiesagainst ASUI-'R and antisera
produced by immunization with puriJied rat or human ASGPR proteins or subunit
polypeptidescontain antibodies recognizing theligandbindingsiteon ASGPR molecules.
Theseantibodiescan inhibitligand bindingto oothpurifiedASGPRand ASGPR associated
with hepatocyte plasmamembranes hi 1';/1"0. The studieson these antibodies have been
summarized in the introduction of Part I (seesection I. 1.3.2) of this thesis.
Recently, few studies have reported on the biological or pathogenic effects of
autoantibody against ASGPR. Treichel ct al. (1992b) publishedan abstract reporting thai
autoantibodies to ASGPR frompatientswith AIHcouldinhibit ligandbindingto ASGPRand
the liganduptake through ASGPR intoHcpG2 cells. This studysuggeststhat the ligand
binding site on human ASGPR is autoimmunogenic. Therefore, it is possible that anti-
ASGPR autoantibody binding 10 ASGPR on the hepatocyte mayblock theendocytosis of
ASGPi/l l'h'o.
3.1.3.3. Ami·ASGPR-mcdiatcd complement-dependent cytotoxicity
Early in the 1950s, Roitt and Dcniach(1958)described the involvement of the
complementsystemin the pathogenesis of autoimmune thyroid diseases, Complement
componentsrepresent a biological sysrcru whichgreatlycontributes to the effectiveness of
humoml anrrame responses andinflnmnuuicn. Afiernctivution, theproteolytic fragments of
complement componentsmediate manybiologic events, such as complement-dependent
cytotoxicity (CDC), opsoelaarlon and phagocytosis, lmniuno-ccmplex clearance,
immunoregalaticn and imlammetion COmpk'111Cm ncnvononcm be inducedby manyfactors.
Activation byantibody - antigencomplexes is oneof Ihl' well-documented pathways
Theoretically, anti-ASGPR binding to ASGI'R on hcpntocytcs may activate
complement andsubsequently lead to the lysis oftarget hcpatocyrcs. The ability ot'untibody
to fix complement is one of the key fuctors controlling complement ucrivntion. At the
beginning of complement activation,one orlhc complement componentsC 1q willhindto the
Cy2 domainon the Feregion ofhuman IgGor C~3 domainuu the Fc region ofhllmall lgM.
The affinity of Ctq binding depends on the IgO subclass, with an atlinity order of
IgG3>lgGI>lgG2>lgG4 in human Ig (Dean et al, 1(83). In this context. Treichelct al
(1993)found thai the Ig classofan ti-ASGPR autoantibodies varies in patientswith dltlcrcnt
liver disorders. IgM class was found in patientswith Alii with severe hulamunulon and in
patientswithchronicviral hepatitis. The 111,1jor IgO subclass of anti-ASGI}Rantibodiesis
IgG2 in AIH and IgG4 in viral-relatedliver disorders. Thus, these data suggcst that anti.
ASGPRautoantibodies from the patients in many cases belongto the Igs which nrc able 10
fix complement.
Under normal circumstances, complemom activation is also highly controlled by
regulatory factors to avoid damage of'autoiogous cellsand tissues, unless these factors nrc
deficient. Inrespectto CDC in the liver,the microcnviromcnt around the target hepntocytes
needs 10 be considered. It is known that hcpatocytcs arc the maj or type uf cells which
produce complement components including their regulators {Perlmutter and Cohen. 19R6;
Ramadori et el., 1985). Thus, liver could be a 1110re susceptible organ lor complement
activation, because of the insun SUPlJlcmC1l1of complement: or it couldbe better protected
from complement pathological effects. since rcgutntursarc syuthestxcd locally Ikeda and
Kurebayashi (1"Sl9I) demonstrated that deposition of C3on the surfaceuf hcp.uoc ytcs could
be induced ill vivo due 10 the reaction between hcpalucytcs and a monocluual antihudy
against liver-specific antigen Deposition or homologous complementuccumpanicd by
UBsAg and lgs in liver tissue has also been described in patients with hepatitis B
(Nowoslawski, etal., [972). Alltheseresults ~uggCStthilt antibody-antigencomplex-induced
complement activation docsoccurinliver.
It isnot known whetheranti-ASGPRantibody-mediated hepatocyte lysismayoccur
in liver. However, cytotoxiceffectof anti·ASGPR under ill vi tro conditions has been
detected by Michalak et al. (1995). Using purified hcpntocytcs frompatients with chronic
hepatitis B, it wasshown that guineapigantibodies to ASaPR werehighlycytotoxic(with
cytotoxicityof90,2± 8,9%) to isolated hcparccytes in thepresenceof activeheterologous
complement. This suggests that isolated hcpatocytes are not well protected from
complement-mediated injury Therefore. it is likely thatanli-ASGPR-mcdinled CDCmay
occur in liver illl·it~1
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3.2. I\1ATER IALS AND I\IET IIODS
3.2.1. Chromatogra phy of lnuuunoglubuliu (Ig) on I'rol l'ill A Column
A method adapted from Ey ct al.(1978) wasused fur purification nflg fractions from
woodchuck andguinea pig sera.
Materials:
( I) Sera: guineapigantisera raised against wt\ SGPR. r,.\SOPR, ':;O-kDa· tll' -l7-kDa-subunit
of rASGPR;sera from healthy,nun-immuuizcd guineapigs(sec section 1.2 K)and scm from
WHV·infected animals (see Table 2,I) with and without an!i· t\SOPR aClivitics were used
(2) Protein A·Sepharose CL·4D: protein A numobilizcdlUI Scphurosc ('I .-'IB {Sigm:ll
(3) I M Tris·HCI buffer, pl'l 8.0
(4) 100 ntM T ris-HCI buffer, pH 8.0
(5) 10 mM Tns ·HCI buffer. pll 8.0
(6) 25 mM Tris·HCI buller. pit 7 6
(7) 100 mM glycine, adjusted pl l to 3.0 with llel
(8) Storagebuffer:0.02% (w/v) NaN, and pretense inhibitors(sec section 12 .1) in 100 mM
Tris-I-IClb uff"er.pH7,6
(9) Washing buffer: 2 M urea and 1 M l.ie l in 100 mM glycinc· l le! h\l ll~l . ll ' l 2 5
Method;
(I) Protein A·SepharoscCL-4Bwas suspendedand swollenin I M Tris-l lCl butler, pl l KII
About I mlof thebendswere packed inlOa J mldispos ablesyringe stopped with glass flbers
Before using, the matrix WI' S equdibratcd with I [1,1 Tris-l l( 'l butler, pll KOThe column
could be re-used afterwashingwith 5 1111 of washing bullerand followed by ct]uililu:l1ion with
I M Tris·HCI buller, pH 8.0
(2) To isolate lg Iracttons. I 102 ml of serum was adjusted [0 pl l H(J using I M Tris·I ICl
bufferand applied10a protein A uohuun The columnwa~ washed with Iu-ucd-vohnncs of
H I
I MTris·IICIbufferand thenwith the sarnevolume of 100111M, and 10mMTris-HCl buffer.
Subsequently, bound proteins were eluted with 100 mM glycine, pH 3.0. 500-fJl or l -ml
fractions were collected into tubescontaining 50 IIIor 100 IIIof 1 M Tris-Hel buffer, pH 8,0,
Finaly.thcprmeincomcmineach flacrionwas determined byspectrophct cmctry at 280 nm.
The purity of the isolated Ig fractions was assessed by5DS-PAGE (see section 1.2.17)
Purified Igfractions were stored at4 ' C in thepresence 01'0.02% NaN) or concentrated by
lyophilization.
3.2.2. Ammoniulll Sulflltc Precipitillion of lg Fractions.
Materials:
(1) Serll:secsection J.2.1
(2) Saturatedammonium sulfate: 761g ammonium sulfate in I Lof'disnlled water. The pH
of this solution was adjusted to 7.8 usingsolidTris base.
(J) Loading buffer: 10mMTris-He l buller,pII8.5.
Methods'
Serum for precipitation was centrifuged at 3,000 / g for 30 min 10 remove large
proteinaggregates. Whilethe serum wasgentlystirred ona magneticstirrer, an equal volume
ofsanrmrcde nmonumsulfatesolution wasaddedslowly. Aller incubation on icefor I hour
orovernight3t 4°C, this serum solutionwas centrifuged at J,OOO ~ g for 30 min. The pellet
was resuspended in 0.5 1111 of loading buller and then extensively dialyzed against thesame
butTer.
3.2.3. Chromatography of Amlllonium Sulrnte Precipitat ed Ig Fr action on DEAE-
Malri ll.
Materials
( I) 19 fractions prepared byammoniumsulfiuc precipitation ofguineapig or woodchuck sera
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(see secnon 3.2.2)
(2) DEAE-matrix: DEAE-Scphacel beads. prcswollcu celluloseion exchanger (Phnnuacia
Fine Chemicals).
(J)0.5N HCI.
(4) 0.5 N NaOH.
(5) Loading buffer: 10 mM Tris-HCI butler,11 118.5
(6) 50 mM NaCI in loading buffer.
(7) 100 mM NaCI in loading buffer.
(8) 200 mM NaCl in loading buller.
(9) 500 mM Nae l in loadingbuffer
(10) 25 mM Tris-Hel buffer, pH 7.6
(II ) 10% (wtv) NaNJ in distilled water.
Method:
(I) 10 ml of DEAE-matrixwas washed with 0.5 N 1\('[ and then 0.5 N Nnuu on a glass
filler. The beads were equilibrated with loading buller till the pl l reached 85 A sll1111l
column (10 em ~ 1 em 4J) was packed with the beads ami washed with] bed volumes of
loading buffer.
(2) Ig solution was applied to the column and then the column was washed with IO·bed-
volumes of loading buffer. Igs were elutedwith increasingconccnmuions ofNa('1in loading
buffer, beginning with 50 mr-.1. then 100 mM, 200 mM and tlnally 500 lllM (using
approximately 25 1030 mlofeach ortile elutingsolutions] Proteincontent was determined
in fractions(5.5 mleach)at All" and the 19 purity was identifiedby SI>S· PAGE (sec section
1.2.17for method} The protein peak fractions werecombinedand dialyzed against25 mM
Tris-HCI buffer, pJ-17.6. Purified Ig fractions were stored 1I14"Cwilh udditiunufN aN, or
concentrated by freeze-drying.
3.2.4. Fhation of Isulnted Hcpatceytes llJld Cultured Cells.
Cellfixation was performed according10Harford et et.(1982),
Materials:
( I) Cells: woodchuck bepatocytes mechanically isolated from liver tissue by a method
described in section 1.2.2.1 andcultured 1-lepG2(sec section1.2.2.2),
(2) PBS (see scction 1.2.2.1)
(3) Paraformaldchyde solution: 5% (w/v) paratonnaldehyde (Sigma) in PBS. The
paraformaldchyde wassolubilized in PBS by heating the solution at 70GC andaddinga few
drops of INNaOH. The pl l was adjustedto 7,0.7,8byadding I N HCIand the solutionwas
cooledon icebefore using.
(4) Glycine solution: I Mglycine(Sigma)inwater.
(5) Washing buffer: 5 mMglycine and 0,02%(w/v) Na;<.j) in PBS
Method:
Isolated hepatocytcs and harvested HepG2celts were washedwith coldPBS and
counted. The cellnumber wasadjusted to WS to 107/ml in PBS. Parafonnaldehyde solution
was addedslowly into the celtsuspensionuntila concennntion of 0.5% was reached. Then
thesuspension wasgentlystirredon icc for 10 min. Subsequently, glycine solution wasadded
to a final concentrationof 170 mM, thecelts werekept on icelor another IOmin and then
washed threetimeswithwashingbuffer. TIle fixed celtswerestored in washingbuffer at 4·C
and used for ASGPR.ligandbindingstudieswithinoneweek.
3.2.5. Alllibody·l\'lt di:ll rd ASGJlIl.Ug:llUl Binding lnhibit lon Assays.
Inhibition of ligand bindingto ASGPR by anti-ASGPR antibodies wasinvestigated
using paraformaldehydc-fixcd woodchuckhepatocytes and HepG2 cells, or affinity-purified
wASGI'RandrASGI'Rpreparations. The assayswere performedaccording to the method
of Harford el al.(1982), with somemodifications
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Materials:
( I) Parafbrmaldehyde-flxed cells:isolated woodchuck hcp.uocytcs and cultured HepG2 ccils
were fixed as describedin section 3.2.4
(2) ASGPR-coated flexible microrhc r plates: plates were coaled with 100 ng of ulfinity-
purified wASGPRor rASGPRin 50 IIIof PElSper well (sec section 1.2.I])
(3) Antibodies: lg fractionspurified by DEAE- or protein A-chrom:uographyIrom guineapig
antiseraraisedagainstwASGPR,rASOPR. 40-kDa- ilnd47-kDa-subunils ofri\SGPR. and
Ig fractions purified by protein A-chromatography from the anli-ASGPR-positivc sera of
woodchuckswithWHY infection. Ig flactlons purified from non-immunized guincupig sera
and from the anti-ASGPR-ncgative sera of'woodchuck with WilY inlection were uscd as
controls (see sections 3.2.1and3.2.3 for details of the parlficutiouof Ig).
(4) Dilution buffer: 25 111M Tris-HCI buffer, pi-I 7.6.
(5) mJ_ASFN: radiolabellcd ASFN in dilution buffer (section 1.2,12)
(6) ASFN solution: 10 mglml asielofctuin(Sigma) in dilution buller.
(7) Reaction bulTer(10 x): 1.5 M NaCI, 250 mM Cl\('l~ and 0.2% (v/v ) Triton X-IOOin
dihnicn buffer.
(8) Hanks' reaction solution: 1.7 mMCllCI~ in I ~ IIllSS
Methods:
(1) Antibodyinhibitionassay using fixed cells. Parnfcnuuldchydc-trcatcd cells were washed
and adjusted to approximately 5>< 10' cells/rul in Hanks' reaction solution. Then, 100 1-1 1of
cellswere incubatedwith 20 j,lgof guineapig Ig or 60 ~lg ofwoodchuck Ig on icc for l){l min
In some instances, increasing amounts of woodchuck Ig T;\llging from 2 IJg to 500 ~ll; of Ig
wereaddedto determine a dose-dependent inhibitory cucct ufthe [g fromthe anli-I\SGPR-
positive sera derived from WItv-infected woodchucks. f or the detection of CIdirect 12\1_
ASFN binding to hepatccytes, cells without added Ig were used. For the detection of
nonspecific binding,cells were incubated with 2 .2 j.lg unlabelled ASFN instead of Ig
Subsequently, 220 ng or Illl.ASFN was added 10 the mixtures and the final volumewas
adjusted to 300 IIIwithHanks' reactionsolution (0.73 j.!g I2Ij.ASFNfml). The mixture was
kept for 90 min on icc and the volumeof the reaction was adjusted to 1 ml with Hanks'
reactionsolution. The cells were centrifuged at 3,000 <s for Sminand500 ul of the upper
supernatant was transferred to another tube. Thc radioactivity presented in the tubes
containing uppersupernatant (U) and the remainingsolution plus the cell pellet(R) was
countedusing a gamma counter(LKB). The percent ofbinding wascalculated according to
the folluwingcalculation: binding percent (%) '" (R-U)/(R+U) " 100%.
Each reactionwas restedin triplicate and themean percent binding was calculated.
Only themeanvaluewith a standard deviation less than 10%would be used, The 12lI.ASFN
bindingto hepatocytes(woodchuck bepmccytes or HepG2 cells) in the presenceoffg was
considered as thebindingancradding 19 forinhibition (I), Thcbindingpresent in the absence
of Jg (T) was assessed by incubation of hepatocytes with 1111_ASFN in Hanks' reaction
solution. Nonspecific binding(N) was defined as the bindingoccurring in the presenceof
l(J(}.fold excess of unlabelled ASFNinstead of lg. The percentofinhibition byantibodies was
calculatedby the followingformula: percent inhibition ('Yo) .. [(T-N)-(I·N)]/(T-N) " lOO%.
(2) Antibodyinhibition assayusingpurified ASGPR. Plates coated with 100 ng affinity-
purified wASGPRor rASGPRwerepreincubatcdwithDEAE-purified guinea pig Ig (10f.lH
proteinfwcll; 0,2 mgprotcillfml) or serialtwo-folddilutionof tileIg (from 1.5625 to 200 ~g
protein/well or 31.25 Ilg protein/ml to 4 mg protcin/ml]. Then, 1111_ASFN (220 ng
protein/well or 4.4 Jig proteinfml)was addedto each welland the reactionwascarriedout
in a totalvolume of SOIlVweliin I x reaction buffer at 4°C overnight. The bindingin the
absence of Ig and the non-specificbinding wereperformedin the samewayas described
aboveforfixed cells. Subsequently, the plates were washedandthe wells were cut off. The
bound radioactivity W,IS counted and the percent of antibody inhibition was calculated as
described above
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3.2.6. Antibody-Mrtlilltrd Cempfem eut-Dcpeudcut C~· tuloxi cit)· (CDC) A~S:IY.
Asthereisno woodchuckhepatocyte celllinecurrentlyavailable, human IlcpG2 cells
were employed as target cells 10 study the contplcmcut-dcpcudent cytotoxic effect s of
antibodies directedagainstASGPR. A MicrocultureTctruzolium(r-,'ITT) nssny was employed
to measure the cytotoxiceffects. accordingto thc method or Alley cr ill. (1981)
Materials:
( I ) HepG2 cells: HepG2 cells were seeded at I ~ 10" 15 ~ \OJ or j .o » 10 ,1 in (00 1,1
medium/wen in tissuemicroculture plates. Allcr 48 hours of'culturc (sec section 1.2.2.2 for
details). the medium was removed from the cellmonolayer and 50 IIIof fresh medium wns
added. Tile cells were then muuediatcly used lor the cytotoxicussay
(2) Antibodies:lg fractions purified by DEAEor protein A-chrumatognlilhy from guine<l pig
antisera raised against wASGPR, rASGPR, 40-kDa- and .17-kDa-subullit of rASGI' R and
from anti-ASGPR-positive sera of animalswith wuv-tnrccrlon wcrc used Ig fractions
purified fromthesera ornon-immunized guineapigs and from the:mti-ASGPR-negali\lcsera
ofwoodehucks with WHY-infectionwereused as controls (see section3,2,I and 3.2,) .
(3) Activecomplement (AC): low-toxic mbbhcomplement{CednrLine Laboratories Limited,
Hornby, Ont., Canada), Each lot was pre-tested for toxicity against IlcpCi2 celts before
using. As a control, complement was also heal-inactivated at S6°C lor 30 min (inactive
complement, IC).
(4) Cell culture medium:D-MEM(see section 1.2,2.2 lOTdetails).
(5) MIT solution: 2% (w/v) ] -[4,S-Oimethylthiazol-2-yIJ-2,S-diphenyllclrazoliulll bromide .
(Sigma) in PBS.
(6) DMSO: dimethylsulfoxide (Sigma).
Method:
The following standard CDC assay conditions were establishedallur preliminary
experiments performed for testingthe number of cells,amountsorcomplement and incubation
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timeusedin eachstep of theassay.
HepG2 cellswereseeded in 9G-wcllplatesranging from 10' , 1.5 ~ 10J and 3)( 10'
per well. Then. the medium was changed(SO~ I of fresh medium/well)and the cellsin the
fresh medium were incubatedat 37"Cwith60 ug of porified lg and 10JlIof AC or IC. Total
reaction volumewas adjusted to 100 IlVwcllwith fresh medium. After2 hour incubation,
MTTsolutionwasadded(100 IJJlwelJ) and incubation was continued at 37°C for another3
hours. Then the medium was carefully removed and DMSOwas added(l aO IlVwell) to
solubilizethe MTT metabolites. Resultswere read using a microplate reader(model3553,
Dio-RAO) at J\.,l ' The final reading was taken fromthemean of 410 5 wells tested,witha
standarddeviation lower than 10% of the mean, The absorbance values (A) obtainedfrom
thewellsin thepresenceofAC and inthe presence of IC wereused for thedeterminationof
percentcytotoxicity (%).
percent cytotoxicity (%) = (Aw - A,Yo.)lAk , x [00%
3.2.7. Slntistk alAnal ysis..
x2 test wasused to determinesignificance in the datn for inhibition andcytotoxicity
mediated bythe woodchuckor guineapigIgfractions with or without anti-ASGPR antibody
activity, l' values less than 0.05 were considered significant.
'"
3.3. RESULTS
3.3.1. Pu rificatio n of 19 Fractions from WOOrJChUl'k ur Gl\ illt'll Pig Sem.
Before examining the biological effects of anli-ASGPR antibodies induced in
woodchucks by WHY infection or raised in guinea pigs by immunizations, two methods,
DEAE-and protein Acbromatographes. were employed lor the purificationorthc antibody-
enrichedI!Sfractions. The purpose ot tuc purificationwas to eliminatethe influenceuf'orhcr
serum components. In our preliminary experiments, it was found tluu serum elements
presentin both anti-ASGPR reactive and non-reactive sen, interfere wilh thenunlysis of the
effects of anti-ASGPR antibody in assays(i.c .• antibody-mediated ASGPR-ligiIilJ binding
inhibition assay and anti-ASGPR antibody-mediated CDC assay). This interference was
eliminated when the Ig fractions of the antisera were used
lg fractions purified from woodchuck sera by either DEAl.: ur protein A
chromatography gave protein elution profiles which were verysimilarto those lh nnguinea
pig sera (Fig . 3.1). The sera for Ig isolation were selected from three woodchucks (No.2 ,
3 and4 which are WF4, WF8and WMI2 in Table 2,I. respectively). From each animal, three
serum samples obtained at different stagesof Wi lY infection(i.c., Al l and CII) were used
The anti-ASGPR activity in these sera rungcd from 4.9% to 7.0% lISdetermined by IHI_
rASGPRbindingin ant i~ASGPR RIA(section 2,2,] ), corresponding10approximate titers of
1;50 to 1;200, Ig fractions were also isolated fromth e mixture oft wo serum s:uIIllles of"
WHY-infected animalwithout ami-ASGI'R response nndused as an ,llui-ASGI'R-negative
control sample. In addition, Ig fiactions were isolated trcm the sera of guinea pigs
immunized with affinity-purified wASGPR (11l1Ii.wASGI' Rj, rASG/'R (anli.r ASOI'R). <10-
kDa(anti-40-kDa) or 47-kDa (anti-47-kDa) polypeptides of rASOl'lt (sec section 1.3.1.3 for
details). Ig fractions were alsoobtainedfrom a pool cl'uon-iuuuunized, normal guinea pig
sera (NGPS). SOS-PAGE analysis dcmonstrntcd rhnt illl the jlUl:li cJ Ig fractiouscontained
Figur e' 3.1. Isol:ll ioll ori llllllu" oglohlilill ( ig i r,':I('liulI, rorm " oolld l1lfl. uud
gllinu pig sera by DE.,\[ · :IIllJ pruld " A-dl roma l o;.: r.lph~' . Ehni.." pancms ohlailk-u1~'
chromatography of crude Ig prcparmjons on nEAE-S~'phar~'d ':1, IU:lIl1S ( , \ iUk! (' I. 11u:
crude Ig was prepared by precipitation of Ilk' woodchuckor ~ll in l'" pig.sc-ra with 5~ io
ammoniumsulfate (see section3.2 2 lor details) Th...-scprq l;ualil1llSor'woodchuc k (.\) \>r
guineapig (C) Ig were applied scp.1raldy on cokunns Aller w;l,hin~ out unl\(\(uklrHlI~·i ns.
the boundIg waseluted successively wah 2 5 lu 3-111.'(1VOJUlIl...·S1,1'5u.100. 200 ami soo mfl. l
NaCI in 10 mM Tris· llel buffer, 11118,5. ;IS indicurcdby ,UTIlI' S:1. h. C amld. r': ~I'~":l i \"cl y
The fractions were collectedundthe protein contentwas 1I\Ilnilllr\'d hy ;lhslJrham;e at 21m\1111
See section 3.2.3 for details of the method.
Elution profiles obtained by chrolllalo!.\nlphy or SCI'ilnum woodchucks and guinea
pigs on protein A columns ( n and D). Sera from woodchuc k (HI ami guinca pig ( I) (2
mlfeach) wasadjustedto pH 8.0 and upplicd10 the column ,\tkl washiug to remove C~CL'!'S
proteins. elution was performed with 100 mM glycinc-IICI hun~·r . plllO, H e collected
fractions were immediately neutralized by 1/10 volume of I fl. 1 Tlis-IICI butler , pll lt O.
Protein content in each fraction was deter mined hy the absorbance lIt 2!10nm The armws
indicate the point where elution bulTl'f W:\S applied un the columns Sl'C!'II.-'Clillll 3.2.1. fLU
derailsofthe method.
These figures show that the clJll.)I1101lOgral,hy patternsof \\lIudchuck Ig mid gnincn pig
Ig were similar.
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polypeptideswith appr oxima tely the same nml..·(OUI3 r n1asS\:s \,1" ~S kDa and SS k1)a which
reflected lhe existence ortbe 1£ligllland heavy chains [data mil slk'wlI) Atlcr dial)"sis.lhc
Ig fraetko,l$Wcre used in the ASGrR- ligand bindingillhit,iliun assay and n x' expc...imcnts
3.302. Inhiblticn of l{ccclllor. Lig:Jutl llinding hy ,\ lIti·AS<;t' !{ 1\ lI l i hu l ti C~ o
3.3.2,I . Guineapig anli·ASGPll llll libodY -llIcdial~·d illhihilillilof ASFN bindiug III purilic d
ASGPR
Guineapig Ig fractions l)luifll'l.l by DEAE-chrolll;ltograllhy we...c testedlor theirahility
to inhibitthe binding ofl! SI·ASFN 10 ..fiiniIY-IIWili\'I.I ,\ SGI' R Resull!!;1\I ';~" J. ~ A and
B show thaiaI!the Ig fractions fromguinea pig sera whh :lIl1i-ASGPIl reacnvity exhibiteda
high inhibitoryeffect onthe 1!'!·ASFN bindin£10 wASGI'R Ill' rASGI' R. CXl,.'t.1J1 Ihc Ig lhllll
anii..47-kDa antiserum AI a cooceutration of 10 Ilg 1>1. .. aSSol Y(0.2 mglnd). when the
inhibitionby 19 fractions fromi1nti·wASGI'R. nnli-r/\SGI'I{ and anli-lO-Id),1,lIIliS\.°ril reached
57.3% to 9O'Ie, the inhibition by anti·47-kDa was unly 12.% In a cnnuul cs pclimclll, the
inhibition orm!·ASFN binding to either wASGI'l{ or rASGI'1{by the Ig fractions from
NGPS was less tban 1%. Su tistical analysis showed " signiflcunt dillcrcuce (Xl test, 1' '-:
0.05)betweeninhibitoryencce or uc Ig I iactiousfrom ;lnli.wASGI'R. 'LIlli·rASGI' j{or anti-
4C-kDa and thai oft he lg fractions from NGI'S. as well as betweenthe inhihilury effects of
Ig fractions from anli-47·kDa and that or the Ig fr.ll;tiuns fromother ;lI1li·i\S(il'R antisera
Fig. 3.2 alsoshowsthat thereis no diff erence in the inhibitionUrl igand billdin!\ In wi\SW'R
and10 rASGPRby lgs (Fig. 3.2Avs Fig. 3.2B), sugg l,.'Sli llg 111:11boih receptors behave in a
similarway in terms of thc ligandand antibodybindings.
To confinnthe specificity orrhcabove observation,,IIIinhibition OlSS:IY was performed
by serial doubledilutionof Ig Imcticus front the sallie muiscra Fig JJ demonstrated the
dose-dependent inhibition of thebindingof'!\I-ASFN 10 wAS(iI'R{Fig, 1JM or 10rASGI'R
(Fig. 3.38) by lg fractions fromantiseraraisedagainst rAS(iI'R (Fig. 3.31\ ), t\o· kl)'l {Fig
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Figure 3.2. Inhibition of li ~;1I 1l1 bindlng 10 purifittl ASG I'R or hepatocyte
l u....~re-bound ASGrR by guillca " ig :lntil,otli('s ratsed :lj,!ainsl ASG PR nnd ASGPR
subunits. Affinity-purifted wASGl' R(M and rASGI'K(U) immobilized on microtitre plates
(100 rig protein in SO ~VwcIlJ were incubated \\itb inununoglcbulin (Ig) fnrtions purified
from guif1C3. pig antiseraagainst rASGi'R. wASGI'R, or 40-I;Da and 47·I;Da subunits of
rASGPR or from I pool of normalguinea pig sera (NGPS) by DEAc <hromatography.
WOo.ldchuckhcpatOC)tcs (C) andcuhured IIcpG2I. ..·;]s(DJprefixedin paraformaldehyde and
washed were also incubated with these Ig fructions (approxhuatcly 2.4x101or Sx10~
ccllslns.q y). The concentration oflg was200pg proicinfllli Alter 90 min on ice. 111!·ASFN
(220 ngfwcll; specificactivity 1.4 2 ~ IOlcplll/ng) wasadded10 each assay find the incubation
continued at 4"C. See sccriou 3.2.5 for details ofthe method Percent inhibitionwas
calculated with silecific bindingof I1lI·ASFN ill the absence: of Ig taken as 100% Bars
represent the meanvalues± SO of'triplicate dcrennluarions
t :5 ~
Inhibition (%)
§ [[]] ~ ~.
Figurt3.3. Uosc-tlcpentlelll inhibition ofl il;and hinding 10 purifled ASCPR by
guinea piganlibodies;lg;l imt r,\ SCI'1{ and Slihullit l'0ln lClllidcs uf rASG I'R. Affinity-
purifiedwASGl'1t(A) andrASGr lt (8 ) immobilized 0 11 microtitrcplates (laOng protein in
SO j.l/welJ) were incubated with increasing amountsor guinea pig immunoglobulin (Ig)
rangingfrom 1.56 to 200 J.lg in50 ul/assay. These19 fmctiOIl' were purifiedfromguineapig
antiseradirected against rASGI'R (dosed symbolsillA), 40-kOa(closed symbols in 8) and
47-klJa (open symbolsinA and IJ) subunitsorr ASGPn by DEAE-chromalograplJy, The
procedure was followed asdescribed in the legend to Figure 3 2. The resultsareexpressed
as the percent inhibition of ligandbinding asdescribed in Figure3,2
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1313) and47·kDa(Figs,13AandD) polypeptides of rASGPR. lg fractions frombothanti-
rASGPR andanti·40·kDa antisera inhibi ted the binding by approximately80· 100% at a
concentration of 100-200 ~g Ig protein perma y(2-4 mgIg protelrrml). Theinhibition by
Igfromanti-47-kDaat tilesame concentrationwas less than l()Olo whenwASGPR wasused
for ligand binding orabout 35%usingrASGI'R. These results suggest that ligandbinding to
purified ASGPR under this solid-phaseassayconditions appears to be mainlymediated by the
4{).kDa butnot the 47-kDusubunitof ASGPR.
1 12,2, Guineapig anli·ASGI'Rantibody-mediated inhibition of ASFNbinding10ASGPR
onhcpatocy tcs
It is C0l111110n knowledge that conformation ofthe purified soluble proteinscan be
different from that ofthe proteins distributed on the cellsurface. Because ASGPR is a
transmembrane protein, some of the receptor antigenic cphopcs maybe inaccessible to the
specificantibodies. Therefore,it is necessaryto rest whether ligandbindingto ASGPRon
hepatocyrcs can be inhibited by antibodies agninst ASGPR For this purpose,
paraformaldehyde-fixedwoodchuck hepatocytes and HepG2cells were usedas targets for
theinhibitionassays. as described by Harford cta l. (1982), The results indicated that the lg
fractions fromguinea pig antisera against the whole ASGPR moleculeor the receptor
subunits displayed 60.9% to 100%inhibition of specific ligand ('lll.ASFN)binding to
woodchuckbcpatccyres(Fig. 3.2 C) Thesame 19fractions exhibited 54.4% to 76.3%
inhibition ofligandbinding 10 human!-lepG2cells(Fig, 3.2 D). Theresults also revealed that
ml_ASFNbinding10 human ,\SGPRonbcpatocytes couldbe inhibited byIg fractions from
anti·wASGPR antiserum, suggestingthat theligand-binding sireson wASGPR and human
ASGPR arc antigenically cross-reactive. This suggestionis supported by our previous
observation (sec section 1.3.1.3) that hepatic wASGPR is antigenically closely related to
hepatic ASGPRfromother species
The inlcresling finding W3S that the Ig frOk'tilll1 from 3I\ti·,n·kDa umiscnnu~\'C
54.4% (Fig. 3.2 D) to 100"/. (Fig 3.:! C) inhilliliull of 'i~md binding. to h','lltlh"lo.:)1l'S,
suggesting that, in contrast to purilied ASGPR. the -l7·kl>J,subunit or the membrane-bound
ASGPR also contributes 10 I~I-ASFN binding 10 tbc 1k'\Ull'll.11Csurface t..lurl'u\·l.'f. this
result implies thai bothsubunits of wASGl'R maycOlltrihuh.'l"\lually10 lig.and hindingto the
plasmamembrane-associated wASGPR, because Ig nacttous fWIlIeither ami-IO-- kl)a (\r ami-
47·kDaantiseraalonecould cOlllpIL1cly inhihit ,~sIMASFN bindingto woodchuckhCp3tl'll.1'h.'S
Results also revealed1113t control Ig fractions fromnou-immenized guine a Ilig sera
did not have any inhibitory effect on 11'I·ASFN binding to hcpntocytcs (Figs J.:!(' 1Il1l1D)
This strengthens the c' elusion that Ihe inhibitoryeffects or :mti·AS(i I'I{ ,lluilllldics fwm
antiMASGPR and anti-subunit nntiscm were ASGI' I~ sjll'cilk
3.3.2.3, Inhibition ofASFN·ASGPRbinding by Ig liactiuns Ilum woodc huck sera with anti-
ASGPR activity induced by WIIV infection
To test whether autoantibodies to ASGPR induee'tI in the co urse of WIIV inl(.'t..1 iull
have an inhibitory effect on ligand.ASGIJRbinding. Ig rr,lCliuns purili..xl hy protein A·
chromatographyirom the anli·ASGPR positive seraof WIIV·infc-ct..,,1wuudchucks were
examinedinaninhibitionassayusing pre-fixed l!cpG2 cells Fig 3.4 shows thai Ig fractions
with anti·ASGPR activity, derived from two of three WIIV·infc-clcd animals(animals No.2
and No.3), displayed the ability 10 inhibit by 86.6% uml J2.4% , res pectively. the ASFN
binding to HepG2 cells at an Ig concentration of 60 Ilg per aSS<IY(0.6 mglml) Under the
same conditions. the Ig fraction from one of the woodchucks Wilh WIIV-induced anti-
ASGPR autoantibodies (animal No.4) did not display any inhibilury ctlccr II conrrollg
fraction from Ilnli-ASGPR nonactive serum ora wll v -infc te d woodchuck [unimnl No.1)
also gave no inhibition of IUI_ASFN binding 10 l!cpU2 cells
The specificity ofthe anti·ASGPR autiuody-mediated inhibition was confirmedusing
15.S
JoigureJ.4 . Inhibition of "~ I-ASI"N binding to lIepG2 cells by Ig fraction s from
woodchucks with W IIV-induced iUlti·ASGI'R autoant ibodies. Paraformaldehyde-fixed
IlcpG2cells(24)' IOJ cell/assay) were incubated withIg fractions (CiO pg/assay,600 Ilglml)
purifiedfrom woodchuck sera bychromatography on n proteinA column, The sera were
obtained fromwoodchucksexperimentally infected withWHVwhich subsequentlydeveloped
anli·A5GPR autoantibodies (animals No.2, 1'\0.3 and No.4) or remained anti·ASGPR
nonreactive[animalNo.1)as determinedby anti·ASGPR RIA(secsection 2,2.3 for details).
Aflcr 90 min on ice, 220 ng of 1ll1·i\S rN was liddedto the cellsand the reaction was
continued for anadditional 90 min Sec sectionJ,2,5 for delailsof the method. Results are
expressedaspercent inhibitioncslcularedby takingspecificbindingof1!IJ_ASFNto HepG2
cells in the absence of 19 as 100% Bars represent the mean valucs e SD of triplicate
determinations
t56
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two-foldserial dilutions of'tbe Igfractions FiS ) ,5 dcnonsnntes tbat the inhibitory effect
of woodchuck Ig from animal N02, with anti-ASGI'R activity induced due 10 WHY
infection, wasdose-dependent. The highest degree of inhibition reaching up to 80% was
observed at theconcentration of~56 pg Ig protein pcr assay(2.56 rug lg protein/ml), Atthe
same Ig protein concentration, the inhibition of ml_ASFN binding to HepG2 cells by Ig
fractions fromcontrol animal No,I, with active \VIIV infection but without anti-ASGPR
antibodies, was lower tlnm 10%
3,3,3. Complclllclil-Ol'11CIl:lclIl-l lcl':Ilocyroroxicity luduc ed by Anli-ASGf' R
Anlibodies.
To determinewhether theantibodies to ,\ SGPR mayhavethe potentialto induceliver
nssucdamage, invitro experiments wen: performed to measure thecomplement-dependent
cytolmdcily (CDC) caused by ilnli-ASGI'R antibodies The antibodies were producedin
guineapigs by immunization with affinity-purified ASGPR or induced in woodchucks by
WilY inlcciion. The guineapig and woodchuck Ig fractions with known inhibitory activity
onligal'ld-ASGPR binding. whichhadbeen rested as presented in section 3.3.2, were usedin
these studies. As thefe is nowoodchuck hepatocyte cell line available. freshlyisolated
woodchuck hcpatocytcswereinitially employed in this experiment. However, due to overall
low viability of woodchuck hcpatocyrcsisolated by the mechanical method and the low
expression of ASGPRon tile surface of heparocytes isolated by thecollagenase digestion
method (evenaller 24 hours' incubation). a human hepatocyte eel!line(HepG2) was finally
used. These cellswere also selected for this experiment based on the fact that both the
expression andbiologicalproperties or ASGPR on HepG2 cells hadbeen wellestablishedby
otherinvestigators. Inaddition, in the course of the present studies, the reactivity of Bep0 2
cellswithantibodiesriscd against wholeASOPRsor ASGPR subunitshad been documented
(i.e., Fig, 1.12,Fig. 3.2, Fig. 3.3and Fig. 3.4).
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Figure 3.5. Dose-d epen dent inhib ition of l~' I ·,\ S Fl\' hiutli ul,:10 Ih' IlG2 celts h~·
woodchu ck Ig rnlctiOIlS with l1ll.Ii·r\SG I'J{ at llU:Lnl ihOilics illtlu n ·t1by \VII V iulrct lon .
Parefcrmejdehyde-treated HcpG2 cells (2,-1' IO'cdls'!ilssayl In'l'l' incubated withincreasing
amounts of woodchuck Ig ranging from 2 to Suu jIg protcin/assav(2UIlg/mll ll :; mglmll
The Ig fractions were purified 11'0111 the scm of \\' IIV·inlcclo.:d woodchucks with (a llimal
No.2) or without (animalNo.1) llnti-ASGPR autoantilnulyncriviry Experimentalprocedure
as described in the legend to Figure .1.-1, Results arc expressed as pcrc\'lll (lfinhi bilhlll
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CulturedHcpG2 cells wereseededat threedifferent conccuuntions(1,000, I,SOO, and
3,000 cells/well) and allo wed to attach to the wells lo r -IllIIr before tile cxpcrimcms 'these
cell concentrationswere selected based all :1preliminarycxpcrimcntperformedin order to
determinethe cellconcentration at whieh there was a linear relationship between cell number
and the formation of MTT metabolites. As the amounts of available woodchuck anti-
ASGPR~positive sera were limited, a single concentration ofanti-ASGPR reactive lg fractions
at 60 Ilg Ig proteinper assay (1.2 lllglml) was selected for investigation. Selectionof IIIis 19
concentration was based on a previous report cvnlunting the CDC cOcct of human anti-
thyroglobulin autoantibodies (Chiovato cr nl., 19(3), In another controlcxperluunu, IIcII0 2
cells were incubated with ACor IC by using different couccmnuionsofm bbit coutplcmcm
at 1:5, I:10 and 1:20 to determinethe possible cytotoxic effect orcomplcmcur alone . It was
foundthatat concentrations of [:5 and 1:I0, ccllmctnbohsmof MTT was nol iutlucncedin
the presence of either ACor IC alone. Therefore, the complement concentration of 1:10
complement was chosen for our standard CDC assay. Results flour CDC assays arc
presented as percent cell lysis
Resultsshownin Fig. 3.6 Aiudicmc tha t nll tcstcd Ig Itucuonspurifiedby protein A-
chromatography from thc sera of woodchucks with WItv -induced an t i ~ASGPR activity
(animal No.2, No.3 anti No.4) werecytotoxiclor IIepG2 cells in thepresence of AC. The
induced effective cell killingranged from 2S% to 125% Resultsalso shnw that lh': Ig
fractions from differentanimals produced different degrees orcytolytic effect nl the same
numberof targetcells. Themean percentcelllysis when usingthese Ig lmctinns ranged nom
13.1% ± 10.3 (mean ± SO) to 18.8% :l:8. l . In addition, Ig fractions fromthe sameanimal
alsoproduceddifferent degrees of'cytolyticeffect when dillcrcnt -urnber of target cells were
used. Themeanpercent celllysis induced by each Ig fraction at ditlcrcmconcentrationsof
targetcellsranged from16,2% ± 5.5 to [7.%1± 11.2. There wasno linear relation between
thecytotoxiceffects of the testedIg fincuons nndthe numberortar gct cells used in the assay.
tsv
Figure 3,6, Cemplemeut-dependent CylutOlicity mediated by woodchuck Ig
fractions with ant i-ASGPR activity huluced by WIIV infection, Woodchuck Ig fractions
«(;0 fJll protein in 100 ~lfassaYJ purified by chromatography on protein A column(A) or
DEA E column(8 ) were added to HepG2cells seeded at 1,000, I ,SOOor 3,000 cells/well,
The IIIfractions were derivedfrom sera of'wltv-in fecred woodchucks withanti-ASGPR
activity (animals No.2, No.3 and No.4) or no anti·ASGPR activity (animal No,I), as
describedin the legend of Fig. 3.4. Subsequently, 10 IIIofnctivc (AC) or heat-inactivated
(lC) rabbit complement wasalsoadded Arrerinccbntionfor 2 h at 37· C, 100 ",1 of2% MTT
inPBS wasaddedandthe cellsiacubnted for illl additional J 11:11 37"C (see section 3.2.6 for
dL1ai ls), Results arc presented as the percent cytotoxicity of woodchuck Ig fractions in the
presenceof AC with cell su....-ival in thepresence of tC taken as 100%, The bars represent
the meanvalucse SD from two experimentseach done with 4 10 5 samples
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Overall, theseresultssuggestthatthere isa highindividualvariabilityin the CDCassayofthe
lg fractions fromthe woodchuckswithWj-lv-induccd nn!i-ASGPRactivity.
Fig. 3.6A also shows thai the control woodchuckIg fraction (derivedfrom anti-
ASGPR-nonactive seraof WI-IV-infectcd animal No. I ) did not producecytotoxiceffectin
the presenceof AC (less than3%), exceptwhen3,000 target cellswere usedfor the tcst
(9.4%). Statistical analysis of thevaluesof percent cell lysis inducedby Ig fractionsof anti-
ASGPR positiveseraand thosefromconrrcllg fractions revealed that the differencebetween
themwassignificant (x.1 test, /, c 0,05).
Sincethe Jgfracrions ofwoodehucksera purifiedby proteinA-chromatographymay
mainly contain IgO-like tg. it was of interest to examine whether other Ig classesor
subclassesmay contribute(Q the hcpatocytolyticeffect. For these purpose,woodchuck Ig
fractions purified by DEAE-chromatography, which should contain all the classes of
woodchuck Igs, wereused for testing. fig . 3.68 shows that the percent celllysisproduced
bytheseIg fractionsfromthe pool ofnnli-ASGPR-reaclivesera rangedfrom8.9% :J:: OJ to
12.1% ± 0.6 (mean ± SD). In contrast, the control Ig fractions punned by DEAE-
chromatographyfrom8nti-ASG/'R-nonrc<lctivesera produceda percent lysisof 0.1% :l:0.1
to 1,7% ± 1.5. Statistical analysis showeda signiftc.1nt differencein percent cytolysisbetween
cells tested withanti-ASGPRpositive versus negative Ig fractions (X! test, P<0.05).
Comparisonof tile cytolysis percentages obtainedusing lg fractionsisolated by different
methods (3.6A and Fig.J .6B) indicatedthat the overall cytotoxic effects of Ig fractions
purifiedby proteinAchromatography (the meanof cytolysis rangedfrom 13.1 to 18.8%.)
werehigherthan thoseof fractionspurified byDEAE-chromatography(the meanofcytolysis
ranged from 8.9 to 12.1%.). This suggest that the cytotoxic antibodies capable of
complement activation arc enriched ill the IgG-like class ill the sera wilh anti-ASGPR-
reactivity inducedbyWHY infection
It was very surprisingthat guinea pig lgs isolated from the antiseraraised againsl
lCi l
wASGPR, rASGPR and rASGPR subunits did nOI reveal any complcmcut-mcdintcd
cytotoxicity to HepG2cells under theassayconditions describedabove. However, it is worth
mentioning thaia CDCeffect of'Igfractionsfrom anli-wASGPRantiserumhas been observed
by other investigators in this laboratory when 8,000 target 1-1cpG2 cells were used
Experience gained in the course of the present work suggests Ihal CDC' induced by Ig
fractions from anti·ASGPR positive woodchuck scm is highly dependent on the assay
conditions (e.g., numbcr oft argetcells), It ispossible that a similar situation may cxist in the
case of'Ig fractions fromguinea pig antisera
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3.4. DISCUSSIONS
3.4.1. AIIIi-ASGPRAllliltotly·M edii ltell lllhilJil ion of Ligand Uililling to Pur ifi ed and
heplllocylt Surf a ce-llolllld ASGP H,
Ligardbindingsiteson ASGPRmoleculesin humanand rat origin arcimmunogenic
(I1arfordetal.,1982. SchwartzcraI., 1981a; 1983). Someof the antibodiesdirected to the
MllJlcreccptororreceplorsuhunitscan inbibit ligandbindingto bothpurified and hepatocyte
plasma membrane-associated ASGPR. Our findings revealedthat antibodiesraised against
purified wASGPR, rASGPR andthe 41·kDa subunit of rASGPRhad the ability to inhibit
A!illP hindi"!lto affinitypurified receptors. as wdl as to ASGI)R on woodchuck bepatocytes
and humanHcpG2 cells. Theseresultssuggesttbar the dominant immunogenic cpiropes of
,heligand binding shesorthe epitopcs related to theligandbindi ng onhepaticASGPRfrom
woodchuck,rabbit andhumanare similar to eachother. Thisnotionis consistent withthe
observation that human, rat, mouse, as well as chicken ASGPRs have homologous
carbohydrate bindingdomainswhich areaccessible on theextracellaar sideofhepatocytes
(Spies, 1990j
In addition, two other illlereSlin[lresults wereobtained in thecourse of this study.
First. the 40-and 47·kDa subuaitsofwASGPRand rASGIJRarc immunogeeieallydistinct.
Anti·40·kDaantiserumonly recognizedthe 4(}.kDa subum and theant i~4HDa antiserum
reacted only with the 47-kDa polypeptidesof the ASGPR, either purified soluble or
Illembrane.bou~d receptors, asshownby Western blotting (see summaryin Table 1.4).
However,the19 fractionsfromboth anti-subunit(anli·40. l.:Da or anti-41~kDa) antiseracould
completely (100%) inhibit ASOP birding to ASGPR on hcpatocytes (Fig. 3.5.). This
iedicates tllalblockingone of'thcsubunits by anlibody is seflicient tc abolishliga nd blnding
tomembrane-associatedASGPR. On this basis. weconcludethat bothsubunitsofw ASGPR
onwoodchuck hepnocytcs formthe ligandbinding site ol the receptor. Alternatively, it is
Hi.•
alsopossible that thereis a distinct binding siteon eachof,hc subunits of wt\SGPIt, but the
specialconfigurationfor ligand bindingis suchihatbindingof antibody 10 oncofthe subunits
blocks ormodulates the ligandbindingactivityoft he secondsubunit, Thesepossibilitiesare
supportedby the findings that the expression ofbath themajor lind minor subuni tsof'human
ASGPRonthe surface o f'transfcc tcdmurine Ilbroblast cellsis n 'ljllired for the binding of 11\1_
ASOR (Shia and Lodish, 1939).
Second, it appears that the ligand binding sue or a structure related to theligand
bindingsite on the 47-kDa·subunit of the purified wASGPR is notacce ssible to antibodies
It wa s demo nstrated in Fig. 3.2 lindr ig . 3.3 that lg fractions from an ti·47-kDll nmlscrum
could notblock ligand bindingto IhCIl'.l ritk'd wASGPRorrASGPR,althoughthe Ig fractions
from anti·40-kDaantiserumdid so, This inaccessibility might becaused byiI confornuuion
changedue10 receptor purilcation orwhen receptorwasilllllObiliA'd o n themicrorircr plates
for ligandbinding study. It has bL'C1l reported that the scnsitlvlty Iu redlll,;ing ugcuts is
differentamong thesubunitsof rat ASGP Jl,(l lalberg cr al., 1( 87). The minor subunits can
be denatured more eas ily. So, it ispossiblethat the binding sitcou the 47-kDll subunit of
wASGPRor rASGPR mighthave beendenatured in thecourse of'reccp tor purificutionor due
to coating the recepto r onto th e plates. Howeve r, it is ev en more likely tha t thelig and
bindingsre on the47-kD a subunit ofwA SGPRor rASGPRwashidden dueto the lilCt thai
purified ASGPR molecules are highly aggregated . This possibility is suppor ted by our
previousobservationthat thereis a lowexpression of47-kDa polypept ideson thc surfac e of
purifiedrASGPRmacromolecules (Fig. 1.4)
Inthe context of't hcabove intcrprctanonand inview uflhn resultsshowing that IS
fractionsftom anli·40-kDa auis erumcould complctciyinhibit ligand binding to the nflnlty-
purified ASGPR, it is reasonable to con sider that the observed lignnd.rcccptor binding
kinetics(Fig. 1.7)may reflectthe activity or tile 40-kIJasub unitonly. Inother words. the
ligandbindingvalues(i.e., K~and B,.." sec section 1.3.1.2.2) determined using a solid-phase
,I'
assay mayonly characterize the binding between ligandand the 40-kDa subunit ofpurified
wASGPR orrASGPR, but notthe whole naturalreceptormolecule,It couldbeexpectedthat
binding mediatedbythehepatocyte plasma membrane-boundASGPRwouldbe me reefficient
Ihanthatexpresedbypurif:edreceptors. In theformer ease, bothsubunitsof wASGPR or
rASGPRwould conributc toligandbinding
Our rcsu'rsrevealedthat thelg fractions fromwoodchuck sera with anti-ASGPR
autoantibody induced by WHV infection also inhibitedligand binding to membrane-bound
ASGPR This suggests thatthe ligandbinding sites ofwASGPR are autoimmunogenio
Therefore, it is possible that the autoantibodies to ASGPR caninterfere with wASGPR
rcccgninen of specific ligands tn I'; WJ and, thereby, may contribute 10 inhibitionof ASGP
endocytosis and accumulation of serum ASGI'. Hyperasialoglyeoprotcinemia has been
observed in patienls with cirrhosis and liver cell cercinoma (Sawarrure et aI., 1984)
Administering a single dose of galactosamine could also experimentally induce
byperasialoglycoprotcincmia intile rat{Sawamurect al. 1(81). Themechanismresponsible
forthis phenomenon is not dear at present . However,the authors found that the levelsof
ASGPRexpressedonthe hepaocytesofcitherpatients orexperimental ratswere decreased
comparedwith thecontrolvalues. Inaddition,the distributio n ofhepaticASGPRwasalso
fou nd abnormal inthepatient. with cirrhosis andHCC byother researcherstjsu rgesser al.,
[992; ~Iyodo et ~L, 1993). Moreover, ami·ASaPR autoantibody could be detected in
patients wilh chronicliverdisorders {Mcfarlaneeral., 1(86). Therefore, anyfactors leading
tothe redaction orASGPRexpression Oil hepatccytcs. dysfunr nonof ASGPRand irductjcn
of ASGPR loss lIIay comrbute to the development of hyperasialoglycoproteinemia.
Aecordingto our observationsand thereport of'Schwartzet al. (1'>86), antibody binding to
ASGPR onHcpG2cells mvitro couldresult inthe blocking ofligand-receptor binding or
antibody-induced ASGPR loss. However. inthe courseof thepresent study it was also
observedthat the ability lor ligand bil1dingstillremainedin thewASGPRassociatedwith
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purified hepatic plasma membranes from WI-IV·inlccted animals (data not shown in this
thesis), Analysis o f oneof these animals showed a high level of allli-ASGPR antibodies illthe
serum. Moreover, that the anti·ASGPR antibodycould bind to the membrane-associated
wASGPRil/ I'im was demonstrated in thiswoodchuck(data not shown). Th ese ubscr....atinns
suggest thai WHY-induced anli-A$G IIRrnuoautibodicsmuyblock the ligandbinding sites
of ASGPR onsome of the hepntocytes. butprobnblynotlUI allof'thc1ll,.1latoc ytes Therefore.
probablythe majorityof the ligand bindingsites on ASGPR molecules in the whole liver need
to bebloc kedinorder to produce any serious effect. The ill \'h'o pathogenic cllcct induced
by autoa ntibodyto ASGPR inthe cou rseof'hepadnavirnlinfection requir e s further studies.
particular ly inrelation to ligand·ASGP Rbinding
In addition, wealso found that there appearedto besomediversity muong Ihe animals
in theautoa ntbody-respcnsc 10the ligand binding siresofwI\ SGPR. Fig. ),4 shows that Ig
fractions fromanimal No.4 did not dis playany lnbiblto ry ellccI on ligand bindingIU IlcllG2
cells. Since theanti-ASGPR·rcactivity inthesera ofanililaI No.4 (5.60/. ± 0, 9%. mean 1 Sf).
ASGPR binding activity determined by RIA) wassimilar to ihat oranima l No,2 (6.1%.L
0.9%) and No.3(7.6'10± 1.3%), one explanation lor this result may be tha t a very low level
of oreven noanti-ASGPR autoantibody specificallydirected aguiustthe ligand hinding sites
was trigger ed in this animal, Me chanisms of induction or lignnd-binding-sue-s pc iflc
autoantibodies in the course of hepadnnviral inlcction require further detailed analysis by
usirg the woodchuck experimental system.
3.4.2. IJ cpaloeYloloxicity or l\ nt i-/\SG l' n Autonntibodlvs Induced in thc Course of
W IIVlnfeelion.
On e of the mechanisms by which autoantibody mny induce cell killing is by
complement-dependcnt-cytoroxlchy (CDC). It has been found that orgnn-spc ciflc
autoantibodies (e.g., directed to pancreatic islets. thyroid epithelial. gas tric parie tal and
1(,(,
adrenal fasciculata) ofrgGclasscanfix complemt:l1t (Deanet aI., 1983), suggestingthat these
autoantibodiesmay induce largclcell killingthrough CDC. 111CCDCeffect orautoantibodies
is usuallymeasuredlIS celllysis byusing labelled target cells{e.g.,ller or europium labelling)
(CuiandBystryn, 1992;Cui et aI., 1993), Interestingly, the value ofcelllysis determined by
usingthese methods is usually lower than 50%. For example, Chiovato et al (1993)used
IICr_labellingofprimarycultures of humanthyroid cellsas thetargets to analyzethe specific
CDCeffectof'autoantitodies (Ihl{} fraction) from seraofpatients with atrophic lhyroiditis and
goitrous Hashimoto's thyroiditis. The authors found that specificlysis of the target cells
ranged from5 to 15%when concentrationsof 1or 2 mg19protein/ml were used. The
interassay coefficient orverlauon was vcI)'high (40%)in theirexperiments.
Inourstudies, Ig fractions with m~j-ASGJ)R-reac ljvily from seraof woodchucks with
WI-IVinfection displayedcytotoxicity to HepG2 cellsranging between 12 and 25% celllysis
at anlg concentration ofl ,2 mg/ml. This result was comparable or evenexcelled thatgiven
by other organ-spccilie autoantibodiesanalyzed byParkes el at. (1994). These low values
of cytotoxicity may suggest that the degree of CDC mediated by naturally occurring
autoantibodytestedunder ill vitroconditions areunlikelyto reach veryhigh values. Oneof
thepos iblereasons canbe that antibodybindingto ASGPRon HepG2 cells resulted in the
receptor loss from thesurface. as described bySchwartz(1986),or induced receptor-
mediated antibody endocytosis. Another reason can be Illat some of the target cells are
expressing lower amounts of amigen on tilesurfacethan others. For cultured cells employed
in thestudies,itwas alsopossibletlmt 11Q! nil the cels wereatthe same stage ouhe cellcycle.
Therefore, targetantigenexpression mightvaryamong thesecelts. In the case of ASGPR
expression onHepG2 cells, wehave analyzed the cellsby immunofluorescent staining using
an!i-ASGPR antibodies(seesection 1.3.2) lind frequently observed that some orthe cellshad
muchlowerstaining intensitythanothers, suggestinga heterogeneity in ASGPRexpression
amcung thesecells. Toconfirmthis.Iimherworkshould bedone by comparing the numbers
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o f ASGPR molecules expressed on the surface of ~vat lk:)"l'S bef o re and 1I1l~'f antibody
treatm ents. To distinguish the possibility of anrlbcdy-lnduccd receptor loss (lr u..'CL111l1r·
mediatedantibodyendocytosis. the incubationssho uldbe done at a lo wer temperature (c.g ,
IO·C).
Like the ligand binding inhibition effects. the CD(' cucc rs of lg fractions from
differentwoodchucks varied. Such varl.1bilitycould bec;IUS~oJ by dillc rClIcL'S in aninily of lhe
au toa ntibodies produced by diffcrent animals In addition. results from CDC esr erillll.."IlIs
using the guineapig IS fractionsenriched with antibodies :l~linSI wASGI· R . rASGI' R and
subunitsofrASGPR revealed that antibodiesderived from immunized animals did not show
evident cytotoxiceffects on HepG2 cells. Oneprobable explanation lor such results may be
the differences in Ig classcomposition or cphopc-spcciflcity or the anli·ASG PRantibodies
produced by guineapigs humunized withASGPRccmpnrcd witliwoodchuck aununubodlcs
induced by\VHVinfection. It is also possible that ouraSSl IY conditionswere not suitable ftlJ
the detectionofCOCeffectsinduced by gu ineapig antiboUics In fact, in a most r~'Ccn l series
of experiments, it wasfoundlhal some guinea pig :llllibodic~ (e g , anti.wASG I·R) tl i~pl:lyal
CDC effects under modified assay conditions (i.e.• using 8 ~ 10' cultured woodchuck
hepatocyteslassay). It hasalsobeen demonstrated thaiguineapigantiserum 10 rASGPR were
cytol oxic to hepatocytes isolated from the liver biopsiesof palicnt5 with chronic ht.-r-"titis R
in the presence cractlvecomplement using a microcytotoxicityassay (Michalak ~1 al., 199 5)
,,.
3.5. CONCLUSION
These in \~/m studieseucmprcd to determinethepossible pathobiological effectsof
antibodies to theASGPR. either inducedalter hepadnavirusinvasion orgenerated due to
immunillltion with the aflinity-puriJicd receptor. Theinvesligationsrevealedtwo mechanisms
by which the antibodies nmycontribute to liver dysfunction
Firstly, both the hcpadnavhus- nnd ASGPR·inducedantibodies were able to recognize
the receptor ligandbinding sitesorstructures located inthe proximity of tilebindingsites and
specifically inhibitasia'oglycoproreln bindingto the purified ASGP R and, more importantly,
to the receptor associatedwith the hepatocyte sunnce. Thisfindingsuggests that tile
naturally occurring anti·ASGPR autoantibodies may interfere with recognition and
endocytosis of the circulating ASGP by hepatocytcs. According to this scenario,it is
reasonable to cspcct that under someextremeconditions. the autoantibody may lcad to such
disorder of the physiological removal of dcsialylated proteins that
hyperasialogtyccproteinenuamayresult.
Secondly,anli-ASGI'R autoantibodies induced inthe courseofWHV infection have
the abilityto activate complement and mediatecompleucrn-dcpcndern killing of'hepatocytes
ill vitro. Thismechanism maydirectly contribute to liverinjuryin viralhepatitis. The true
pathogenic significance of this flndingrequires funher evaluation in anill \ ' ; \"(1 system. In
addition, othercytotoxic mechanisms of virus-inducedASGPRspecificautoimmunity (Le.,
T cellmediatedresponses) need tobeelucidated in furthe r investigations. The woodchuck
model of WHV·lriggercd ASGPR-specilic nutcinmunhyshould contribute to our bener
understandingofthe complexityoftile mechanismsleading to hepatocytedamage and the
development orchronlc liver disease in viralhepatitis
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Although it is generally accepted that viral injections can initiate o r enhance
autoimmune phenomena or autoimmunediseaxes, the pathogenic mechanisms(\1'this process
and the relationship betweenviral invasionand autoimmunityremains under investigation
Studies involved in this thesis have touched on a lewof the1)1I ~'stiO IlS about the biolugicalnn d
patholo gical consequences orhepadnavhul infccrionnnd the virus-induced liver-specific
autoantibodyresponse. Based on the results ofthe presentwork andcurrentknowledgeon
this issue , further ;1I 1'j\'(J studieson two of the above topicswhichshould beaddressed arc
proposed .
4.1. In Vivo Experiments 10 Stud y Anli- ASGI' J(-J\h'llialt'd Liver Inj ury Throug h
Enlargemellt ofAutoanlibody R CSIJOllSl ' Agnillsl ASGI' lt.
One of the major purposes of the present work was to evaluate the uppcurancc,
specificity and biological or pathologicaleffects ofautonutibodiesagainst hepatic ASGI'R in
woodchucks with WHY infection. Results prescracd in this thesis show that the
experimentally induced WHY infection triggers the appearance of Hnti-ASGPR
autoa ntibodies. Results also reve aled that wl\SGPR W<lS expressed un the surface of
bepatocytesand is accessible toboth ligand (c.g., I)-Gat andI\SGI's) and specificantibodies,
suggesting thai hepatocyte injuryor dysflmction might be inducedbyanli· i\SGPR antibodies
whenplasma membrane associated hepatic wi\SGPR becomes the target of'uuronuribody
response . Ofconsiderable interest in this regard was our finding that the iv varo reactions
between ASGPR on IlepG2 cells and specificantibodies resultcd in the lysis of'bcpruocytcs
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in the presence of complementlindin the inhibition of'Hgund binding. However, whether
similar CDC effects toward woodchuckhcparccytcs ill vnro could be prcducedable and
whether pathobiological e ffects of anti-ASGPR autoamibodies could occur in vivo remains
to be determined.
Animalmodels of ffver injuryarc usually established by treatment withchemicals (e.g.,
CCI~, endotoxin,galactosamine andacetaminophen)(Arthur,et al., 1985, 1988; Laskin, 1990;
Winwood and Arthur, 1( 93). Attemptsto establishanimalmodelsof liver lesions mediated
by liver-specificautoimmune reactions, also calledcxpcrimcmnlautoimmunehepatitis, have
beenmade by injection ornnimalswith liver antigens ine FA (for reviewsec Lohse, 1991).
II modelof chronicautoimmune hcpntiris wasestablishcd byrepeated injection of rabbits with
human liverantigens in CFII. 1I1I\ibodics against hepatic tissueantigens were detected both
in the circulation amion the isolated hcpatocytcs. Lymphocyte proliferation in response to
liver antigen preparations was also observed in thesc animals. The target antigens were
identified as LSI' or its subfraction L1'2. Experimental nutciuunune hepatitis has also been
established in mice by immunization with allogenic or syngcnic liver homogenate as
immunogen. Results ofpassvc transfer experiments suggest the Importance of T cells in the
pathogenesis of'uuroirnmunc hepatitis
III 1'; 1'0 studieson the liver damage caused by antibodies arc usuallycarried out by
intravenousinjection of antibodies into animals, Porullat'l til (1987) prepared a monoclonal
antibody ngninst rabhit liver-specific protein with a molecular mess of 43 klja. After
intravenous injection of this antibody into rabbits, an increase of river enzyme (LDH, an
indicatorofliver damage) levels in the sera and hepatocyte necrosiswere found, suggesting
hepaticdamageinducedby thisantibody. The hepatotoxicity of another monoclonalantibody
riscdagainstrat liver-specificmembrane component whha molecular mass of 105 kOn was
demonstrated illl'im byIkedaand Kurcbayashi (1990). They injected intravenously anti-105-
kOa antibody to rats and detected the appearance of acute massive hepatocellularnecrosis
which was associated with an increase in liver enzyme (:\ 1.'1' and AST) activities and II
decrease in complement concenmulon in the sera of these nits. C3 deposition in the
hepatocyte cytoplasm or at the surface of degenerated and necrotic liver cells was also
identified. Theseresultssuggestedthat hepatocyte il~u ry caused hy this monoclonal antibody
was due to ccrnplemem-mcdiatcdimmune atmck.
The ill vivo studies of antibodies against ASGI'R through 1/1 situ perfusionofmt
liverswith polyclona1guinea pig anti-ASGPR antibodies or urouoclonalanli-hllnmn-ASGllR
antibodywere performedby Mcf-arlane l' l lI l (1990). They showed the dcpositionof'nrui-
ASGPR antibodies on liver cells in the periportal areas The muhors postulated thnt the
periponalHvcrcellnecrosis in pmicmswith AlIll11ighl be caused by an equivalent deposition
of natural anli·ASGPR autoantibodies. However, they did not provide histological or
immunohistochemical evidence to demonstrate hepatocyte injuryaflcr IIISi l 1i pcrfhshm of the
anti-ASGPR antibodies. In addition, they reported lh'll no hcputocyrc damage W;IS observed
in liversof guineapigsimmunizedwith rASGPR, although theseanimals produced high levels
of anti·ASGPR antibodies. In our present studies un the woodchucks with experimental
WHYinfection, it was found that the scrumnutomuiborticsagainst ASGI'R were detectable
aRerrecoveryfrom acuc viral hepatitis. Also, no biochemicalevidence of liverinjury could
bedetectedin theseSLAI-I animals, although minimul intlllllulUltOlychanges were observed
Therefore, if there was a pathogenic effect of virus-induced llntj·ASGI'R autnnntibodics, it
is likely that such effect could be transient and not detectable using tho current lllunitoring
technique.
To verify the pathological significance of anti-i\ SGI'R autoantibodies induced by
WHYinfection, valuable information may be obtained by injectionof wltv.inIccted animals
with affinity-purified ASGPR. This may enhance the autoimmuneresponses to ASGPR in
these animals. For this purpose, two sets of illl'il'fJ experiments could be proposed First,
to enhance the degree of anti-ASGPR autoantibody response originally induced by Wi lY
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infection. animals withchronic viral hepatitis willbe injectcd withafflnity-purifledASGPR
inadjuvant {CFA for the fin;tinjection and IFA for the remaininginjections}. Serial sera will
be collected weekly or biweekly and tested lor anti-ASGPR activity,marker enzymes for liver
injury(e.g.•ALT and LDB)andserum complementlevels. A liver biopsy will be performed
lit the timewhen biochemical indicators of liver injury appear. Autopsy will be considered
insomeoft heanimals to examine histological changes and to identify the specific deposition
and biological effects ofanti·ASGPRantibodieson the hcpa.ocytes. Acontrol group willbe
set up by injcctionof chronically infected animals with adjuvantsalone. Second. to examine
the specificityof hepatocyte damage in woodchucks. a passive transfer experiment will be
performedby usinganti·I\SGPR antibodies triggered by WHV infection. These antibodies
willbe purified by amni!y chromatography all ASGPR and injected into healthywoodchucks
or animals withWHYinlcction. Followinginjection. serum sampleswill be collected for the
detection of ALT. complement andanli-ASGPR antibody levels. Histological examination
of the liver tissue will be done to connrm thc liver damage. Results from these ill l'il 'O
experiments may provide some evidence to reveal the pathogenic effects of anti-ASGPR
autoantibodies in the course of viral hepatitis
4.2. II/Vim Experiments and Clinical luvcsrtgattc » 10 Study the Rd ntiollshill Between
Antj·ASGPR Autnantihudy Rl.'SIlOIlSennd Vir:ll l·l' rs isll.'nrl.',
Theevidence to date is verystrong that a causative relationshipexists between host
immune responseand chronic hepatitis [) (for a review. see Chisari and Ferrari, 1995a). It
has been shown that the strength and speciticity of the T cell response to HBVcould be
imponant for viral clearance or viral persistence, although the mechanismscontrolling the
strength and specificity in different individuals are unknown. In view of the association
between the presenceof autoantibody reactivity to ASGPR in preinoculation sera and the
developmentof chronic WHYinfection,it would be intriguing to study viralpersistence in
tn
anim:lIs ....ith fiver-specillc autoimrmmc responses . Due rc urc prcc.xiSlcnceofliver-specific
lUIoimmune responses. lhehosl: in~ syscmmay1101 n-sp:.nd \0 \ira!antig\.'I1S in IImanner
that wouldiimit the spreadof infettion. Experiments testing the WIIV inf\.'Oion rate in
animals withpre-existing 8lI\i-ASGPRacti\;ty should be p...,.-fonncd:lS discuS-.<;j..,j in part II
In these ;1/V;l 'l:/ expenmems, perhaps. the mostdillicult pan is10 pcoducc experimental
autoimmune response 10 A.SGPR in hcalthy woodchucks. Aceording ro rour CllfTeI1I
experience,anti-ASGPR antibodies a n be induced by imlllunization of woodchucks wjlh
purifiedrA.SGPR, The produced antibodiesrecognize epitcpcson both wASGI'R and
rASGPR. It is expected that inductionofan autoimmuneresponseto ASGI' R mayalsobe
achievedbyintroducingb actcria, parilsitcs or chcl11 ical ageuls inlo woodchucLs However,
whether thesameASGPRCpilOPCS will be recognized by tbeautcantioodicsproduced under
these artificia l conditionsand by WHV-inf\.'i:lion stillneeds to bedctcnnincd. The results
from these experiments will help us to ask Ihe right questionsand to ulldersland lhe
underlying basicmechanisms regardingthe pathogenic ruleof ASGI'R·spccific autoimmune
Last. but nol teasl. the conclusions from all these i ll I '/Ill e~Jll,:rimCl\ts should
eventuallylead us to performc1inic31 studes, such as in\,ot ig.l ling lhc incidl'flCC ofchronic
hepatitis B in individuals with the pl'cc!(isting ASGI' R-spcdflCautoimmune responses.and
hopefully allow the developmenl of newpreventive and 11h.-rap.'Ulic strategies for chronic
hepatitisB ,
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